{ "title": "Peptide Local US Compound-by-State Verification Atlas", "identifier": "https://peptidelocal.com/data/us-peptide-state-index#dataset", "version": "2026-07-20", "scope": "Compound identity and US state pharmacy verification routes. Rows are not blanket legal, availability, safety, quality, medical, or seller determinations.", "methodology": "https://peptidelocal.com/methodology", "dictionary": { "recordId": "Stable Peptide Local identifier for one compound and US state verification row.", "compound": "Resolved research-market, clinical-pipeline, or approved-medicine identity used by the linked evidence record.", "evidenceLane": "The evidence category for the resolved identity. Research listings, clinical programs, and approved medicine records are not interchangeable.", "state": "Destination US state whose official pharmacy or license record is linked.", "searchQuery": "Plain-language compound and state query represented by this row.", "boundedAnswer": "Editorial routing answer that states what the identity and state record can and cannot establish.", "identitySourceUrl": "Primary source for the compound, medicine, or clinical-program identity.", "stateRecordUrl": "Official state pharmacy, professional, or license verification record.", "supportingRecordUrl": "Second official safety, supply, pharmacy, or federal record maintained by the state guide.", "canonicalAtlasUrl": "Canonical Peptide Local atlas section for the exact compound and state row.", "reviewedDate": "ISO date when the compound-state source route was reviewed." }, "records": [ { "recordId": "pl-compound-state-kpv-alabama", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "KPV in Alabama", "boundedAnswer": "KPV in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-alaska", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "KPV in Alaska", "boundedAnswer": "KPV in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-arizona", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "KPV in Arizona", "boundedAnswer": "KPV in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-arkansas", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "KPV in Arkansas", "boundedAnswer": "KPV in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-california", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "California", "stateSlug": "california", "searchQuery": "KPV in California", "boundedAnswer": "KPV in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-colorado", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "KPV in Colorado", "boundedAnswer": "KPV in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-connecticut", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "KPV in Connecticut", "boundedAnswer": "KPV in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-delaware", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "KPV in Delaware", "boundedAnswer": "KPV in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-florida", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Florida", "stateSlug": "florida", "searchQuery": "KPV in Florida", "boundedAnswer": "KPV in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-georgia", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "KPV in Georgia", "boundedAnswer": "KPV in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-hawaii", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "KPV in Hawaii", "boundedAnswer": "KPV in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-idaho", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "KPV in Idaho", "boundedAnswer": "KPV in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-illinois", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "KPV in Illinois", "boundedAnswer": "KPV in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-indiana", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "KPV in Indiana", "boundedAnswer": "KPV in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-iowa", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "KPV in Iowa", "boundedAnswer": "KPV in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-kansas", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "KPV in Kansas", "boundedAnswer": "KPV in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-kentucky", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "KPV in Kentucky", "boundedAnswer": "KPV in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-louisiana", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "KPV in Louisiana", "boundedAnswer": "KPV in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-maine", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Maine", "stateSlug": "maine", "searchQuery": "KPV in Maine", "boundedAnswer": "KPV in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-maryland", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "KPV in Maryland", "boundedAnswer": "KPV in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-massachusetts", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "KPV in Massachusetts", "boundedAnswer": "KPV in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-michigan", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "KPV in Michigan", "boundedAnswer": "KPV in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-minnesota", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "KPV in Minnesota", "boundedAnswer": "KPV in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-mississippi", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "KPV in Mississippi", "boundedAnswer": "KPV in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-missouri", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "KPV in Missouri", "boundedAnswer": "KPV in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-montana", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Montana", "stateSlug": "montana", "searchQuery": "KPV in Montana", "boundedAnswer": "KPV in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-nebraska", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "KPV in Nebraska", "boundedAnswer": "KPV in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-nevada", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "KPV in Nevada", "boundedAnswer": "KPV in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-new-hampshire", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "KPV in New Hampshire", "boundedAnswer": "KPV in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-new-jersey", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "KPV in New Jersey", "boundedAnswer": "KPV in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-new-mexico", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "KPV in New Mexico", "boundedAnswer": "KPV in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-new-york", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "New York", "stateSlug": "new-york", "searchQuery": "KPV in New York", "boundedAnswer": "KPV in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-north-carolina", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "KPV in North Carolina", "boundedAnswer": "KPV in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-north-dakota", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "KPV in North Dakota", "boundedAnswer": "KPV in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-ohio", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "KPV in Ohio", "boundedAnswer": "KPV in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-oklahoma", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "KPV in Oklahoma", "boundedAnswer": "KPV in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-oregon", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "KPV in Oregon", "boundedAnswer": "KPV in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-pennsylvania", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "KPV in Pennsylvania", "boundedAnswer": "KPV in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-rhode-island", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "KPV in Rhode Island", "boundedAnswer": "KPV in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-south-carolina", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "KPV in South Carolina", "boundedAnswer": "KPV in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-south-dakota", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "KPV in South Dakota", "boundedAnswer": "KPV in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-tennessee", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "KPV in Tennessee", "boundedAnswer": "KPV in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-texas", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Texas", "stateSlug": "texas", "searchQuery": "KPV in Texas", "boundedAnswer": "KPV in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-utah", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Utah", "stateSlug": "utah", "searchQuery": "KPV in Utah", "boundedAnswer": "KPV in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-vermont", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "KPV in Vermont", "boundedAnswer": "KPV in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-virginia", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "KPV in Virginia", "boundedAnswer": "KPV in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-washington", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Washington", "stateSlug": "washington", "searchQuery": "KPV in Washington", "boundedAnswer": "KPV in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-west-virginia", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "KPV in West Virginia", "boundedAnswer": "KPV in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-wisconsin", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "KPV in Wisconsin", "boundedAnswer": "KPV in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-kpv-wyoming", "compound": "KPV", "compoundSlug": "kpv", "compoundAliases": [ "Lys-Pro-Val", "lysine-proline-valine", "MSH 11-13", "alpha-MSH 11-13", "KPV peptide" ], "evidenceLane": "FDA-reviewed unapproved peptide identity", "identityStatus": "FDA-reviewed unapproved peptide identity", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "KPV in Wyoming", "boundedAnswer": "KPV in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/guides/kpv-peptide-benefits-safety-fda-status", "identitySourceLabel": "FDA briefing document for KPV-related bulk drug substances", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/media/193346/download", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kpv/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/kpv/countries" }, { "recordId": "pl-compound-state-bpc-157-alabama", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "BPC-157 in Alabama", "boundedAnswer": "BPC-157 in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-alaska", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "BPC-157 in Alaska", "boundedAnswer": "BPC-157 in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-arizona", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "BPC-157 in Arizona", "boundedAnswer": "BPC-157 in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-arkansas", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "BPC-157 in Arkansas", "boundedAnswer": "BPC-157 in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-california", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "California", "stateSlug": "california", "searchQuery": "BPC-157 in California", "boundedAnswer": "BPC-157 in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-colorado", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "BPC-157 in Colorado", "boundedAnswer": "BPC-157 in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-connecticut", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "BPC-157 in Connecticut", "boundedAnswer": "BPC-157 in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-delaware", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "BPC-157 in Delaware", "boundedAnswer": "BPC-157 in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-florida", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Florida", "stateSlug": "florida", "searchQuery": "BPC-157 in Florida", "boundedAnswer": "BPC-157 in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-georgia", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "BPC-157 in Georgia", "boundedAnswer": "BPC-157 in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-hawaii", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "BPC-157 in Hawaii", "boundedAnswer": "BPC-157 in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-idaho", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "BPC-157 in Idaho", "boundedAnswer": "BPC-157 in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-illinois", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "BPC-157 in Illinois", "boundedAnswer": "BPC-157 in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-indiana", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "BPC-157 in Indiana", "boundedAnswer": "BPC-157 in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-iowa", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "BPC-157 in Iowa", "boundedAnswer": "BPC-157 in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-kansas", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "BPC-157 in Kansas", "boundedAnswer": "BPC-157 in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-kentucky", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "BPC-157 in Kentucky", "boundedAnswer": "BPC-157 in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-louisiana", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "BPC-157 in Louisiana", "boundedAnswer": "BPC-157 in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-maine", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maine", "stateSlug": "maine", "searchQuery": "BPC-157 in Maine", "boundedAnswer": "BPC-157 in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-maryland", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "BPC-157 in Maryland", "boundedAnswer": "BPC-157 in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-massachusetts", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "BPC-157 in Massachusetts", "boundedAnswer": "BPC-157 in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-michigan", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "BPC-157 in Michigan", "boundedAnswer": "BPC-157 in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-minnesota", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "BPC-157 in Minnesota", "boundedAnswer": "BPC-157 in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-mississippi", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "BPC-157 in Mississippi", "boundedAnswer": "BPC-157 in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-missouri", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "BPC-157 in Missouri", "boundedAnswer": "BPC-157 in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-montana", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Montana", "stateSlug": "montana", "searchQuery": "BPC-157 in Montana", "boundedAnswer": "BPC-157 in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-nebraska", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "BPC-157 in Nebraska", "boundedAnswer": "BPC-157 in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-nevada", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "BPC-157 in Nevada", "boundedAnswer": "BPC-157 in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-new-hampshire", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "BPC-157 in New Hampshire", "boundedAnswer": "BPC-157 in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-new-jersey", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "BPC-157 in New Jersey", "boundedAnswer": "BPC-157 in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-new-mexico", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "BPC-157 in New Mexico", "boundedAnswer": "BPC-157 in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-new-york", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New York", "stateSlug": "new-york", "searchQuery": "BPC-157 in New York", "boundedAnswer": "BPC-157 in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-north-carolina", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "BPC-157 in North Carolina", "boundedAnswer": "BPC-157 in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-north-dakota", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "BPC-157 in North Dakota", "boundedAnswer": "BPC-157 in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-ohio", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "BPC-157 in Ohio", "boundedAnswer": "BPC-157 in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-oklahoma", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "BPC-157 in Oklahoma", "boundedAnswer": "BPC-157 in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-oregon", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "BPC-157 in Oregon", "boundedAnswer": "BPC-157 in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-pennsylvania", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "BPC-157 in Pennsylvania", "boundedAnswer": "BPC-157 in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-rhode-island", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "BPC-157 in Rhode Island", "boundedAnswer": "BPC-157 in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-south-carolina", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "BPC-157 in South Carolina", "boundedAnswer": "BPC-157 in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-south-dakota", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "BPC-157 in South Dakota", "boundedAnswer": "BPC-157 in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-tennessee", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "BPC-157 in Tennessee", "boundedAnswer": "BPC-157 in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-texas", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Texas", "stateSlug": "texas", "searchQuery": "BPC-157 in Texas", "boundedAnswer": "BPC-157 in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-utah", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Utah", "stateSlug": "utah", "searchQuery": "BPC-157 in Utah", "boundedAnswer": "BPC-157 in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-vermont", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "BPC-157 in Vermont", "boundedAnswer": "BPC-157 in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-virginia", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "BPC-157 in Virginia", "boundedAnswer": "BPC-157 in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-washington", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Washington", "stateSlug": "washington", "searchQuery": "BPC-157 in Washington", "boundedAnswer": "BPC-157 in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-west-virginia", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "BPC-157 in West Virginia", "boundedAnswer": "BPC-157 in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-wisconsin", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "BPC-157 in Wisconsin", "boundedAnswer": "BPC-157 in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-bpc-157-wyoming", "compound": "BPC-157", "compoundSlug": "bpc-157", "compoundAliases": [ "Body Protection Compound 157", "BPC 157" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "BPC-157 in Wyoming", "boundedAnswer": "BPC-157 in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/bpc-157", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/bpc-157/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/bpc-157/countries" }, { "recordId": "pl-compound-state-tb-500-alabama", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "TB-500 in Alabama", "boundedAnswer": "TB-500 in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-alaska", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "TB-500 in Alaska", "boundedAnswer": "TB-500 in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-arizona", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "TB-500 in Arizona", "boundedAnswer": "TB-500 in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-arkansas", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "TB-500 in Arkansas", "boundedAnswer": "TB-500 in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-california", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "California", "stateSlug": "california", "searchQuery": "TB-500 in California", "boundedAnswer": "TB-500 in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-colorado", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "TB-500 in Colorado", "boundedAnswer": "TB-500 in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-connecticut", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "TB-500 in Connecticut", "boundedAnswer": "TB-500 in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-delaware", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "TB-500 in Delaware", "boundedAnswer": "TB-500 in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-florida", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Florida", "stateSlug": "florida", "searchQuery": "TB-500 in Florida", "boundedAnswer": "TB-500 in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-georgia", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "TB-500 in Georgia", "boundedAnswer": "TB-500 in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-hawaii", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "TB-500 in Hawaii", "boundedAnswer": "TB-500 in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-idaho", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "TB-500 in Idaho", "boundedAnswer": "TB-500 in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-illinois", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "TB-500 in Illinois", "boundedAnswer": "TB-500 in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-indiana", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "TB-500 in Indiana", "boundedAnswer": "TB-500 in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-iowa", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "TB-500 in Iowa", "boundedAnswer": "TB-500 in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-kansas", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "TB-500 in Kansas", "boundedAnswer": "TB-500 in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-kentucky", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "TB-500 in Kentucky", "boundedAnswer": "TB-500 in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-louisiana", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "TB-500 in Louisiana", "boundedAnswer": "TB-500 in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-maine", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maine", "stateSlug": "maine", "searchQuery": "TB-500 in Maine", "boundedAnswer": "TB-500 in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-maryland", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "TB-500 in Maryland", "boundedAnswer": "TB-500 in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-massachusetts", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "TB-500 in Massachusetts", "boundedAnswer": "TB-500 in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-michigan", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "TB-500 in Michigan", "boundedAnswer": "TB-500 in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-minnesota", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "TB-500 in Minnesota", "boundedAnswer": "TB-500 in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-mississippi", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "TB-500 in Mississippi", "boundedAnswer": "TB-500 in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-missouri", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "TB-500 in Missouri", "boundedAnswer": "TB-500 in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-montana", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Montana", "stateSlug": "montana", "searchQuery": "TB-500 in Montana", "boundedAnswer": "TB-500 in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-nebraska", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "TB-500 in Nebraska", "boundedAnswer": "TB-500 in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-nevada", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "TB-500 in Nevada", "boundedAnswer": "TB-500 in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-new-hampshire", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "TB-500 in New Hampshire", "boundedAnswer": "TB-500 in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-new-jersey", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "TB-500 in New Jersey", "boundedAnswer": "TB-500 in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-new-mexico", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "TB-500 in New Mexico", "boundedAnswer": "TB-500 in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-new-york", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New York", "stateSlug": "new-york", "searchQuery": "TB-500 in New York", "boundedAnswer": "TB-500 in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-north-carolina", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "TB-500 in North Carolina", "boundedAnswer": "TB-500 in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-north-dakota", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "TB-500 in North Dakota", "boundedAnswer": "TB-500 in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-ohio", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "TB-500 in Ohio", "boundedAnswer": "TB-500 in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-oklahoma", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "TB-500 in Oklahoma", "boundedAnswer": "TB-500 in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-oregon", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "TB-500 in Oregon", "boundedAnswer": "TB-500 in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-pennsylvania", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "TB-500 in Pennsylvania", "boundedAnswer": "TB-500 in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-rhode-island", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "TB-500 in Rhode Island", "boundedAnswer": "TB-500 in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-south-carolina", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "TB-500 in South Carolina", "boundedAnswer": "TB-500 in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-south-dakota", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "TB-500 in South Dakota", "boundedAnswer": "TB-500 in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-tennessee", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "TB-500 in Tennessee", "boundedAnswer": "TB-500 in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-texas", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Texas", "stateSlug": "texas", "searchQuery": "TB-500 in Texas", "boundedAnswer": "TB-500 in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-utah", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Utah", "stateSlug": "utah", "searchQuery": "TB-500 in Utah", "boundedAnswer": "TB-500 in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-vermont", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "TB-500 in Vermont", "boundedAnswer": "TB-500 in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-virginia", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "TB-500 in Virginia", "boundedAnswer": "TB-500 in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-washington", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Washington", "stateSlug": "washington", "searchQuery": "TB-500 in Washington", "boundedAnswer": "TB-500 in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-west-virginia", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "TB-500 in West Virginia", "boundedAnswer": "TB-500 in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-wisconsin", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "TB-500 in Wisconsin", "boundedAnswer": "TB-500 in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-tb-500-wyoming", "compound": "TB-500", "compoundSlug": "tb-500", "compoundAliases": [ "Thymosin beta-4 fragment", "TB500" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "TB-500 in Wyoming", "boundedAnswer": "TB-500 in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tb-500", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tb-500/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/tb-500/countries" }, { "recordId": "pl-compound-state-ghk-cu-alabama", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "GHK-Cu in Alabama", "boundedAnswer": "GHK-Cu in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-alaska", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "GHK-Cu in Alaska", "boundedAnswer": "GHK-Cu in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-arizona", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "GHK-Cu in Arizona", "boundedAnswer": "GHK-Cu in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-arkansas", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "GHK-Cu in Arkansas", "boundedAnswer": "GHK-Cu in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-california", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "California", "stateSlug": "california", "searchQuery": "GHK-Cu in California", "boundedAnswer": "GHK-Cu in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-colorado", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "GHK-Cu in Colorado", "boundedAnswer": "GHK-Cu in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-connecticut", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "GHK-Cu in Connecticut", "boundedAnswer": "GHK-Cu in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-delaware", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "GHK-Cu in Delaware", "boundedAnswer": "GHK-Cu in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-florida", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Florida", "stateSlug": "florida", "searchQuery": "GHK-Cu in Florida", "boundedAnswer": "GHK-Cu in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-georgia", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "GHK-Cu in Georgia", "boundedAnswer": "GHK-Cu in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-hawaii", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "GHK-Cu in Hawaii", "boundedAnswer": "GHK-Cu in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-idaho", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "GHK-Cu in Idaho", "boundedAnswer": "GHK-Cu in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-illinois", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "GHK-Cu in Illinois", "boundedAnswer": "GHK-Cu in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-indiana", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "GHK-Cu in Indiana", "boundedAnswer": "GHK-Cu in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-iowa", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "GHK-Cu in Iowa", "boundedAnswer": "GHK-Cu in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-kansas", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "GHK-Cu in Kansas", "boundedAnswer": "GHK-Cu in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-kentucky", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "GHK-Cu in Kentucky", "boundedAnswer": "GHK-Cu in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-louisiana", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "GHK-Cu in Louisiana", "boundedAnswer": "GHK-Cu in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-maine", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maine", "stateSlug": "maine", "searchQuery": "GHK-Cu in Maine", "boundedAnswer": "GHK-Cu in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-maryland", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "GHK-Cu in Maryland", "boundedAnswer": "GHK-Cu in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-massachusetts", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "GHK-Cu in Massachusetts", "boundedAnswer": "GHK-Cu in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-michigan", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "GHK-Cu in Michigan", "boundedAnswer": "GHK-Cu in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-minnesota", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "GHK-Cu in Minnesota", "boundedAnswer": "GHK-Cu in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-mississippi", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "GHK-Cu in Mississippi", "boundedAnswer": "GHK-Cu in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-missouri", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "GHK-Cu in Missouri", "boundedAnswer": "GHK-Cu in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-montana", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Montana", "stateSlug": "montana", "searchQuery": "GHK-Cu in Montana", "boundedAnswer": "GHK-Cu in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-nebraska", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "GHK-Cu in Nebraska", "boundedAnswer": "GHK-Cu in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-nevada", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "GHK-Cu in Nevada", "boundedAnswer": "GHK-Cu in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-new-hampshire", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "GHK-Cu in New Hampshire", "boundedAnswer": "GHK-Cu in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-new-jersey", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "GHK-Cu in New Jersey", "boundedAnswer": "GHK-Cu in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-new-mexico", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "GHK-Cu in New Mexico", "boundedAnswer": "GHK-Cu in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-new-york", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New York", "stateSlug": "new-york", "searchQuery": "GHK-Cu in New York", "boundedAnswer": "GHK-Cu in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-north-carolina", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "GHK-Cu in North Carolina", "boundedAnswer": "GHK-Cu in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-north-dakota", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "GHK-Cu in North Dakota", "boundedAnswer": "GHK-Cu in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-ohio", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "GHK-Cu in Ohio", "boundedAnswer": "GHK-Cu in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-oklahoma", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "GHK-Cu in Oklahoma", "boundedAnswer": "GHK-Cu in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-oregon", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "GHK-Cu in Oregon", "boundedAnswer": "GHK-Cu in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-pennsylvania", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "GHK-Cu in Pennsylvania", "boundedAnswer": "GHK-Cu in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-rhode-island", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "GHK-Cu in Rhode Island", "boundedAnswer": "GHK-Cu in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-south-carolina", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "GHK-Cu in South Carolina", "boundedAnswer": "GHK-Cu in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-south-dakota", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "GHK-Cu in South Dakota", "boundedAnswer": "GHK-Cu in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-tennessee", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "GHK-Cu in Tennessee", "boundedAnswer": "GHK-Cu in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-texas", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Texas", "stateSlug": "texas", "searchQuery": "GHK-Cu in Texas", "boundedAnswer": "GHK-Cu in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-utah", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Utah", "stateSlug": "utah", "searchQuery": "GHK-Cu in Utah", "boundedAnswer": "GHK-Cu in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-vermont", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "GHK-Cu in Vermont", "boundedAnswer": "GHK-Cu in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-virginia", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "GHK-Cu in Virginia", "boundedAnswer": "GHK-Cu in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-washington", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Washington", "stateSlug": "washington", "searchQuery": "GHK-Cu in Washington", "boundedAnswer": "GHK-Cu in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-west-virginia", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "GHK-Cu in West Virginia", "boundedAnswer": "GHK-Cu in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-wisconsin", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "GHK-Cu in Wisconsin", "boundedAnswer": "GHK-Cu in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-ghk-cu-wyoming", "compound": "GHK-Cu", "compoundSlug": "ghk-cu", "compoundAliases": [ "Copper tripeptide", "GHK Cu", "Copper tripeptide-1", "Prezatide copper" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "GHK-Cu in Wyoming", "boundedAnswer": "GHK-Cu in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ghk-cu", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/71587328", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ghk-cu/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/ghk-cu/countries" }, { "recordId": "pl-compound-state-semax-alabama", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Semax in Alabama", "boundedAnswer": "Semax in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-alaska", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Semax in Alaska", "boundedAnswer": "Semax in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-arizona", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Semax in Arizona", "boundedAnswer": "Semax in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-arkansas", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Semax in Arkansas", "boundedAnswer": "Semax in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-california", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "California", "stateSlug": "california", "searchQuery": "Semax in California", "boundedAnswer": "Semax in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-colorado", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Semax in Colorado", "boundedAnswer": "Semax in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-connecticut", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Semax in Connecticut", "boundedAnswer": "Semax in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-delaware", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Semax in Delaware", "boundedAnswer": "Semax in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-florida", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Florida", "stateSlug": "florida", "searchQuery": "Semax in Florida", "boundedAnswer": "Semax in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-georgia", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Semax in Georgia", "boundedAnswer": "Semax in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-hawaii", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Semax in Hawaii", "boundedAnswer": "Semax in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-idaho", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Semax in Idaho", "boundedAnswer": "Semax in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-illinois", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Semax in Illinois", "boundedAnswer": "Semax in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-indiana", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Semax in Indiana", "boundedAnswer": "Semax in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-iowa", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Semax in Iowa", "boundedAnswer": "Semax in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-kansas", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Semax in Kansas", "boundedAnswer": "Semax in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-kentucky", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Semax in Kentucky", "boundedAnswer": "Semax in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-louisiana", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Semax in Louisiana", "boundedAnswer": "Semax in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-maine", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maine", "stateSlug": "maine", "searchQuery": "Semax in Maine", "boundedAnswer": "Semax in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-maryland", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Semax in Maryland", "boundedAnswer": "Semax in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-massachusetts", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Semax in Massachusetts", "boundedAnswer": "Semax in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-michigan", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Semax in Michigan", "boundedAnswer": "Semax in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-minnesota", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Semax in Minnesota", "boundedAnswer": "Semax in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-mississippi", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Semax in Mississippi", "boundedAnswer": "Semax in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-missouri", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Semax in Missouri", "boundedAnswer": "Semax in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-montana", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Montana", "stateSlug": "montana", "searchQuery": "Semax in Montana", "boundedAnswer": "Semax in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-nebraska", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Semax in Nebraska", "boundedAnswer": "Semax in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-nevada", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Semax in Nevada", "boundedAnswer": "Semax in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-new-hampshire", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Semax in New Hampshire", "boundedAnswer": "Semax in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-new-jersey", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Semax in New Jersey", "boundedAnswer": "Semax in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-new-mexico", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Semax in New Mexico", "boundedAnswer": "Semax in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-new-york", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New York", "stateSlug": "new-york", "searchQuery": "Semax in New York", "boundedAnswer": "Semax in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-north-carolina", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Semax in North Carolina", "boundedAnswer": "Semax in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-north-dakota", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Semax in North Dakota", "boundedAnswer": "Semax in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-ohio", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Semax in Ohio", "boundedAnswer": "Semax in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-oklahoma", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Semax in Oklahoma", "boundedAnswer": "Semax in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-oregon", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Semax in Oregon", "boundedAnswer": "Semax in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-pennsylvania", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Semax in Pennsylvania", "boundedAnswer": "Semax in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-rhode-island", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Semax in Rhode Island", "boundedAnswer": "Semax in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-south-carolina", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Semax in South Carolina", "boundedAnswer": "Semax in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-south-dakota", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Semax in South Dakota", "boundedAnswer": "Semax in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-tennessee", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Semax in Tennessee", "boundedAnswer": "Semax in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-texas", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Texas", "stateSlug": "texas", "searchQuery": "Semax in Texas", "boundedAnswer": "Semax in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-utah", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Utah", "stateSlug": "utah", "searchQuery": "Semax in Utah", "boundedAnswer": "Semax in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-vermont", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Semax in Vermont", "boundedAnswer": "Semax in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-virginia", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Semax in Virginia", "boundedAnswer": "Semax in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-washington", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Washington", "stateSlug": "washington", "searchQuery": "Semax in Washington", "boundedAnswer": "Semax in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-west-virginia", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Semax in West Virginia", "boundedAnswer": "Semax in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-wisconsin", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Semax in Wisconsin", "boundedAnswer": "Semax in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-semax-wyoming", "compound": "Semax", "compoundSlug": "semax", "compoundAliases": [ "ACTH(4-7)-PGP", "MEHFPGP", "Semax heptapeptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Semax in Wyoming", "boundedAnswer": "Semax in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/semax", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semax/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/semax/countries" }, { "recordId": "pl-compound-state-melanotan-ii-alabama", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Melanotan II in Alabama", "boundedAnswer": "Melanotan II in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-alaska", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Melanotan II in Alaska", "boundedAnswer": "Melanotan II in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-arizona", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Melanotan II in Arizona", "boundedAnswer": "Melanotan II in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-arkansas", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Melanotan II in Arkansas", "boundedAnswer": "Melanotan II in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-california", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "California", "stateSlug": "california", "searchQuery": "Melanotan II in California", "boundedAnswer": "Melanotan II in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-colorado", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Melanotan II in Colorado", "boundedAnswer": "Melanotan II in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-connecticut", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Melanotan II in Connecticut", "boundedAnswer": "Melanotan II in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-delaware", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Melanotan II in Delaware", "boundedAnswer": "Melanotan II in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-florida", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Florida", "stateSlug": "florida", "searchQuery": "Melanotan II in Florida", "boundedAnswer": "Melanotan II in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-georgia", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Melanotan II in Georgia", "boundedAnswer": "Melanotan II in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-hawaii", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Melanotan II in Hawaii", "boundedAnswer": "Melanotan II in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-idaho", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Melanotan II in Idaho", "boundedAnswer": "Melanotan II in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-illinois", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Melanotan II in Illinois", "boundedAnswer": "Melanotan II in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-indiana", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Melanotan II in Indiana", "boundedAnswer": "Melanotan II in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-iowa", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Melanotan II in Iowa", "boundedAnswer": "Melanotan II in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-kansas", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Melanotan II in Kansas", "boundedAnswer": "Melanotan II in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-kentucky", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Melanotan II in Kentucky", "boundedAnswer": "Melanotan II in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-louisiana", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Melanotan II in Louisiana", "boundedAnswer": "Melanotan II in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-maine", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maine", "stateSlug": "maine", "searchQuery": "Melanotan II in Maine", "boundedAnswer": "Melanotan II in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-maryland", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Melanotan II in Maryland", "boundedAnswer": "Melanotan II in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-massachusetts", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Melanotan II in Massachusetts", "boundedAnswer": "Melanotan II in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-michigan", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Melanotan II in Michigan", "boundedAnswer": "Melanotan II in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-minnesota", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Melanotan II in Minnesota", "boundedAnswer": "Melanotan II in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-mississippi", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Melanotan II in Mississippi", "boundedAnswer": "Melanotan II in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-missouri", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Melanotan II in Missouri", "boundedAnswer": "Melanotan II in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-montana", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Montana", "stateSlug": "montana", "searchQuery": "Melanotan II in Montana", "boundedAnswer": "Melanotan II in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-nebraska", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Melanotan II in Nebraska", "boundedAnswer": "Melanotan II in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-nevada", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Melanotan II in Nevada", "boundedAnswer": "Melanotan II in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-new-hampshire", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Melanotan II in New Hampshire", "boundedAnswer": "Melanotan II in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-new-jersey", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Melanotan II in New Jersey", "boundedAnswer": "Melanotan II in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-new-mexico", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Melanotan II in New Mexico", "boundedAnswer": "Melanotan II in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-new-york", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New York", "stateSlug": "new-york", "searchQuery": "Melanotan II in New York", "boundedAnswer": "Melanotan II in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-north-carolina", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Melanotan II in North Carolina", "boundedAnswer": "Melanotan II in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-north-dakota", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Melanotan II in North Dakota", "boundedAnswer": "Melanotan II in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-ohio", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Melanotan II in Ohio", "boundedAnswer": "Melanotan II in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-oklahoma", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Melanotan II in Oklahoma", "boundedAnswer": "Melanotan II in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-oregon", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Melanotan II in Oregon", "boundedAnswer": "Melanotan II in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-pennsylvania", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Melanotan II in Pennsylvania", "boundedAnswer": "Melanotan II in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-rhode-island", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Melanotan II in Rhode Island", "boundedAnswer": "Melanotan II in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-south-carolina", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Melanotan II in South Carolina", "boundedAnswer": "Melanotan II in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-south-dakota", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Melanotan II in South Dakota", "boundedAnswer": "Melanotan II in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-tennessee", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Melanotan II in Tennessee", "boundedAnswer": "Melanotan II in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-texas", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Texas", "stateSlug": "texas", "searchQuery": "Melanotan II in Texas", "boundedAnswer": "Melanotan II in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-utah", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Utah", "stateSlug": "utah", "searchQuery": "Melanotan II in Utah", "boundedAnswer": "Melanotan II in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-vermont", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Melanotan II in Vermont", "boundedAnswer": "Melanotan II in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-virginia", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Melanotan II in Virginia", "boundedAnswer": "Melanotan II in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-washington", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Washington", "stateSlug": "washington", "searchQuery": "Melanotan II in Washington", "boundedAnswer": "Melanotan II in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-west-virginia", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Melanotan II in West Virginia", "boundedAnswer": "Melanotan II in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-wisconsin", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Melanotan II in Wisconsin", "boundedAnswer": "Melanotan II in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-melanotan-ii-wyoming", "compound": "Melanotan II", "compoundSlug": "melanotan-ii", "compoundAliases": [ "MT-II", "MT2", "Melanotan 2" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Melanotan II in Wyoming", "boundedAnswer": "Melanotan II in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-ii", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-ii/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-ii/countries" }, { "recordId": "pl-compound-state-mots-c-alabama", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "MOTS-c in Alabama", "boundedAnswer": "MOTS-c in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-alaska", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "MOTS-c in Alaska", "boundedAnswer": "MOTS-c in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-arizona", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "MOTS-c in Arizona", "boundedAnswer": "MOTS-c in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-arkansas", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "MOTS-c in Arkansas", "boundedAnswer": "MOTS-c in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-california", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "California", "stateSlug": "california", "searchQuery": "MOTS-c in California", "boundedAnswer": "MOTS-c in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-colorado", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "MOTS-c in Colorado", "boundedAnswer": "MOTS-c in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-connecticut", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "MOTS-c in Connecticut", "boundedAnswer": "MOTS-c in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-delaware", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "MOTS-c in Delaware", "boundedAnswer": "MOTS-c in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-florida", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Florida", "stateSlug": "florida", "searchQuery": "MOTS-c in Florida", "boundedAnswer": "MOTS-c in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-georgia", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "MOTS-c in Georgia", "boundedAnswer": "MOTS-c in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-hawaii", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "MOTS-c in Hawaii", "boundedAnswer": "MOTS-c in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-idaho", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "MOTS-c in Idaho", "boundedAnswer": "MOTS-c in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-illinois", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "MOTS-c in Illinois", "boundedAnswer": "MOTS-c in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-indiana", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "MOTS-c in Indiana", "boundedAnswer": "MOTS-c in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-iowa", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "MOTS-c in Iowa", "boundedAnswer": "MOTS-c in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-kansas", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "MOTS-c in Kansas", "boundedAnswer": "MOTS-c in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-kentucky", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "MOTS-c in Kentucky", "boundedAnswer": "MOTS-c in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-louisiana", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "MOTS-c in Louisiana", "boundedAnswer": "MOTS-c in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-maine", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maine", "stateSlug": "maine", "searchQuery": "MOTS-c in Maine", "boundedAnswer": "MOTS-c in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-maryland", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "MOTS-c in Maryland", "boundedAnswer": "MOTS-c in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-massachusetts", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "MOTS-c in Massachusetts", "boundedAnswer": "MOTS-c in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-michigan", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "MOTS-c in Michigan", "boundedAnswer": "MOTS-c in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-minnesota", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "MOTS-c in Minnesota", "boundedAnswer": "MOTS-c in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-mississippi", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "MOTS-c in Mississippi", "boundedAnswer": "MOTS-c in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-missouri", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "MOTS-c in Missouri", "boundedAnswer": "MOTS-c in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-montana", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Montana", "stateSlug": "montana", "searchQuery": "MOTS-c in Montana", "boundedAnswer": "MOTS-c in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-nebraska", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "MOTS-c in Nebraska", "boundedAnswer": "MOTS-c in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-nevada", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "MOTS-c in Nevada", "boundedAnswer": "MOTS-c in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-new-hampshire", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "MOTS-c in New Hampshire", "boundedAnswer": "MOTS-c in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-new-jersey", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "MOTS-c in New Jersey", "boundedAnswer": "MOTS-c in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-new-mexico", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "MOTS-c in New Mexico", "boundedAnswer": "MOTS-c in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-new-york", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New York", "stateSlug": "new-york", "searchQuery": "MOTS-c in New York", "boundedAnswer": "MOTS-c in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-north-carolina", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "MOTS-c in North Carolina", "boundedAnswer": "MOTS-c in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-north-dakota", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "MOTS-c in North Dakota", "boundedAnswer": "MOTS-c in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-ohio", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "MOTS-c in Ohio", "boundedAnswer": "MOTS-c in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-oklahoma", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "MOTS-c in Oklahoma", "boundedAnswer": "MOTS-c in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-oregon", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "MOTS-c in Oregon", "boundedAnswer": "MOTS-c in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-pennsylvania", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "MOTS-c in Pennsylvania", "boundedAnswer": "MOTS-c in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-rhode-island", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "MOTS-c in Rhode Island", "boundedAnswer": "MOTS-c in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-south-carolina", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "MOTS-c in South Carolina", "boundedAnswer": "MOTS-c in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-south-dakota", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "MOTS-c in South Dakota", "boundedAnswer": "MOTS-c in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-tennessee", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "MOTS-c in Tennessee", "boundedAnswer": "MOTS-c in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-texas", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Texas", "stateSlug": "texas", "searchQuery": "MOTS-c in Texas", "boundedAnswer": "MOTS-c in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-utah", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Utah", "stateSlug": "utah", "searchQuery": "MOTS-c in Utah", "boundedAnswer": "MOTS-c in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-vermont", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "MOTS-c in Vermont", "boundedAnswer": "MOTS-c in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-virginia", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "MOTS-c in Virginia", "boundedAnswer": "MOTS-c in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-washington", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Washington", "stateSlug": "washington", "searchQuery": "MOTS-c in Washington", "boundedAnswer": "MOTS-c in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-west-virginia", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "MOTS-c in West Virginia", "boundedAnswer": "MOTS-c in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-wisconsin", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "MOTS-c in Wisconsin", "boundedAnswer": "MOTS-c in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-mots-c-wyoming", "compound": "MOTS-c", "compoundSlug": "mots-c", "compoundAliases": [ "MOTS c", "Mitochondrial open reading frame peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "MOTS-c in Wyoming", "boundedAnswer": "MOTS-c in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/mots-c", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mots-c/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/mots-c/countries" }, { "recordId": "pl-compound-state-tesamorelin-alabama", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Tesamorelin in Alabama", "boundedAnswer": "Tesamorelin in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-alaska", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Tesamorelin in Alaska", "boundedAnswer": "Tesamorelin in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-arizona", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Tesamorelin in Arizona", "boundedAnswer": "Tesamorelin in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-arkansas", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Tesamorelin in Arkansas", "boundedAnswer": "Tesamorelin in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-california", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "California", "stateSlug": "california", "searchQuery": "Tesamorelin in California", "boundedAnswer": "Tesamorelin in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-colorado", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Tesamorelin in Colorado", "boundedAnswer": "Tesamorelin in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-connecticut", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Tesamorelin in Connecticut", "boundedAnswer": "Tesamorelin in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-delaware", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Tesamorelin in Delaware", "boundedAnswer": "Tesamorelin in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-florida", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Florida", "stateSlug": "florida", "searchQuery": "Tesamorelin in Florida", "boundedAnswer": "Tesamorelin in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-georgia", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Tesamorelin in Georgia", "boundedAnswer": "Tesamorelin in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-hawaii", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Tesamorelin in Hawaii", "boundedAnswer": "Tesamorelin in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-idaho", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Tesamorelin in Idaho", "boundedAnswer": "Tesamorelin in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-illinois", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Tesamorelin in Illinois", "boundedAnswer": "Tesamorelin in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-indiana", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Tesamorelin in Indiana", "boundedAnswer": "Tesamorelin in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-iowa", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Tesamorelin in Iowa", "boundedAnswer": "Tesamorelin in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-kansas", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Tesamorelin in Kansas", "boundedAnswer": "Tesamorelin in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-kentucky", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Tesamorelin in Kentucky", "boundedAnswer": "Tesamorelin in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-louisiana", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Tesamorelin in Louisiana", "boundedAnswer": "Tesamorelin in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-maine", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Maine", "stateSlug": "maine", "searchQuery": "Tesamorelin in Maine", "boundedAnswer": "Tesamorelin in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-maryland", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Tesamorelin in Maryland", "boundedAnswer": "Tesamorelin in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-massachusetts", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Tesamorelin in Massachusetts", "boundedAnswer": "Tesamorelin in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-michigan", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Tesamorelin in Michigan", "boundedAnswer": "Tesamorelin in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-minnesota", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Tesamorelin in Minnesota", "boundedAnswer": "Tesamorelin in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-mississippi", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Tesamorelin in Mississippi", "boundedAnswer": "Tesamorelin in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-missouri", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Tesamorelin in Missouri", "boundedAnswer": "Tesamorelin in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-montana", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Montana", "stateSlug": "montana", "searchQuery": "Tesamorelin in Montana", "boundedAnswer": "Tesamorelin in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-nebraska", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Tesamorelin in Nebraska", "boundedAnswer": "Tesamorelin in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-nevada", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Tesamorelin in Nevada", "boundedAnswer": "Tesamorelin in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-new-hampshire", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Tesamorelin in New Hampshire", "boundedAnswer": "Tesamorelin in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-new-jersey", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Tesamorelin in New Jersey", "boundedAnswer": "Tesamorelin in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-new-mexico", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Tesamorelin in New Mexico", "boundedAnswer": "Tesamorelin in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-new-york", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "New York", "stateSlug": "new-york", "searchQuery": "Tesamorelin in New York", "boundedAnswer": "Tesamorelin in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-north-carolina", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Tesamorelin in North Carolina", "boundedAnswer": "Tesamorelin in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-north-dakota", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Tesamorelin in North Dakota", "boundedAnswer": "Tesamorelin in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-ohio", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Tesamorelin in Ohio", "boundedAnswer": "Tesamorelin in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-oklahoma", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Tesamorelin in Oklahoma", "boundedAnswer": "Tesamorelin in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-oregon", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Tesamorelin in Oregon", "boundedAnswer": "Tesamorelin in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-pennsylvania", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Tesamorelin in Pennsylvania", "boundedAnswer": "Tesamorelin in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-rhode-island", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Tesamorelin in Rhode Island", "boundedAnswer": "Tesamorelin in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-south-carolina", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Tesamorelin in South Carolina", "boundedAnswer": "Tesamorelin in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-south-dakota", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Tesamorelin in South Dakota", "boundedAnswer": "Tesamorelin in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-tennessee", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Tesamorelin in Tennessee", "boundedAnswer": "Tesamorelin in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-texas", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Texas", "stateSlug": "texas", "searchQuery": "Tesamorelin in Texas", "boundedAnswer": "Tesamorelin in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-utah", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Utah", "stateSlug": "utah", "searchQuery": "Tesamorelin in Utah", "boundedAnswer": "Tesamorelin in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-vermont", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Tesamorelin in Vermont", "boundedAnswer": "Tesamorelin in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-virginia", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Tesamorelin in Virginia", "boundedAnswer": "Tesamorelin in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-washington", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Washington", "stateSlug": "washington", "searchQuery": "Tesamorelin in Washington", "boundedAnswer": "Tesamorelin in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-west-virginia", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Tesamorelin in West Virginia", "boundedAnswer": "Tesamorelin in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-wisconsin", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Tesamorelin in Wisconsin", "boundedAnswer": "Tesamorelin in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-tesamorelin-wyoming", "compound": "Tesamorelin", "compoundSlug": "tesamorelin", "compoundAliases": [ "Egrifta", "TH9507" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-licensed medicine record", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Tesamorelin in Wyoming", "boundedAnswer": "Tesamorelin in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/tesamorelin", "identitySourceLabel": "Check the FDA Purple Book product record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://purplebooksearch.fda.gov/index.cfm?blaNo=022505&event=productdetails", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tesamorelin/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/tesamorelin/countries" }, { "recordId": "pl-compound-state-aod-9604-alabama", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "AOD-9604 in Alabama", "boundedAnswer": "AOD-9604 in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-alaska", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "AOD-9604 in Alaska", "boundedAnswer": "AOD-9604 in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-arizona", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "AOD-9604 in Arizona", "boundedAnswer": "AOD-9604 in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-arkansas", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "AOD-9604 in Arkansas", "boundedAnswer": "AOD-9604 in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-california", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "California", "stateSlug": "california", "searchQuery": "AOD-9604 in California", "boundedAnswer": "AOD-9604 in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-colorado", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "AOD-9604 in Colorado", "boundedAnswer": "AOD-9604 in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-connecticut", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "AOD-9604 in Connecticut", "boundedAnswer": "AOD-9604 in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-delaware", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "AOD-9604 in Delaware", "boundedAnswer": "AOD-9604 in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-florida", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Florida", "stateSlug": "florida", "searchQuery": "AOD-9604 in Florida", "boundedAnswer": "AOD-9604 in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-georgia", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "AOD-9604 in Georgia", "boundedAnswer": "AOD-9604 in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-hawaii", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "AOD-9604 in Hawaii", "boundedAnswer": "AOD-9604 in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-idaho", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "AOD-9604 in Idaho", "boundedAnswer": "AOD-9604 in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-illinois", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "AOD-9604 in Illinois", "boundedAnswer": "AOD-9604 in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-indiana", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "AOD-9604 in Indiana", "boundedAnswer": "AOD-9604 in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-iowa", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "AOD-9604 in Iowa", "boundedAnswer": "AOD-9604 in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-kansas", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "AOD-9604 in Kansas", "boundedAnswer": "AOD-9604 in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-kentucky", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "AOD-9604 in Kentucky", "boundedAnswer": "AOD-9604 in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-louisiana", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "AOD-9604 in Louisiana", "boundedAnswer": "AOD-9604 in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-maine", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Maine", "stateSlug": "maine", "searchQuery": "AOD-9604 in Maine", "boundedAnswer": "AOD-9604 in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-maryland", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "AOD-9604 in Maryland", "boundedAnswer": "AOD-9604 in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-massachusetts", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "AOD-9604 in Massachusetts", "boundedAnswer": "AOD-9604 in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-michigan", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "AOD-9604 in Michigan", "boundedAnswer": "AOD-9604 in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-minnesota", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "AOD-9604 in Minnesota", "boundedAnswer": "AOD-9604 in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-mississippi", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "AOD-9604 in Mississippi", "boundedAnswer": "AOD-9604 in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-missouri", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "AOD-9604 in Missouri", "boundedAnswer": "AOD-9604 in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-montana", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Montana", "stateSlug": "montana", "searchQuery": "AOD-9604 in Montana", "boundedAnswer": "AOD-9604 in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-nebraska", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "AOD-9604 in Nebraska", "boundedAnswer": "AOD-9604 in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-nevada", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "AOD-9604 in Nevada", "boundedAnswer": "AOD-9604 in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-new-hampshire", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "AOD-9604 in New Hampshire", "boundedAnswer": "AOD-9604 in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-new-jersey", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "AOD-9604 in New Jersey", "boundedAnswer": "AOD-9604 in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-new-mexico", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "AOD-9604 in New Mexico", "boundedAnswer": "AOD-9604 in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-new-york", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "New York", "stateSlug": "new-york", "searchQuery": "AOD-9604 in New York", "boundedAnswer": "AOD-9604 in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-north-carolina", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "AOD-9604 in North Carolina", "boundedAnswer": "AOD-9604 in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-north-dakota", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "AOD-9604 in North Dakota", "boundedAnswer": "AOD-9604 in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-ohio", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "AOD-9604 in Ohio", "boundedAnswer": "AOD-9604 in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-oklahoma", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "AOD-9604 in Oklahoma", "boundedAnswer": "AOD-9604 in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-oregon", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "AOD-9604 in Oregon", "boundedAnswer": "AOD-9604 in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-pennsylvania", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "AOD-9604 in Pennsylvania", "boundedAnswer": "AOD-9604 in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-rhode-island", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "AOD-9604 in Rhode Island", "boundedAnswer": "AOD-9604 in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-south-carolina", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "AOD-9604 in South Carolina", "boundedAnswer": "AOD-9604 in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-south-dakota", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "AOD-9604 in South Dakota", "boundedAnswer": "AOD-9604 in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-tennessee", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "AOD-9604 in Tennessee", "boundedAnswer": "AOD-9604 in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-texas", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Texas", "stateSlug": "texas", "searchQuery": "AOD-9604 in Texas", "boundedAnswer": "AOD-9604 in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-utah", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Utah", "stateSlug": "utah", "searchQuery": "AOD-9604 in Utah", "boundedAnswer": "AOD-9604 in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-vermont", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "AOD-9604 in Vermont", "boundedAnswer": "AOD-9604 in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-virginia", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "AOD-9604 in Virginia", "boundedAnswer": "AOD-9604 in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-washington", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Washington", "stateSlug": "washington", "searchQuery": "AOD-9604 in Washington", "boundedAnswer": "AOD-9604 in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-west-virginia", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "AOD-9604 in West Virginia", "boundedAnswer": "AOD-9604 in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-wisconsin", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "AOD-9604 in Wisconsin", "boundedAnswer": "AOD-9604 in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-aod-9604-wyoming", "compound": "AOD-9604", "compoundSlug": "aod-9604", "compoundAliases": [ "AOD 9604", "AOD9604", "Tyr-hGH 177-191" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a failed oral obesity program and no FDA-approved drug", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "AOD-9604 in Wyoming", "boundedAnswer": "AOD-9604 in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/aod-9604", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/aod-9604/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/aod-9604/countries" }, { "recordId": "pl-compound-state-ipamorelin-alabama", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Ipamorelin in Alabama", "boundedAnswer": "Ipamorelin in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-alaska", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Ipamorelin in Alaska", "boundedAnswer": "Ipamorelin in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-arizona", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Ipamorelin in Arizona", "boundedAnswer": "Ipamorelin in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-arkansas", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Ipamorelin in Arkansas", "boundedAnswer": "Ipamorelin in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-california", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "California", "stateSlug": "california", "searchQuery": "Ipamorelin in California", "boundedAnswer": "Ipamorelin in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-colorado", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Ipamorelin in Colorado", "boundedAnswer": "Ipamorelin in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-connecticut", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Ipamorelin in Connecticut", "boundedAnswer": "Ipamorelin in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-delaware", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Ipamorelin in Delaware", "boundedAnswer": "Ipamorelin in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-florida", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Florida", "stateSlug": "florida", "searchQuery": "Ipamorelin in Florida", "boundedAnswer": "Ipamorelin in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-georgia", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Ipamorelin in Georgia", "boundedAnswer": "Ipamorelin in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-hawaii", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Ipamorelin in Hawaii", "boundedAnswer": "Ipamorelin in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-idaho", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Ipamorelin in Idaho", "boundedAnswer": "Ipamorelin in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-illinois", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Ipamorelin in Illinois", "boundedAnswer": "Ipamorelin in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-indiana", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Ipamorelin in Indiana", "boundedAnswer": "Ipamorelin in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-iowa", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Ipamorelin in Iowa", "boundedAnswer": "Ipamorelin in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-kansas", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Ipamorelin in Kansas", "boundedAnswer": "Ipamorelin in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-kentucky", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Ipamorelin in Kentucky", "boundedAnswer": "Ipamorelin in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-louisiana", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Ipamorelin in Louisiana", "boundedAnswer": "Ipamorelin in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-maine", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maine", "stateSlug": "maine", "searchQuery": "Ipamorelin in Maine", "boundedAnswer": "Ipamorelin in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-maryland", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Ipamorelin in Maryland", "boundedAnswer": "Ipamorelin in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-massachusetts", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Ipamorelin in Massachusetts", "boundedAnswer": "Ipamorelin in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-michigan", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Ipamorelin in Michigan", "boundedAnswer": "Ipamorelin in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-minnesota", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Ipamorelin in Minnesota", "boundedAnswer": "Ipamorelin in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-mississippi", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Ipamorelin in Mississippi", "boundedAnswer": "Ipamorelin in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-missouri", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Ipamorelin in Missouri", "boundedAnswer": "Ipamorelin in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-montana", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Montana", "stateSlug": "montana", "searchQuery": "Ipamorelin in Montana", "boundedAnswer": "Ipamorelin in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-nebraska", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Ipamorelin in Nebraska", "boundedAnswer": "Ipamorelin in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-nevada", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Ipamorelin in Nevada", "boundedAnswer": "Ipamorelin in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-new-hampshire", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Ipamorelin in New Hampshire", "boundedAnswer": "Ipamorelin in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-new-jersey", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Ipamorelin in New Jersey", "boundedAnswer": "Ipamorelin in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-new-mexico", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Ipamorelin in New Mexico", "boundedAnswer": "Ipamorelin in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-new-york", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New York", "stateSlug": "new-york", "searchQuery": "Ipamorelin in New York", "boundedAnswer": "Ipamorelin in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-north-carolina", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Ipamorelin in North Carolina", "boundedAnswer": "Ipamorelin in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-north-dakota", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Ipamorelin in North Dakota", "boundedAnswer": "Ipamorelin in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-ohio", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Ipamorelin in Ohio", "boundedAnswer": "Ipamorelin in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-oklahoma", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Ipamorelin in Oklahoma", "boundedAnswer": "Ipamorelin in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-oregon", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Ipamorelin in Oregon", "boundedAnswer": "Ipamorelin in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-pennsylvania", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Ipamorelin in Pennsylvania", "boundedAnswer": "Ipamorelin in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-rhode-island", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Ipamorelin in Rhode Island", "boundedAnswer": "Ipamorelin in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-south-carolina", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Ipamorelin in South Carolina", "boundedAnswer": "Ipamorelin in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-south-dakota", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Ipamorelin in South Dakota", "boundedAnswer": "Ipamorelin in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-tennessee", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Ipamorelin in Tennessee", "boundedAnswer": "Ipamorelin in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-texas", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Texas", "stateSlug": "texas", "searchQuery": "Ipamorelin in Texas", "boundedAnswer": "Ipamorelin in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-utah", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Utah", "stateSlug": "utah", "searchQuery": "Ipamorelin in Utah", "boundedAnswer": "Ipamorelin in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-vermont", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Ipamorelin in Vermont", "boundedAnswer": "Ipamorelin in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-virginia", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Ipamorelin in Virginia", "boundedAnswer": "Ipamorelin in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-washington", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Washington", "stateSlug": "washington", "searchQuery": "Ipamorelin in Washington", "boundedAnswer": "Ipamorelin in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-west-virginia", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Ipamorelin in West Virginia", "boundedAnswer": "Ipamorelin in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-wisconsin", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Ipamorelin in Wisconsin", "boundedAnswer": "Ipamorelin in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-ipamorelin-wyoming", "compound": "Ipamorelin", "compoundSlug": "ipamorelin", "compoundAliases": [ "NNC 26-0161", "growth hormone secretagogue" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Ipamorelin in Wyoming", "boundedAnswer": "Ipamorelin in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/ipamorelin", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ipamorelin/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/ipamorelin/countries" }, { "recordId": "pl-compound-state-selank-alabama", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Selank in Alabama", "boundedAnswer": "Selank in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-alaska", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Selank in Alaska", "boundedAnswer": "Selank in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-arizona", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Selank in Arizona", "boundedAnswer": "Selank in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-arkansas", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Selank in Arkansas", "boundedAnswer": "Selank in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-california", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "California", "stateSlug": "california", "searchQuery": "Selank in California", "boundedAnswer": "Selank in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-colorado", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Selank in Colorado", "boundedAnswer": "Selank in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-connecticut", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Selank in Connecticut", "boundedAnswer": "Selank in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-delaware", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Selank in Delaware", "boundedAnswer": "Selank in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-florida", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Florida", "stateSlug": "florida", "searchQuery": "Selank in Florida", "boundedAnswer": "Selank in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-georgia", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Selank in Georgia", "boundedAnswer": "Selank in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-hawaii", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Selank in Hawaii", "boundedAnswer": "Selank in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-idaho", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Selank in Idaho", "boundedAnswer": "Selank in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-illinois", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Selank in Illinois", "boundedAnswer": "Selank in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-indiana", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Selank in Indiana", "boundedAnswer": "Selank in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-iowa", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Selank in Iowa", "boundedAnswer": "Selank in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-kansas", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Selank in Kansas", "boundedAnswer": "Selank in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-kentucky", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Selank in Kentucky", "boundedAnswer": "Selank in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-louisiana", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Selank in Louisiana", "boundedAnswer": "Selank in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-maine", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maine", "stateSlug": "maine", "searchQuery": "Selank in Maine", "boundedAnswer": "Selank in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-maryland", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Selank in Maryland", "boundedAnswer": "Selank in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-massachusetts", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Selank in Massachusetts", "boundedAnswer": "Selank in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-michigan", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Selank in Michigan", "boundedAnswer": "Selank in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-minnesota", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Selank in Minnesota", "boundedAnswer": "Selank in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-mississippi", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Selank in Mississippi", "boundedAnswer": "Selank in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-missouri", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Selank in Missouri", "boundedAnswer": "Selank in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-montana", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Montana", "stateSlug": "montana", "searchQuery": "Selank in Montana", "boundedAnswer": "Selank in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-nebraska", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Selank in Nebraska", "boundedAnswer": "Selank in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-nevada", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Selank in Nevada", "boundedAnswer": "Selank in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-new-hampshire", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Selank in New Hampshire", "boundedAnswer": "Selank in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-new-jersey", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Selank in New Jersey", "boundedAnswer": "Selank in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-new-mexico", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Selank in New Mexico", "boundedAnswer": "Selank in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-new-york", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New York", "stateSlug": "new-york", "searchQuery": "Selank in New York", "boundedAnswer": "Selank in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-north-carolina", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Selank in North Carolina", "boundedAnswer": "Selank in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-north-dakota", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Selank in North Dakota", "boundedAnswer": "Selank in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-ohio", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Selank in Ohio", "boundedAnswer": "Selank in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-oklahoma", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Selank in Oklahoma", "boundedAnswer": "Selank in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-oregon", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Selank in Oregon", "boundedAnswer": "Selank in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-pennsylvania", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Selank in Pennsylvania", "boundedAnswer": "Selank in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-rhode-island", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Selank in Rhode Island", "boundedAnswer": "Selank in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-south-carolina", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Selank in South Carolina", "boundedAnswer": "Selank in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-south-dakota", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Selank in South Dakota", "boundedAnswer": "Selank in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-tennessee", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Selank in Tennessee", "boundedAnswer": "Selank in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-texas", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Texas", "stateSlug": "texas", "searchQuery": "Selank in Texas", "boundedAnswer": "Selank in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-utah", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Utah", "stateSlug": "utah", "searchQuery": "Selank in Utah", "boundedAnswer": "Selank in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-vermont", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Selank in Vermont", "boundedAnswer": "Selank in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-virginia", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Selank in Virginia", "boundedAnswer": "Selank in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-washington", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Washington", "stateSlug": "washington", "searchQuery": "Selank in Washington", "boundedAnswer": "Selank in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-west-virginia", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Selank in West Virginia", "boundedAnswer": "Selank in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-wisconsin", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Selank in Wisconsin", "boundedAnswer": "Selank in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-selank-wyoming", "compound": "Selank", "compoundSlug": "selank", "compoundAliases": [ "TP-7", "selank acetate" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Selank in Wyoming", "boundedAnswer": "Selank in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/selank", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/selank/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/selank/countries" }, { "recordId": "pl-compound-state-pt-141-alabama", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "PT-141 / Bremelanotide in Alabama", "boundedAnswer": "PT-141 / Bremelanotide in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-alaska", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "PT-141 / Bremelanotide in Alaska", "boundedAnswer": "PT-141 / Bremelanotide in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-arizona", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "PT-141 / Bremelanotide in Arizona", "boundedAnswer": "PT-141 / Bremelanotide in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-arkansas", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "PT-141 / Bremelanotide in Arkansas", "boundedAnswer": "PT-141 / Bremelanotide in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-california", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "California", "stateSlug": "california", "searchQuery": "PT-141 / Bremelanotide in California", "boundedAnswer": "PT-141 / Bremelanotide in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-colorado", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "PT-141 / Bremelanotide in Colorado", "boundedAnswer": "PT-141 / Bremelanotide in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-connecticut", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "PT-141 / Bremelanotide in Connecticut", "boundedAnswer": "PT-141 / Bremelanotide in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-delaware", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "PT-141 / Bremelanotide in Delaware", "boundedAnswer": "PT-141 / Bremelanotide in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-florida", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Florida", "stateSlug": "florida", "searchQuery": "PT-141 / Bremelanotide in Florida", "boundedAnswer": "PT-141 / Bremelanotide in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-georgia", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "PT-141 / Bremelanotide in Georgia", "boundedAnswer": "PT-141 / Bremelanotide in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-hawaii", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "PT-141 / Bremelanotide in Hawaii", "boundedAnswer": "PT-141 / Bremelanotide in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-idaho", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "PT-141 / Bremelanotide in Idaho", "boundedAnswer": "PT-141 / Bremelanotide in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-illinois", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "PT-141 / Bremelanotide in Illinois", "boundedAnswer": "PT-141 / Bremelanotide in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-indiana", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "PT-141 / Bremelanotide in Indiana", "boundedAnswer": "PT-141 / Bremelanotide in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-iowa", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "PT-141 / Bremelanotide in Iowa", "boundedAnswer": "PT-141 / Bremelanotide in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-kansas", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "PT-141 / Bremelanotide in Kansas", "boundedAnswer": "PT-141 / Bremelanotide in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-kentucky", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "PT-141 / Bremelanotide in Kentucky", "boundedAnswer": "PT-141 / Bremelanotide in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-louisiana", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "PT-141 / Bremelanotide in Louisiana", "boundedAnswer": "PT-141 / Bremelanotide in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-maine", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Maine", "stateSlug": "maine", "searchQuery": "PT-141 / Bremelanotide in Maine", "boundedAnswer": "PT-141 / Bremelanotide in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-maryland", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "PT-141 / Bremelanotide in Maryland", "boundedAnswer": "PT-141 / Bremelanotide in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-massachusetts", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "PT-141 / Bremelanotide in Massachusetts", "boundedAnswer": "PT-141 / Bremelanotide in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-michigan", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "PT-141 / Bremelanotide in Michigan", "boundedAnswer": "PT-141 / Bremelanotide in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-minnesota", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "PT-141 / Bremelanotide in Minnesota", "boundedAnswer": "PT-141 / Bremelanotide in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-mississippi", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "PT-141 / Bremelanotide in Mississippi", "boundedAnswer": "PT-141 / Bremelanotide in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-missouri", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "PT-141 / Bremelanotide in Missouri", "boundedAnswer": "PT-141 / Bremelanotide in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-montana", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Montana", "stateSlug": "montana", "searchQuery": "PT-141 / Bremelanotide in Montana", "boundedAnswer": "PT-141 / Bremelanotide in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-nebraska", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "PT-141 / Bremelanotide in Nebraska", "boundedAnswer": "PT-141 / Bremelanotide in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-nevada", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "PT-141 / Bremelanotide in Nevada", "boundedAnswer": "PT-141 / Bremelanotide in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-new-hampshire", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "PT-141 / Bremelanotide in New Hampshire", "boundedAnswer": "PT-141 / Bremelanotide in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-new-jersey", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "PT-141 / Bremelanotide in New Jersey", "boundedAnswer": "PT-141 / Bremelanotide in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-new-mexico", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "PT-141 / Bremelanotide in New Mexico", "boundedAnswer": "PT-141 / Bremelanotide in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-new-york", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "New York", "stateSlug": "new-york", "searchQuery": "PT-141 / Bremelanotide in New York", "boundedAnswer": "PT-141 / Bremelanotide in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-north-carolina", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "PT-141 / Bremelanotide in North Carolina", "boundedAnswer": "PT-141 / Bremelanotide in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-north-dakota", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "PT-141 / Bremelanotide in North Dakota", "boundedAnswer": "PT-141 / Bremelanotide in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-ohio", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "PT-141 / Bremelanotide in Ohio", "boundedAnswer": "PT-141 / Bremelanotide in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-oklahoma", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "PT-141 / Bremelanotide in Oklahoma", "boundedAnswer": "PT-141 / Bremelanotide in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-oregon", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "PT-141 / Bremelanotide in Oregon", "boundedAnswer": "PT-141 / Bremelanotide in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-pennsylvania", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "PT-141 / Bremelanotide in Pennsylvania", "boundedAnswer": "PT-141 / Bremelanotide in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-rhode-island", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "PT-141 / Bremelanotide in Rhode Island", "boundedAnswer": "PT-141 / Bremelanotide in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-south-carolina", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "PT-141 / Bremelanotide in South Carolina", "boundedAnswer": "PT-141 / Bremelanotide in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-south-dakota", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "PT-141 / Bremelanotide in South Dakota", "boundedAnswer": "PT-141 / Bremelanotide in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-tennessee", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "PT-141 / Bremelanotide in Tennessee", "boundedAnswer": "PT-141 / Bremelanotide in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-texas", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Texas", "stateSlug": "texas", "searchQuery": "PT-141 / Bremelanotide in Texas", "boundedAnswer": "PT-141 / Bremelanotide in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-utah", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Utah", "stateSlug": "utah", "searchQuery": "PT-141 / Bremelanotide in Utah", "boundedAnswer": "PT-141 / Bremelanotide in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-vermont", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "PT-141 / Bremelanotide in Vermont", "boundedAnswer": "PT-141 / Bremelanotide in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-virginia", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "PT-141 / Bremelanotide in Virginia", "boundedAnswer": "PT-141 / Bremelanotide in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-washington", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Washington", "stateSlug": "washington", "searchQuery": "PT-141 / Bremelanotide in Washington", "boundedAnswer": "PT-141 / Bremelanotide in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-west-virginia", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "PT-141 / Bremelanotide in West Virginia", "boundedAnswer": "PT-141 / Bremelanotide in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-wisconsin", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "PT-141 / Bremelanotide in Wisconsin", "boundedAnswer": "PT-141 / Bremelanotide in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-pt-141-wyoming", "compound": "PT-141 / Bremelanotide", "compoundSlug": "pt-141", "compoundAliases": [ "PT 141", "Bremelanotide", "Vyleesi" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a separate FDA-approved medicine record", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "PT-141 / Bremelanotide in Wyoming", "boundedAnswer": "PT-141 / Bremelanotide in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/pt-141", "identitySourceLabel": "Read the current DailyMed drug label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pt-141/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/pt-141/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-alabama", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "CJC-1295 no DAC in Alabama", "boundedAnswer": "CJC-1295 no DAC in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-alaska", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "CJC-1295 no DAC in Alaska", "boundedAnswer": "CJC-1295 no DAC in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-arizona", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "CJC-1295 no DAC in Arizona", "boundedAnswer": "CJC-1295 no DAC in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-arkansas", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "CJC-1295 no DAC in Arkansas", "boundedAnswer": "CJC-1295 no DAC in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-california", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "California", "stateSlug": "california", "searchQuery": "CJC-1295 no DAC in California", "boundedAnswer": "CJC-1295 no DAC in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-colorado", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "CJC-1295 no DAC in Colorado", "boundedAnswer": "CJC-1295 no DAC in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-connecticut", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "CJC-1295 no DAC in Connecticut", "boundedAnswer": "CJC-1295 no DAC in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-delaware", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "CJC-1295 no DAC in Delaware", "boundedAnswer": "CJC-1295 no DAC in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-florida", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Florida", "stateSlug": "florida", "searchQuery": "CJC-1295 no DAC in Florida", "boundedAnswer": "CJC-1295 no DAC in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-georgia", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "CJC-1295 no DAC in Georgia", "boundedAnswer": "CJC-1295 no DAC in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-hawaii", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "CJC-1295 no DAC in Hawaii", "boundedAnswer": "CJC-1295 no DAC in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-idaho", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "CJC-1295 no DAC in Idaho", "boundedAnswer": "CJC-1295 no DAC in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-illinois", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "CJC-1295 no DAC in Illinois", "boundedAnswer": "CJC-1295 no DAC in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-indiana", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "CJC-1295 no DAC in Indiana", "boundedAnswer": "CJC-1295 no DAC in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-iowa", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "CJC-1295 no DAC in Iowa", "boundedAnswer": "CJC-1295 no DAC in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-kansas", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "CJC-1295 no DAC in Kansas", "boundedAnswer": "CJC-1295 no DAC in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-kentucky", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "CJC-1295 no DAC in Kentucky", "boundedAnswer": "CJC-1295 no DAC in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-louisiana", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "CJC-1295 no DAC in Louisiana", "boundedAnswer": "CJC-1295 no DAC in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-maine", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maine", "stateSlug": "maine", "searchQuery": "CJC-1295 no DAC in Maine", "boundedAnswer": "CJC-1295 no DAC in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-maryland", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "CJC-1295 no DAC in Maryland", "boundedAnswer": "CJC-1295 no DAC in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-massachusetts", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "CJC-1295 no DAC in Massachusetts", "boundedAnswer": "CJC-1295 no DAC in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-michigan", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "CJC-1295 no DAC in Michigan", "boundedAnswer": "CJC-1295 no DAC in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-minnesota", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "CJC-1295 no DAC in Minnesota", "boundedAnswer": "CJC-1295 no DAC in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-mississippi", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "CJC-1295 no DAC in Mississippi", "boundedAnswer": "CJC-1295 no DAC in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-missouri", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "CJC-1295 no DAC in Missouri", "boundedAnswer": "CJC-1295 no DAC in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-montana", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Montana", "stateSlug": "montana", "searchQuery": "CJC-1295 no DAC in Montana", "boundedAnswer": "CJC-1295 no DAC in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-nebraska", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "CJC-1295 no DAC in Nebraska", "boundedAnswer": "CJC-1295 no DAC in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-nevada", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "CJC-1295 no DAC in Nevada", "boundedAnswer": "CJC-1295 no DAC in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-new-hampshire", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "CJC-1295 no DAC in New Hampshire", "boundedAnswer": "CJC-1295 no DAC in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-new-jersey", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "CJC-1295 no DAC in New Jersey", "boundedAnswer": "CJC-1295 no DAC in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-new-mexico", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "CJC-1295 no DAC in New Mexico", "boundedAnswer": "CJC-1295 no DAC in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-new-york", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New York", "stateSlug": "new-york", "searchQuery": "CJC-1295 no DAC in New York", "boundedAnswer": "CJC-1295 no DAC in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-north-carolina", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "CJC-1295 no DAC in North Carolina", "boundedAnswer": "CJC-1295 no DAC in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-north-dakota", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "CJC-1295 no DAC in North Dakota", "boundedAnswer": "CJC-1295 no DAC in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-ohio", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "CJC-1295 no DAC in Ohio", "boundedAnswer": "CJC-1295 no DAC in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-oklahoma", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "CJC-1295 no DAC in Oklahoma", "boundedAnswer": "CJC-1295 no DAC in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-oregon", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "CJC-1295 no DAC in Oregon", "boundedAnswer": "CJC-1295 no DAC in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-pennsylvania", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "CJC-1295 no DAC in Pennsylvania", "boundedAnswer": "CJC-1295 no DAC in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-rhode-island", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "CJC-1295 no DAC in Rhode Island", "boundedAnswer": "CJC-1295 no DAC in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-south-carolina", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "CJC-1295 no DAC in South Carolina", "boundedAnswer": "CJC-1295 no DAC in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-south-dakota", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "CJC-1295 no DAC in South Dakota", "boundedAnswer": "CJC-1295 no DAC in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-tennessee", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "CJC-1295 no DAC in Tennessee", "boundedAnswer": "CJC-1295 no DAC in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-texas", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Texas", "stateSlug": "texas", "searchQuery": "CJC-1295 no DAC in Texas", "boundedAnswer": "CJC-1295 no DAC in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-utah", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Utah", "stateSlug": "utah", "searchQuery": "CJC-1295 no DAC in Utah", "boundedAnswer": "CJC-1295 no DAC in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-vermont", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "CJC-1295 no DAC in Vermont", "boundedAnswer": "CJC-1295 no DAC in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-virginia", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "CJC-1295 no DAC in Virginia", "boundedAnswer": "CJC-1295 no DAC in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-washington", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Washington", "stateSlug": "washington", "searchQuery": "CJC-1295 no DAC in Washington", "boundedAnswer": "CJC-1295 no DAC in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-west-virginia", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "CJC-1295 no DAC in West Virginia", "boundedAnswer": "CJC-1295 no DAC in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-wisconsin", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "CJC-1295 no DAC in Wisconsin", "boundedAnswer": "CJC-1295 no DAC in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-no-dac-wyoming", "compound": "CJC-1295 no DAC", "compoundSlug": "cjc-1295-no-dac", "compoundAliases": [ "Modified GRF 1-29", "Mod GRF 1-29", "CJC 1295 without DAC" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "CJC-1295 no DAC in Wyoming", "boundedAnswer": "CJC-1295 no DAC in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-no-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-no-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-alabama", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "CJC-1295 DAC in Alabama", "boundedAnswer": "CJC-1295 DAC in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-alaska", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "CJC-1295 DAC in Alaska", "boundedAnswer": "CJC-1295 DAC in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-arizona", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "CJC-1295 DAC in Arizona", "boundedAnswer": "CJC-1295 DAC in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-arkansas", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "CJC-1295 DAC in Arkansas", "boundedAnswer": "CJC-1295 DAC in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-california", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "California", "stateSlug": "california", "searchQuery": "CJC-1295 DAC in California", "boundedAnswer": "CJC-1295 DAC in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-colorado", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "CJC-1295 DAC in Colorado", "boundedAnswer": "CJC-1295 DAC in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-connecticut", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "CJC-1295 DAC in Connecticut", "boundedAnswer": "CJC-1295 DAC in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-delaware", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "CJC-1295 DAC in Delaware", "boundedAnswer": "CJC-1295 DAC in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-florida", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Florida", "stateSlug": "florida", "searchQuery": "CJC-1295 DAC in Florida", "boundedAnswer": "CJC-1295 DAC in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-georgia", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "CJC-1295 DAC in Georgia", "boundedAnswer": "CJC-1295 DAC in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-hawaii", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "CJC-1295 DAC in Hawaii", "boundedAnswer": "CJC-1295 DAC in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-idaho", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "CJC-1295 DAC in Idaho", "boundedAnswer": "CJC-1295 DAC in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-illinois", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "CJC-1295 DAC in Illinois", "boundedAnswer": "CJC-1295 DAC in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-indiana", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "CJC-1295 DAC in Indiana", "boundedAnswer": "CJC-1295 DAC in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-iowa", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "CJC-1295 DAC in Iowa", "boundedAnswer": "CJC-1295 DAC in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-kansas", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "CJC-1295 DAC in Kansas", "boundedAnswer": "CJC-1295 DAC in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-kentucky", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "CJC-1295 DAC in Kentucky", "boundedAnswer": "CJC-1295 DAC in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-louisiana", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "CJC-1295 DAC in Louisiana", "boundedAnswer": "CJC-1295 DAC in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-maine", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maine", "stateSlug": "maine", "searchQuery": "CJC-1295 DAC in Maine", "boundedAnswer": "CJC-1295 DAC in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-maryland", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "CJC-1295 DAC in Maryland", "boundedAnswer": "CJC-1295 DAC in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-massachusetts", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "CJC-1295 DAC in Massachusetts", "boundedAnswer": "CJC-1295 DAC in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-michigan", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "CJC-1295 DAC in Michigan", "boundedAnswer": "CJC-1295 DAC in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-minnesota", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "CJC-1295 DAC in Minnesota", "boundedAnswer": "CJC-1295 DAC in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-mississippi", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "CJC-1295 DAC in Mississippi", "boundedAnswer": "CJC-1295 DAC in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-missouri", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "CJC-1295 DAC in Missouri", "boundedAnswer": "CJC-1295 DAC in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-montana", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Montana", "stateSlug": "montana", "searchQuery": "CJC-1295 DAC in Montana", "boundedAnswer": "CJC-1295 DAC in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-nebraska", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "CJC-1295 DAC in Nebraska", "boundedAnswer": "CJC-1295 DAC in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-nevada", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "CJC-1295 DAC in Nevada", "boundedAnswer": "CJC-1295 DAC in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-new-hampshire", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "CJC-1295 DAC in New Hampshire", "boundedAnswer": "CJC-1295 DAC in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-new-jersey", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "CJC-1295 DAC in New Jersey", "boundedAnswer": "CJC-1295 DAC in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-new-mexico", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "CJC-1295 DAC in New Mexico", "boundedAnswer": "CJC-1295 DAC in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-new-york", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New York", "stateSlug": "new-york", "searchQuery": "CJC-1295 DAC in New York", "boundedAnswer": "CJC-1295 DAC in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-north-carolina", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "CJC-1295 DAC in North Carolina", "boundedAnswer": "CJC-1295 DAC in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-north-dakota", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "CJC-1295 DAC in North Dakota", "boundedAnswer": "CJC-1295 DAC in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-ohio", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "CJC-1295 DAC in Ohio", "boundedAnswer": "CJC-1295 DAC in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-oklahoma", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "CJC-1295 DAC in Oklahoma", "boundedAnswer": "CJC-1295 DAC in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-oregon", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "CJC-1295 DAC in Oregon", "boundedAnswer": "CJC-1295 DAC in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-pennsylvania", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "CJC-1295 DAC in Pennsylvania", "boundedAnswer": "CJC-1295 DAC in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-rhode-island", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "CJC-1295 DAC in Rhode Island", "boundedAnswer": "CJC-1295 DAC in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-south-carolina", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "CJC-1295 DAC in South Carolina", "boundedAnswer": "CJC-1295 DAC in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-south-dakota", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "CJC-1295 DAC in South Dakota", "boundedAnswer": "CJC-1295 DAC in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-tennessee", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "CJC-1295 DAC in Tennessee", "boundedAnswer": "CJC-1295 DAC in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-texas", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Texas", "stateSlug": "texas", "searchQuery": "CJC-1295 DAC in Texas", "boundedAnswer": "CJC-1295 DAC in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-utah", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Utah", "stateSlug": "utah", "searchQuery": "CJC-1295 DAC in Utah", "boundedAnswer": "CJC-1295 DAC in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-vermont", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "CJC-1295 DAC in Vermont", "boundedAnswer": "CJC-1295 DAC in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-virginia", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "CJC-1295 DAC in Virginia", "boundedAnswer": "CJC-1295 DAC in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-washington", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Washington", "stateSlug": "washington", "searchQuery": "CJC-1295 DAC in Washington", "boundedAnswer": "CJC-1295 DAC in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-west-virginia", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "CJC-1295 DAC in West Virginia", "boundedAnswer": "CJC-1295 DAC in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-wisconsin", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "CJC-1295 DAC in Wisconsin", "boundedAnswer": "CJC-1295 DAC in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-cjc-1295-dac-wyoming", "compound": "CJC-1295 DAC", "compoundSlug": "cjc-1295-dac", "compoundAliases": [ "CJC-1295 with DAC", "CJC 1295 DAC", "DAC:GRF" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "CJC-1295 DAC in Wyoming", "boundedAnswer": "CJC-1295 DAC in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/cjc-1295-dac", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/cjc-1295-dac/countries" }, { "recordId": "pl-compound-state-retatrutide-alabama", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Retatrutide in Alabama", "boundedAnswer": "Retatrutide in Alabama refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-alaska", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Retatrutide in Alaska", "boundedAnswer": "Retatrutide in Alaska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-arizona", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Retatrutide in Arizona", "boundedAnswer": "Retatrutide in Arizona refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-arkansas", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Retatrutide in Arkansas", "boundedAnswer": "Retatrutide in Arkansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-california", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "California", "stateSlug": "california", "searchQuery": "Retatrutide in California", "boundedAnswer": "Retatrutide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-colorado", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Retatrutide in Colorado", "boundedAnswer": "Retatrutide in Colorado refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-connecticut", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Retatrutide in Connecticut", "boundedAnswer": "Retatrutide in Connecticut refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-delaware", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Retatrutide in Delaware", "boundedAnswer": "Retatrutide in Delaware refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-florida", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Florida", "stateSlug": "florida", "searchQuery": "Retatrutide in Florida", "boundedAnswer": "Retatrutide in Florida refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-georgia", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Retatrutide in Georgia", "boundedAnswer": "Retatrutide in Georgia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-hawaii", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Retatrutide in Hawaii", "boundedAnswer": "Retatrutide in Hawaii refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-idaho", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Retatrutide in Idaho", "boundedAnswer": "Retatrutide in Idaho refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-illinois", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Retatrutide in Illinois", "boundedAnswer": "Retatrutide in Illinois refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-indiana", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Retatrutide in Indiana", "boundedAnswer": "Retatrutide in Indiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-iowa", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Retatrutide in Iowa", "boundedAnswer": "Retatrutide in Iowa refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-kansas", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Retatrutide in Kansas", "boundedAnswer": "Retatrutide in Kansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-kentucky", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Retatrutide in Kentucky", "boundedAnswer": "Retatrutide in Kentucky refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-louisiana", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Retatrutide in Louisiana", "boundedAnswer": "Retatrutide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-maine", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maine", "stateSlug": "maine", "searchQuery": "Retatrutide in Maine", "boundedAnswer": "Retatrutide in Maine refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-maryland", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Retatrutide in Maryland", "boundedAnswer": "Retatrutide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-massachusetts", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Retatrutide in Massachusetts", "boundedAnswer": "Retatrutide in Massachusetts refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-michigan", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Retatrutide in Michigan", "boundedAnswer": "Retatrutide in Michigan refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-minnesota", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Retatrutide in Minnesota", "boundedAnswer": "Retatrutide in Minnesota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-mississippi", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Retatrutide in Mississippi", "boundedAnswer": "Retatrutide in Mississippi refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-missouri", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Retatrutide in Missouri", "boundedAnswer": "Retatrutide in Missouri refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-montana", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Montana", "stateSlug": "montana", "searchQuery": "Retatrutide in Montana", "boundedAnswer": "Retatrutide in Montana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-nebraska", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Retatrutide in Nebraska", "boundedAnswer": "Retatrutide in Nebraska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-nevada", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Retatrutide in Nevada", "boundedAnswer": "Retatrutide in Nevada refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-new-hampshire", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Retatrutide in New Hampshire", "boundedAnswer": "Retatrutide in New Hampshire refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-new-jersey", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Retatrutide in New Jersey", "boundedAnswer": "Retatrutide in New Jersey refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-new-mexico", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Retatrutide in New Mexico", "boundedAnswer": "Retatrutide in New Mexico refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-new-york", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New York", "stateSlug": "new-york", "searchQuery": "Retatrutide in New York", "boundedAnswer": "Retatrutide in New York refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-north-carolina", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Retatrutide in North Carolina", "boundedAnswer": "Retatrutide in North Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-north-dakota", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Retatrutide in North Dakota", "boundedAnswer": "Retatrutide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-ohio", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Retatrutide in Ohio", "boundedAnswer": "Retatrutide in Ohio refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-oklahoma", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Retatrutide in Oklahoma", "boundedAnswer": "Retatrutide in Oklahoma refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-oregon", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Retatrutide in Oregon", "boundedAnswer": "Retatrutide in Oregon refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-pennsylvania", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Retatrutide in Pennsylvania", "boundedAnswer": "Retatrutide in Pennsylvania refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-rhode-island", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Retatrutide in Rhode Island", "boundedAnswer": "Retatrutide in Rhode Island refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-south-carolina", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Retatrutide in South Carolina", "boundedAnswer": "Retatrutide in South Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-south-dakota", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Retatrutide in South Dakota", "boundedAnswer": "Retatrutide in South Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-tennessee", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Retatrutide in Tennessee", "boundedAnswer": "Retatrutide in Tennessee refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-texas", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Texas", "stateSlug": "texas", "searchQuery": "Retatrutide in Texas", "boundedAnswer": "Retatrutide in Texas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-utah", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Utah", "stateSlug": "utah", "searchQuery": "Retatrutide in Utah", "boundedAnswer": "Retatrutide in Utah refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-vermont", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Retatrutide in Vermont", "boundedAnswer": "Retatrutide in Vermont refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-virginia", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Retatrutide in Virginia", "boundedAnswer": "Retatrutide in Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-washington", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Washington", "stateSlug": "washington", "searchQuery": "Retatrutide in Washington", "boundedAnswer": "Retatrutide in Washington refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-west-virginia", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Retatrutide in West Virginia", "boundedAnswer": "Retatrutide in West Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-wisconsin", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Retatrutide in Wisconsin", "boundedAnswer": "Retatrutide in Wisconsin refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-retatrutide-wyoming", "compound": "Retatrutide", "compoundSlug": "retatrutide", "compoundAliases": [ "LY3437943", "triple agonist", "reta", "reta peptide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Retatrutide in Wyoming", "boundedAnswer": "Retatrutide in Wyoming refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/retatrutide", "identitySourceLabel": "TRIUMPH-1 Phase 3 study - NCT05929066", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05929066", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/retatrutide/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/retatrutide/countries" }, { "recordId": "pl-compound-state-mazdutide-alabama", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Mazdutide in Alabama", "boundedAnswer": "Mazdutide in Alabama refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-alaska", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Mazdutide in Alaska", "boundedAnswer": "Mazdutide in Alaska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-arizona", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Mazdutide in Arizona", "boundedAnswer": "Mazdutide in Arizona refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-arkansas", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Mazdutide in Arkansas", "boundedAnswer": "Mazdutide in Arkansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-california", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "California", "stateSlug": "california", "searchQuery": "Mazdutide in California", "boundedAnswer": "Mazdutide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-colorado", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Mazdutide in Colorado", "boundedAnswer": "Mazdutide in Colorado refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-connecticut", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Mazdutide in Connecticut", "boundedAnswer": "Mazdutide in Connecticut refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-delaware", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Mazdutide in Delaware", "boundedAnswer": "Mazdutide in Delaware refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-florida", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Florida", "stateSlug": "florida", "searchQuery": "Mazdutide in Florida", "boundedAnswer": "Mazdutide in Florida refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-georgia", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Mazdutide in Georgia", "boundedAnswer": "Mazdutide in Georgia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-hawaii", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Mazdutide in Hawaii", "boundedAnswer": "Mazdutide in Hawaii refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-idaho", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Mazdutide in Idaho", "boundedAnswer": "Mazdutide in Idaho refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-illinois", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Mazdutide in Illinois", "boundedAnswer": "Mazdutide in Illinois refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-indiana", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Mazdutide in Indiana", "boundedAnswer": "Mazdutide in Indiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-iowa", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Mazdutide in Iowa", "boundedAnswer": "Mazdutide in Iowa refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-kansas", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Mazdutide in Kansas", "boundedAnswer": "Mazdutide in Kansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-kentucky", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Mazdutide in Kentucky", "boundedAnswer": "Mazdutide in Kentucky refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-louisiana", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Mazdutide in Louisiana", "boundedAnswer": "Mazdutide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-maine", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Maine", "stateSlug": "maine", "searchQuery": "Mazdutide in Maine", "boundedAnswer": "Mazdutide in Maine refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-maryland", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Mazdutide in Maryland", "boundedAnswer": "Mazdutide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-massachusetts", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Mazdutide in Massachusetts", "boundedAnswer": "Mazdutide in Massachusetts refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-michigan", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Mazdutide in Michigan", "boundedAnswer": "Mazdutide in Michigan refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-minnesota", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Mazdutide in Minnesota", "boundedAnswer": "Mazdutide in Minnesota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-mississippi", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Mazdutide in Mississippi", "boundedAnswer": "Mazdutide in Mississippi refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-missouri", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Mazdutide in Missouri", "boundedAnswer": "Mazdutide in Missouri refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-montana", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Montana", "stateSlug": "montana", "searchQuery": "Mazdutide in Montana", "boundedAnswer": "Mazdutide in Montana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-nebraska", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Mazdutide in Nebraska", "boundedAnswer": "Mazdutide in Nebraska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-nevada", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Mazdutide in Nevada", "boundedAnswer": "Mazdutide in Nevada refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-new-hampshire", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Mazdutide in New Hampshire", "boundedAnswer": "Mazdutide in New Hampshire refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-new-jersey", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Mazdutide in New Jersey", "boundedAnswer": "Mazdutide in New Jersey refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-new-mexico", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Mazdutide in New Mexico", "boundedAnswer": "Mazdutide in New Mexico refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-new-york", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "New York", "stateSlug": "new-york", "searchQuery": "Mazdutide in New York", "boundedAnswer": "Mazdutide in New York refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-north-carolina", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Mazdutide in North Carolina", "boundedAnswer": "Mazdutide in North Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-north-dakota", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Mazdutide in North Dakota", "boundedAnswer": "Mazdutide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-ohio", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Mazdutide in Ohio", "boundedAnswer": "Mazdutide in Ohio refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-oklahoma", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Mazdutide in Oklahoma", "boundedAnswer": "Mazdutide in Oklahoma refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-oregon", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Mazdutide in Oregon", "boundedAnswer": "Mazdutide in Oregon refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-pennsylvania", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Mazdutide in Pennsylvania", "boundedAnswer": "Mazdutide in Pennsylvania refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-rhode-island", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Mazdutide in Rhode Island", "boundedAnswer": "Mazdutide in Rhode Island refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-south-carolina", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Mazdutide in South Carolina", "boundedAnswer": "Mazdutide in South Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-south-dakota", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Mazdutide in South Dakota", "boundedAnswer": "Mazdutide in South Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-tennessee", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Mazdutide in Tennessee", "boundedAnswer": "Mazdutide in Tennessee refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-texas", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Texas", "stateSlug": "texas", "searchQuery": "Mazdutide in Texas", "boundedAnswer": "Mazdutide in Texas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-utah", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Utah", "stateSlug": "utah", "searchQuery": "Mazdutide in Utah", "boundedAnswer": "Mazdutide in Utah refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-vermont", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Mazdutide in Vermont", "boundedAnswer": "Mazdutide in Vermont refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-virginia", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Mazdutide in Virginia", "boundedAnswer": "Mazdutide in Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-washington", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Washington", "stateSlug": "washington", "searchQuery": "Mazdutide in Washington", "boundedAnswer": "Mazdutide in Washington refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-west-virginia", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Mazdutide in West Virginia", "boundedAnswer": "Mazdutide in West Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-wisconsin", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Mazdutide in Wisconsin", "boundedAnswer": "Mazdutide in Wisconsin refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-mazdutide-wyoming", "compound": "Mazdutide", "compoundSlug": "mazdutide", "compoundAliases": [ "IBI362", "LY3305677", "GLP-1/glucagon dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active clinical program", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Mazdutide in Wyoming", "boundedAnswer": "Mazdutide in Wyoming refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/mazdutide", "identitySourceLabel": "GLORY-1 Phase 3 study - NCT05607680", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05607680", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/mazdutide/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/mazdutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-alabama", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Ecnoglutide in Alabama", "boundedAnswer": "Ecnoglutide in Alabama refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-alaska", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Ecnoglutide in Alaska", "boundedAnswer": "Ecnoglutide in Alaska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-arizona", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Ecnoglutide in Arizona", "boundedAnswer": "Ecnoglutide in Arizona refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-arkansas", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Ecnoglutide in Arkansas", "boundedAnswer": "Ecnoglutide in Arkansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-california", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "California", "stateSlug": "california", "searchQuery": "Ecnoglutide in California", "boundedAnswer": "Ecnoglutide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-colorado", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Ecnoglutide in Colorado", "boundedAnswer": "Ecnoglutide in Colorado refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-connecticut", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Ecnoglutide in Connecticut", "boundedAnswer": "Ecnoglutide in Connecticut refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-delaware", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Ecnoglutide in Delaware", "boundedAnswer": "Ecnoglutide in Delaware refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-florida", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Florida", "stateSlug": "florida", "searchQuery": "Ecnoglutide in Florida", "boundedAnswer": "Ecnoglutide in Florida refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-georgia", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Ecnoglutide in Georgia", "boundedAnswer": "Ecnoglutide in Georgia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-hawaii", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Ecnoglutide in Hawaii", "boundedAnswer": "Ecnoglutide in Hawaii refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-idaho", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Ecnoglutide in Idaho", "boundedAnswer": "Ecnoglutide in Idaho refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-illinois", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Ecnoglutide in Illinois", "boundedAnswer": "Ecnoglutide in Illinois refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-indiana", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Ecnoglutide in Indiana", "boundedAnswer": "Ecnoglutide in Indiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-iowa", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Ecnoglutide in Iowa", "boundedAnswer": "Ecnoglutide in Iowa refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-kansas", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Ecnoglutide in Kansas", "boundedAnswer": "Ecnoglutide in Kansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-kentucky", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Ecnoglutide in Kentucky", "boundedAnswer": "Ecnoglutide in Kentucky refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-louisiana", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Ecnoglutide in Louisiana", "boundedAnswer": "Ecnoglutide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-maine", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Maine", "stateSlug": "maine", "searchQuery": "Ecnoglutide in Maine", "boundedAnswer": "Ecnoglutide in Maine refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-maryland", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Ecnoglutide in Maryland", "boundedAnswer": "Ecnoglutide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-massachusetts", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Ecnoglutide in Massachusetts", "boundedAnswer": "Ecnoglutide in Massachusetts refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-michigan", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Ecnoglutide in Michigan", "boundedAnswer": "Ecnoglutide in Michigan refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-minnesota", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Ecnoglutide in Minnesota", "boundedAnswer": "Ecnoglutide in Minnesota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-mississippi", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Ecnoglutide in Mississippi", "boundedAnswer": "Ecnoglutide in Mississippi refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-missouri", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Ecnoglutide in Missouri", "boundedAnswer": "Ecnoglutide in Missouri refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-montana", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Montana", "stateSlug": "montana", "searchQuery": "Ecnoglutide in Montana", "boundedAnswer": "Ecnoglutide in Montana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-nebraska", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Ecnoglutide in Nebraska", "boundedAnswer": "Ecnoglutide in Nebraska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-nevada", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Ecnoglutide in Nevada", "boundedAnswer": "Ecnoglutide in Nevada refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-new-hampshire", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Ecnoglutide in New Hampshire", "boundedAnswer": "Ecnoglutide in New Hampshire refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-new-jersey", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Ecnoglutide in New Jersey", "boundedAnswer": "Ecnoglutide in New Jersey refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-new-mexico", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Ecnoglutide in New Mexico", "boundedAnswer": "Ecnoglutide in New Mexico refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-new-york", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "New York", "stateSlug": "new-york", "searchQuery": "Ecnoglutide in New York", "boundedAnswer": "Ecnoglutide in New York refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-north-carolina", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Ecnoglutide in North Carolina", "boundedAnswer": "Ecnoglutide in North Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-north-dakota", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Ecnoglutide in North Dakota", "boundedAnswer": "Ecnoglutide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-ohio", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Ecnoglutide in Ohio", "boundedAnswer": "Ecnoglutide in Ohio refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-oklahoma", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Ecnoglutide in Oklahoma", "boundedAnswer": "Ecnoglutide in Oklahoma refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-oregon", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Ecnoglutide in Oregon", "boundedAnswer": "Ecnoglutide in Oregon refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-pennsylvania", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Ecnoglutide in Pennsylvania", "boundedAnswer": "Ecnoglutide in Pennsylvania refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-rhode-island", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Ecnoglutide in Rhode Island", "boundedAnswer": "Ecnoglutide in Rhode Island refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-south-carolina", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Ecnoglutide in South Carolina", "boundedAnswer": "Ecnoglutide in South Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-south-dakota", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Ecnoglutide in South Dakota", "boundedAnswer": "Ecnoglutide in South Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-tennessee", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Ecnoglutide in Tennessee", "boundedAnswer": "Ecnoglutide in Tennessee refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-texas", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Texas", "stateSlug": "texas", "searchQuery": "Ecnoglutide in Texas", "boundedAnswer": "Ecnoglutide in Texas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-utah", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Utah", "stateSlug": "utah", "searchQuery": "Ecnoglutide in Utah", "boundedAnswer": "Ecnoglutide in Utah refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-vermont", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Ecnoglutide in Vermont", "boundedAnswer": "Ecnoglutide in Vermont refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-virginia", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Ecnoglutide in Virginia", "boundedAnswer": "Ecnoglutide in Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-washington", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Washington", "stateSlug": "washington", "searchQuery": "Ecnoglutide in Washington", "boundedAnswer": "Ecnoglutide in Washington refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-west-virginia", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Ecnoglutide in West Virginia", "boundedAnswer": "Ecnoglutide in West Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-wisconsin", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Ecnoglutide in Wisconsin", "boundedAnswer": "Ecnoglutide in Wisconsin refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-ecnoglutide-wyoming", "compound": "Ecnoglutide", "compoundSlug": "ecnoglutide", "compoundAliases": [ "XW003", "Sciwind ecnoglutide", "cAMP-biased GLP-1 receptor agonist", "埃诺格鲁肽" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "China-approved medicine and active development program", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Ecnoglutide in Wyoming", "boundedAnswer": "Ecnoglutide in Wyoming refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/ecnoglutide", "identitySourceLabel": "SLIMMER Phase 3 study - NCT05813795", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05813795", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/ecnoglutide/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/ecnoglutide/countries" }, { "recordId": "pl-compound-state-enicepatide-alabama", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Enicepatide in Alabama", "boundedAnswer": "Enicepatide in Alabama refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-alaska", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Enicepatide in Alaska", "boundedAnswer": "Enicepatide in Alaska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-arizona", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Enicepatide in Arizona", "boundedAnswer": "Enicepatide in Arizona refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-arkansas", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Enicepatide in Arkansas", "boundedAnswer": "Enicepatide in Arkansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-california", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "California", "stateSlug": "california", "searchQuery": "Enicepatide in California", "boundedAnswer": "Enicepatide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-colorado", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Enicepatide in Colorado", "boundedAnswer": "Enicepatide in Colorado refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-connecticut", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Enicepatide in Connecticut", "boundedAnswer": "Enicepatide in Connecticut refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-delaware", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Enicepatide in Delaware", "boundedAnswer": "Enicepatide in Delaware refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-florida", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Florida", "stateSlug": "florida", "searchQuery": "Enicepatide in Florida", "boundedAnswer": "Enicepatide in Florida refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-georgia", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Enicepatide in Georgia", "boundedAnswer": "Enicepatide in Georgia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-hawaii", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Enicepatide in Hawaii", "boundedAnswer": "Enicepatide in Hawaii refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-idaho", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Enicepatide in Idaho", "boundedAnswer": "Enicepatide in Idaho refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-illinois", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Enicepatide in Illinois", "boundedAnswer": "Enicepatide in Illinois refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-indiana", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Enicepatide in Indiana", "boundedAnswer": "Enicepatide in Indiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-iowa", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Enicepatide in Iowa", "boundedAnswer": "Enicepatide in Iowa refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-kansas", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Enicepatide in Kansas", "boundedAnswer": "Enicepatide in Kansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-kentucky", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Enicepatide in Kentucky", "boundedAnswer": "Enicepatide in Kentucky refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-louisiana", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Enicepatide in Louisiana", "boundedAnswer": "Enicepatide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-maine", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maine", "stateSlug": "maine", "searchQuery": "Enicepatide in Maine", "boundedAnswer": "Enicepatide in Maine refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-maryland", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Enicepatide in Maryland", "boundedAnswer": "Enicepatide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-massachusetts", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Enicepatide in Massachusetts", "boundedAnswer": "Enicepatide in Massachusetts refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-michigan", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Enicepatide in Michigan", "boundedAnswer": "Enicepatide in Michigan refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-minnesota", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Enicepatide in Minnesota", "boundedAnswer": "Enicepatide in Minnesota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-mississippi", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Enicepatide in Mississippi", "boundedAnswer": "Enicepatide in Mississippi refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-missouri", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Enicepatide in Missouri", "boundedAnswer": "Enicepatide in Missouri refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-montana", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Montana", "stateSlug": "montana", "searchQuery": "Enicepatide in Montana", "boundedAnswer": "Enicepatide in Montana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-nebraska", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Enicepatide in Nebraska", "boundedAnswer": "Enicepatide in Nebraska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-nevada", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Enicepatide in Nevada", "boundedAnswer": "Enicepatide in Nevada refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-new-hampshire", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Enicepatide in New Hampshire", "boundedAnswer": "Enicepatide in New Hampshire refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-new-jersey", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Enicepatide in New Jersey", "boundedAnswer": "Enicepatide in New Jersey refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-new-mexico", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Enicepatide in New Mexico", "boundedAnswer": "Enicepatide in New Mexico refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-new-york", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New York", "stateSlug": "new-york", "searchQuery": "Enicepatide in New York", "boundedAnswer": "Enicepatide in New York refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-north-carolina", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Enicepatide in North Carolina", "boundedAnswer": "Enicepatide in North Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-north-dakota", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Enicepatide in North Dakota", "boundedAnswer": "Enicepatide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-ohio", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Enicepatide in Ohio", "boundedAnswer": "Enicepatide in Ohio refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-oklahoma", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Enicepatide in Oklahoma", "boundedAnswer": "Enicepatide in Oklahoma refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-oregon", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Enicepatide in Oregon", "boundedAnswer": "Enicepatide in Oregon refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-pennsylvania", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Enicepatide in Pennsylvania", "boundedAnswer": "Enicepatide in Pennsylvania refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-rhode-island", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Enicepatide in Rhode Island", "boundedAnswer": "Enicepatide in Rhode Island refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-south-carolina", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Enicepatide in South Carolina", "boundedAnswer": "Enicepatide in South Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-south-dakota", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Enicepatide in South Dakota", "boundedAnswer": "Enicepatide in South Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-tennessee", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Enicepatide in Tennessee", "boundedAnswer": "Enicepatide in Tennessee refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-texas", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Texas", "stateSlug": "texas", "searchQuery": "Enicepatide in Texas", "boundedAnswer": "Enicepatide in Texas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-utah", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Utah", "stateSlug": "utah", "searchQuery": "Enicepatide in Utah", "boundedAnswer": "Enicepatide in Utah refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-vermont", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Enicepatide in Vermont", "boundedAnswer": "Enicepatide in Vermont refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-virginia", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Enicepatide in Virginia", "boundedAnswer": "Enicepatide in Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-washington", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Washington", "stateSlug": "washington", "searchQuery": "Enicepatide in Washington", "boundedAnswer": "Enicepatide in Washington refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-west-virginia", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Enicepatide in West Virginia", "boundedAnswer": "Enicepatide in West Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-wisconsin", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Enicepatide in Wisconsin", "boundedAnswer": "Enicepatide in Wisconsin refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-enicepatide-wyoming", "compound": "Enicepatide", "compoundSlug": "enicepatide", "compoundAliases": [ "CT-388", "RO7795068", "RG6640" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Enicepatide in Wyoming", "boundedAnswer": "Enicepatide in Wyoming refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/enicepatide", "identitySourceLabel": "CT388-103 Phase 2 study - NCT06525935", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06525935", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/enicepatide/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/enicepatide/countries" }, { "recordId": "pl-compound-state-eloralintide-alabama", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Eloralintide in Alabama", "boundedAnswer": "Eloralintide in Alabama refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-alaska", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Eloralintide in Alaska", "boundedAnswer": "Eloralintide in Alaska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-arizona", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Eloralintide in Arizona", "boundedAnswer": "Eloralintide in Arizona refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-arkansas", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Eloralintide in Arkansas", "boundedAnswer": "Eloralintide in Arkansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-california", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "California", "stateSlug": "california", "searchQuery": "Eloralintide in California", "boundedAnswer": "Eloralintide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-colorado", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Eloralintide in Colorado", "boundedAnswer": "Eloralintide in Colorado refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-connecticut", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Eloralintide in Connecticut", "boundedAnswer": "Eloralintide in Connecticut refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-delaware", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Eloralintide in Delaware", "boundedAnswer": "Eloralintide in Delaware refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-florida", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Florida", "stateSlug": "florida", "searchQuery": "Eloralintide in Florida", "boundedAnswer": "Eloralintide in Florida refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-georgia", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Eloralintide in Georgia", "boundedAnswer": "Eloralintide in Georgia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-hawaii", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Eloralintide in Hawaii", "boundedAnswer": "Eloralintide in Hawaii refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-idaho", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Eloralintide in Idaho", "boundedAnswer": "Eloralintide in Idaho refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-illinois", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Eloralintide in Illinois", "boundedAnswer": "Eloralintide in Illinois refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-indiana", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Eloralintide in Indiana", "boundedAnswer": "Eloralintide in Indiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-iowa", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Eloralintide in Iowa", "boundedAnswer": "Eloralintide in Iowa refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-kansas", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Eloralintide in Kansas", "boundedAnswer": "Eloralintide in Kansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-kentucky", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Eloralintide in Kentucky", "boundedAnswer": "Eloralintide in Kentucky refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-louisiana", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Eloralintide in Louisiana", "boundedAnswer": "Eloralintide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-maine", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maine", "stateSlug": "maine", "searchQuery": "Eloralintide in Maine", "boundedAnswer": "Eloralintide in Maine refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-maryland", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Eloralintide in Maryland", "boundedAnswer": "Eloralintide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-massachusetts", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Eloralintide in Massachusetts", "boundedAnswer": "Eloralintide in Massachusetts refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-michigan", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Eloralintide in Michigan", "boundedAnswer": "Eloralintide in Michigan refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-minnesota", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Eloralintide in Minnesota", "boundedAnswer": "Eloralintide in Minnesota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-mississippi", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Eloralintide in Mississippi", "boundedAnswer": "Eloralintide in Mississippi refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-missouri", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Eloralintide in Missouri", "boundedAnswer": "Eloralintide in Missouri refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-montana", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Montana", "stateSlug": "montana", "searchQuery": "Eloralintide in Montana", "boundedAnswer": "Eloralintide in Montana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-nebraska", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Eloralintide in Nebraska", "boundedAnswer": "Eloralintide in Nebraska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-nevada", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Eloralintide in Nevada", "boundedAnswer": "Eloralintide in Nevada refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-new-hampshire", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Eloralintide in New Hampshire", "boundedAnswer": "Eloralintide in New Hampshire refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-new-jersey", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Eloralintide in New Jersey", "boundedAnswer": "Eloralintide in New Jersey refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-new-mexico", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Eloralintide in New Mexico", "boundedAnswer": "Eloralintide in New Mexico refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-new-york", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New York", "stateSlug": "new-york", "searchQuery": "Eloralintide in New York", "boundedAnswer": "Eloralintide in New York refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-north-carolina", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Eloralintide in North Carolina", "boundedAnswer": "Eloralintide in North Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-north-dakota", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Eloralintide in North Dakota", "boundedAnswer": "Eloralintide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-ohio", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Eloralintide in Ohio", "boundedAnswer": "Eloralintide in Ohio refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-oklahoma", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Eloralintide in Oklahoma", "boundedAnswer": "Eloralintide in Oklahoma refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-oregon", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Eloralintide in Oregon", "boundedAnswer": "Eloralintide in Oregon refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-pennsylvania", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Eloralintide in Pennsylvania", "boundedAnswer": "Eloralintide in Pennsylvania refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-rhode-island", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Eloralintide in Rhode Island", "boundedAnswer": "Eloralintide in Rhode Island refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-south-carolina", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Eloralintide in South Carolina", "boundedAnswer": "Eloralintide in South Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-south-dakota", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Eloralintide in South Dakota", "boundedAnswer": "Eloralintide in South Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-tennessee", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Eloralintide in Tennessee", "boundedAnswer": "Eloralintide in Tennessee refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-texas", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Texas", "stateSlug": "texas", "searchQuery": "Eloralintide in Texas", "boundedAnswer": "Eloralintide in Texas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-utah", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Utah", "stateSlug": "utah", "searchQuery": "Eloralintide in Utah", "boundedAnswer": "Eloralintide in Utah refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-vermont", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Eloralintide in Vermont", "boundedAnswer": "Eloralintide in Vermont refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-virginia", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Eloralintide in Virginia", "boundedAnswer": "Eloralintide in Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-washington", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Washington", "stateSlug": "washington", "searchQuery": "Eloralintide in Washington", "boundedAnswer": "Eloralintide in Washington refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-west-virginia", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Eloralintide in West Virginia", "boundedAnswer": "Eloralintide in West Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-wisconsin", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Eloralintide in Wisconsin", "boundedAnswer": "Eloralintide in Wisconsin refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-eloralintide-wyoming", "compound": "Eloralintide", "compoundSlug": "eloralintide", "compoundAliases": [ "LY3841136", "eloralintide peptide", "selective amylin receptor agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Eloralintide in Wyoming", "boundedAnswer": "Eloralintide in Wyoming refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/eloralintide", "identitySourceLabel": "Eloralintide Phase 2 study - NCT06230523", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06230523", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/eloralintide/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/eloralintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-alabama", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Cagrilintide in Alabama", "boundedAnswer": "Cagrilintide in Alabama refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-alaska", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Cagrilintide in Alaska", "boundedAnswer": "Cagrilintide in Alaska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-arizona", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Cagrilintide in Arizona", "boundedAnswer": "Cagrilintide in Arizona refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-arkansas", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Cagrilintide in Arkansas", "boundedAnswer": "Cagrilintide in Arkansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-california", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "California", "stateSlug": "california", "searchQuery": "Cagrilintide in California", "boundedAnswer": "Cagrilintide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-colorado", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Cagrilintide in Colorado", "boundedAnswer": "Cagrilintide in Colorado refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-connecticut", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Cagrilintide in Connecticut", "boundedAnswer": "Cagrilintide in Connecticut refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-delaware", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Cagrilintide in Delaware", "boundedAnswer": "Cagrilintide in Delaware refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-florida", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Florida", "stateSlug": "florida", "searchQuery": "Cagrilintide in Florida", "boundedAnswer": "Cagrilintide in Florida refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-georgia", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Cagrilintide in Georgia", "boundedAnswer": "Cagrilintide in Georgia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-hawaii", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Cagrilintide in Hawaii", "boundedAnswer": "Cagrilintide in Hawaii refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-idaho", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Cagrilintide in Idaho", "boundedAnswer": "Cagrilintide in Idaho refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-illinois", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Cagrilintide in Illinois", "boundedAnswer": "Cagrilintide in Illinois refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-indiana", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Cagrilintide in Indiana", "boundedAnswer": "Cagrilintide in Indiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-iowa", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Cagrilintide in Iowa", "boundedAnswer": "Cagrilintide in Iowa refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-kansas", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Cagrilintide in Kansas", "boundedAnswer": "Cagrilintide in Kansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-kentucky", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Cagrilintide in Kentucky", "boundedAnswer": "Cagrilintide in Kentucky refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-louisiana", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Cagrilintide in Louisiana", "boundedAnswer": "Cagrilintide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-maine", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maine", "stateSlug": "maine", "searchQuery": "Cagrilintide in Maine", "boundedAnswer": "Cagrilintide in Maine refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-maryland", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Cagrilintide in Maryland", "boundedAnswer": "Cagrilintide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-massachusetts", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Cagrilintide in Massachusetts", "boundedAnswer": "Cagrilintide in Massachusetts refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-michigan", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Cagrilintide in Michigan", "boundedAnswer": "Cagrilintide in Michigan refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-minnesota", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Cagrilintide in Minnesota", "boundedAnswer": "Cagrilintide in Minnesota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-mississippi", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Cagrilintide in Mississippi", "boundedAnswer": "Cagrilintide in Mississippi refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-missouri", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Cagrilintide in Missouri", "boundedAnswer": "Cagrilintide in Missouri refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-montana", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Montana", "stateSlug": "montana", "searchQuery": "Cagrilintide in Montana", "boundedAnswer": "Cagrilintide in Montana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-nebraska", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Cagrilintide in Nebraska", "boundedAnswer": "Cagrilintide in Nebraska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-nevada", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Cagrilintide in Nevada", "boundedAnswer": "Cagrilintide in Nevada refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-new-hampshire", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Cagrilintide in New Hampshire", "boundedAnswer": "Cagrilintide in New Hampshire refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-new-jersey", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Cagrilintide in New Jersey", "boundedAnswer": "Cagrilintide in New Jersey refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-new-mexico", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Cagrilintide in New Mexico", "boundedAnswer": "Cagrilintide in New Mexico refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-new-york", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New York", "stateSlug": "new-york", "searchQuery": "Cagrilintide in New York", "boundedAnswer": "Cagrilintide in New York refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-north-carolina", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Cagrilintide in North Carolina", "boundedAnswer": "Cagrilintide in North Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-north-dakota", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Cagrilintide in North Dakota", "boundedAnswer": "Cagrilintide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-ohio", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Cagrilintide in Ohio", "boundedAnswer": "Cagrilintide in Ohio refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-oklahoma", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Cagrilintide in Oklahoma", "boundedAnswer": "Cagrilintide in Oklahoma refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-oregon", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Cagrilintide in Oregon", "boundedAnswer": "Cagrilintide in Oregon refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-pennsylvania", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Cagrilintide in Pennsylvania", "boundedAnswer": "Cagrilintide in Pennsylvania refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-rhode-island", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Cagrilintide in Rhode Island", "boundedAnswer": "Cagrilintide in Rhode Island refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-south-carolina", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Cagrilintide in South Carolina", "boundedAnswer": "Cagrilintide in South Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-south-dakota", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Cagrilintide in South Dakota", "boundedAnswer": "Cagrilintide in South Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-tennessee", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Cagrilintide in Tennessee", "boundedAnswer": "Cagrilintide in Tennessee refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-texas", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Texas", "stateSlug": "texas", "searchQuery": "Cagrilintide in Texas", "boundedAnswer": "Cagrilintide in Texas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-utah", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Utah", "stateSlug": "utah", "searchQuery": "Cagrilintide in Utah", "boundedAnswer": "Cagrilintide in Utah refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-vermont", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Cagrilintide in Vermont", "boundedAnswer": "Cagrilintide in Vermont refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-virginia", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Cagrilintide in Virginia", "boundedAnswer": "Cagrilintide in Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-washington", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Washington", "stateSlug": "washington", "searchQuery": "Cagrilintide in Washington", "boundedAnswer": "Cagrilintide in Washington refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-west-virginia", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Cagrilintide in West Virginia", "boundedAnswer": "Cagrilintide in West Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-wisconsin", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Cagrilintide in Wisconsin", "boundedAnswer": "Cagrilintide in Wisconsin refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-cagrilintide-wyoming", "compound": "Cagrilintide", "compoundSlug": "cagrilintide", "compoundAliases": [ "AM833", "NNC0174-0833" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Cagrilintide in Wyoming", "boundedAnswer": "Cagrilintide in Wyoming refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrilintide", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrilintide/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/cagrilintide/countries" }, { "recordId": "pl-compound-state-petrelintide-alabama", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Petrelintide in Alabama", "boundedAnswer": "Petrelintide in Alabama refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-alaska", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Petrelintide in Alaska", "boundedAnswer": "Petrelintide in Alaska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-arizona", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Petrelintide in Arizona", "boundedAnswer": "Petrelintide in Arizona refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-arkansas", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Petrelintide in Arkansas", "boundedAnswer": "Petrelintide in Arkansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-california", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "California", "stateSlug": "california", "searchQuery": "Petrelintide in California", "boundedAnswer": "Petrelintide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-colorado", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Petrelintide in Colorado", "boundedAnswer": "Petrelintide in Colorado refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-connecticut", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Petrelintide in Connecticut", "boundedAnswer": "Petrelintide in Connecticut refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-delaware", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Petrelintide in Delaware", "boundedAnswer": "Petrelintide in Delaware refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-florida", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Florida", "stateSlug": "florida", "searchQuery": "Petrelintide in Florida", "boundedAnswer": "Petrelintide in Florida refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-georgia", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Petrelintide in Georgia", "boundedAnswer": "Petrelintide in Georgia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-hawaii", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Petrelintide in Hawaii", "boundedAnswer": "Petrelintide in Hawaii refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-idaho", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Petrelintide in Idaho", "boundedAnswer": "Petrelintide in Idaho refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-illinois", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Petrelintide in Illinois", "boundedAnswer": "Petrelintide in Illinois refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-indiana", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Petrelintide in Indiana", "boundedAnswer": "Petrelintide in Indiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-iowa", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Petrelintide in Iowa", "boundedAnswer": "Petrelintide in Iowa refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-kansas", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Petrelintide in Kansas", "boundedAnswer": "Petrelintide in Kansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-kentucky", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Petrelintide in Kentucky", "boundedAnswer": "Petrelintide in Kentucky refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-louisiana", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Petrelintide in Louisiana", "boundedAnswer": "Petrelintide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-maine", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maine", "stateSlug": "maine", "searchQuery": "Petrelintide in Maine", "boundedAnswer": "Petrelintide in Maine refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-maryland", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Petrelintide in Maryland", "boundedAnswer": "Petrelintide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-massachusetts", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Petrelintide in Massachusetts", "boundedAnswer": "Petrelintide in Massachusetts refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-michigan", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Petrelintide in Michigan", "boundedAnswer": "Petrelintide in Michigan refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-minnesota", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Petrelintide in Minnesota", "boundedAnswer": "Petrelintide in Minnesota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-mississippi", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Petrelintide in Mississippi", "boundedAnswer": "Petrelintide in Mississippi refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-missouri", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Petrelintide in Missouri", "boundedAnswer": "Petrelintide in Missouri refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-montana", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Montana", "stateSlug": "montana", "searchQuery": "Petrelintide in Montana", "boundedAnswer": "Petrelintide in Montana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-nebraska", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Petrelintide in Nebraska", "boundedAnswer": "Petrelintide in Nebraska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-nevada", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Petrelintide in Nevada", "boundedAnswer": "Petrelintide in Nevada refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-new-hampshire", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Petrelintide in New Hampshire", "boundedAnswer": "Petrelintide in New Hampshire refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-new-jersey", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Petrelintide in New Jersey", "boundedAnswer": "Petrelintide in New Jersey refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-new-mexico", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Petrelintide in New Mexico", "boundedAnswer": "Petrelintide in New Mexico refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-new-york", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New York", "stateSlug": "new-york", "searchQuery": "Petrelintide in New York", "boundedAnswer": "Petrelintide in New York refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-north-carolina", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Petrelintide in North Carolina", "boundedAnswer": "Petrelintide in North Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-north-dakota", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Petrelintide in North Dakota", "boundedAnswer": "Petrelintide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-ohio", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Petrelintide in Ohio", "boundedAnswer": "Petrelintide in Ohio refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-oklahoma", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Petrelintide in Oklahoma", "boundedAnswer": "Petrelintide in Oklahoma refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-oregon", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Petrelintide in Oregon", "boundedAnswer": "Petrelintide in Oregon refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-pennsylvania", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Petrelintide in Pennsylvania", "boundedAnswer": "Petrelintide in Pennsylvania refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-rhode-island", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Petrelintide in Rhode Island", "boundedAnswer": "Petrelintide in Rhode Island refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-south-carolina", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Petrelintide in South Carolina", "boundedAnswer": "Petrelintide in South Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-south-dakota", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Petrelintide in South Dakota", "boundedAnswer": "Petrelintide in South Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-tennessee", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Petrelintide in Tennessee", "boundedAnswer": "Petrelintide in Tennessee refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-texas", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Texas", "stateSlug": "texas", "searchQuery": "Petrelintide in Texas", "boundedAnswer": "Petrelintide in Texas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-utah", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Utah", "stateSlug": "utah", "searchQuery": "Petrelintide in Utah", "boundedAnswer": "Petrelintide in Utah refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-vermont", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Petrelintide in Vermont", "boundedAnswer": "Petrelintide in Vermont refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-virginia", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Petrelintide in Virginia", "boundedAnswer": "Petrelintide in Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-washington", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Washington", "stateSlug": "washington", "searchQuery": "Petrelintide in Washington", "boundedAnswer": "Petrelintide in Washington refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-west-virginia", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Petrelintide in West Virginia", "boundedAnswer": "Petrelintide in West Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-wisconsin", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Petrelintide in Wisconsin", "boundedAnswer": "Petrelintide in Wisconsin refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-petrelintide-wyoming", "compound": "Petrelintide", "compoundSlug": "petrelintide", "compoundAliases": [ "ZP8396", "long-acting amylin analogue" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Petrelintide in Wyoming", "boundedAnswer": "Petrelintide in Wyoming refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/petrelintide", "identitySourceLabel": "ZUPREME-1 Phase 2 study - NCT06662539", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06662539", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/petrelintide/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/petrelintide/countries" }, { "recordId": "pl-compound-state-cagrisema-alabama", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "CagriSema in Alabama", "boundedAnswer": "CagriSema in Alabama refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-alaska", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "CagriSema in Alaska", "boundedAnswer": "CagriSema in Alaska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-arizona", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "CagriSema in Arizona", "boundedAnswer": "CagriSema in Arizona refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-arkansas", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "CagriSema in Arkansas", "boundedAnswer": "CagriSema in Arkansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-california", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "California", "stateSlug": "california", "searchQuery": "CagriSema in California", "boundedAnswer": "CagriSema in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-colorado", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "CagriSema in Colorado", "boundedAnswer": "CagriSema in Colorado refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-connecticut", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "CagriSema in Connecticut", "boundedAnswer": "CagriSema in Connecticut refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-delaware", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "CagriSema in Delaware", "boundedAnswer": "CagriSema in Delaware refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-florida", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Florida", "stateSlug": "florida", "searchQuery": "CagriSema in Florida", "boundedAnswer": "CagriSema in Florida refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-georgia", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "CagriSema in Georgia", "boundedAnswer": "CagriSema in Georgia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-hawaii", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "CagriSema in Hawaii", "boundedAnswer": "CagriSema in Hawaii refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-idaho", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "CagriSema in Idaho", "boundedAnswer": "CagriSema in Idaho refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-illinois", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "CagriSema in Illinois", "boundedAnswer": "CagriSema in Illinois refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-indiana", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "CagriSema in Indiana", "boundedAnswer": "CagriSema in Indiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-iowa", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "CagriSema in Iowa", "boundedAnswer": "CagriSema in Iowa refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-kansas", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "CagriSema in Kansas", "boundedAnswer": "CagriSema in Kansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-kentucky", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "CagriSema in Kentucky", "boundedAnswer": "CagriSema in Kentucky refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-louisiana", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "CagriSema in Louisiana", "boundedAnswer": "CagriSema in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-maine", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maine", "stateSlug": "maine", "searchQuery": "CagriSema in Maine", "boundedAnswer": "CagriSema in Maine refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-maryland", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "CagriSema in Maryland", "boundedAnswer": "CagriSema in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-massachusetts", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "CagriSema in Massachusetts", "boundedAnswer": "CagriSema in Massachusetts refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-michigan", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "CagriSema in Michigan", "boundedAnswer": "CagriSema in Michigan refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-minnesota", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "CagriSema in Minnesota", "boundedAnswer": "CagriSema in Minnesota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-mississippi", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "CagriSema in Mississippi", "boundedAnswer": "CagriSema in Mississippi refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-missouri", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "CagriSema in Missouri", "boundedAnswer": "CagriSema in Missouri refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-montana", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Montana", "stateSlug": "montana", "searchQuery": "CagriSema in Montana", "boundedAnswer": "CagriSema in Montana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-nebraska", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "CagriSema in Nebraska", "boundedAnswer": "CagriSema in Nebraska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-nevada", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "CagriSema in Nevada", "boundedAnswer": "CagriSema in Nevada refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-new-hampshire", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "CagriSema in New Hampshire", "boundedAnswer": "CagriSema in New Hampshire refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-new-jersey", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "CagriSema in New Jersey", "boundedAnswer": "CagriSema in New Jersey refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-new-mexico", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "CagriSema in New Mexico", "boundedAnswer": "CagriSema in New Mexico refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-new-york", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New York", "stateSlug": "new-york", "searchQuery": "CagriSema in New York", "boundedAnswer": "CagriSema in New York refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-north-carolina", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "CagriSema in North Carolina", "boundedAnswer": "CagriSema in North Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-north-dakota", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "CagriSema in North Dakota", "boundedAnswer": "CagriSema in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-ohio", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "CagriSema in Ohio", "boundedAnswer": "CagriSema in Ohio refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-oklahoma", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "CagriSema in Oklahoma", "boundedAnswer": "CagriSema in Oklahoma refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-oregon", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "CagriSema in Oregon", "boundedAnswer": "CagriSema in Oregon refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-pennsylvania", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "CagriSema in Pennsylvania", "boundedAnswer": "CagriSema in Pennsylvania refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-rhode-island", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "CagriSema in Rhode Island", "boundedAnswer": "CagriSema in Rhode Island refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-south-carolina", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "CagriSema in South Carolina", "boundedAnswer": "CagriSema in South Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-south-dakota", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "CagriSema in South Dakota", "boundedAnswer": "CagriSema in South Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-tennessee", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "CagriSema in Tennessee", "boundedAnswer": "CagriSema in Tennessee refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-texas", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Texas", "stateSlug": "texas", "searchQuery": "CagriSema in Texas", "boundedAnswer": "CagriSema in Texas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-utah", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Utah", "stateSlug": "utah", "searchQuery": "CagriSema in Utah", "boundedAnswer": "CagriSema in Utah refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-vermont", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "CagriSema in Vermont", "boundedAnswer": "CagriSema in Vermont refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-virginia", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "CagriSema in Virginia", "boundedAnswer": "CagriSema in Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-washington", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Washington", "stateSlug": "washington", "searchQuery": "CagriSema in Washington", "boundedAnswer": "CagriSema in Washington refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-west-virginia", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "CagriSema in West Virginia", "boundedAnswer": "CagriSema in West Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-wisconsin", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "CagriSema in Wisconsin", "boundedAnswer": "CagriSema in Wisconsin refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-cagrisema-wyoming", "compound": "CagriSema", "compoundSlug": "cagrisema", "compoundAliases": [ "cagrilintide + semaglutide", "REDEFINE 1", "REIMAGINE 1-3" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "CagriSema in Wyoming", "boundedAnswer": "CagriSema in Wyoming refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/cagrisema", "identitySourceLabel": "REDEFINE 1 Phase 3 study - NCT05567796", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05567796", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/cagrisema/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/cagrisema/countries" }, { "recordId": "pl-compound-state-maritide-alabama", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "MariTide in Alabama", "boundedAnswer": "MariTide in Alabama refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-alaska", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "MariTide in Alaska", "boundedAnswer": "MariTide in Alaska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-arizona", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "MariTide in Arizona", "boundedAnswer": "MariTide in Arizona refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-arkansas", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "MariTide in Arkansas", "boundedAnswer": "MariTide in Arkansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-california", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "California", "stateSlug": "california", "searchQuery": "MariTide in California", "boundedAnswer": "MariTide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-colorado", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "MariTide in Colorado", "boundedAnswer": "MariTide in Colorado refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-connecticut", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "MariTide in Connecticut", "boundedAnswer": "MariTide in Connecticut refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-delaware", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "MariTide in Delaware", "boundedAnswer": "MariTide in Delaware refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-florida", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Florida", "stateSlug": "florida", "searchQuery": "MariTide in Florida", "boundedAnswer": "MariTide in Florida refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-georgia", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "MariTide in Georgia", "boundedAnswer": "MariTide in Georgia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-hawaii", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "MariTide in Hawaii", "boundedAnswer": "MariTide in Hawaii refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-idaho", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "MariTide in Idaho", "boundedAnswer": "MariTide in Idaho refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-illinois", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "MariTide in Illinois", "boundedAnswer": "MariTide in Illinois refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-indiana", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "MariTide in Indiana", "boundedAnswer": "MariTide in Indiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-iowa", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "MariTide in Iowa", "boundedAnswer": "MariTide in Iowa refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-kansas", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "MariTide in Kansas", "boundedAnswer": "MariTide in Kansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-kentucky", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "MariTide in Kentucky", "boundedAnswer": "MariTide in Kentucky refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-louisiana", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "MariTide in Louisiana", "boundedAnswer": "MariTide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-maine", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maine", "stateSlug": "maine", "searchQuery": "MariTide in Maine", "boundedAnswer": "MariTide in Maine refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-maryland", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "MariTide in Maryland", "boundedAnswer": "MariTide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-massachusetts", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "MariTide in Massachusetts", "boundedAnswer": "MariTide in Massachusetts refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-michigan", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "MariTide in Michigan", "boundedAnswer": "MariTide in Michigan refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-minnesota", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "MariTide in Minnesota", "boundedAnswer": "MariTide in Minnesota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-mississippi", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "MariTide in Mississippi", "boundedAnswer": "MariTide in Mississippi refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-missouri", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "MariTide in Missouri", "boundedAnswer": "MariTide in Missouri refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-montana", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Montana", "stateSlug": "montana", "searchQuery": "MariTide in Montana", "boundedAnswer": "MariTide in Montana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-nebraska", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "MariTide in Nebraska", "boundedAnswer": "MariTide in Nebraska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-nevada", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "MariTide in Nevada", "boundedAnswer": "MariTide in Nevada refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-new-hampshire", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "MariTide in New Hampshire", "boundedAnswer": "MariTide in New Hampshire refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-new-jersey", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "MariTide in New Jersey", "boundedAnswer": "MariTide in New Jersey refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-new-mexico", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "MariTide in New Mexico", "boundedAnswer": "MariTide in New Mexico refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-new-york", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New York", "stateSlug": "new-york", "searchQuery": "MariTide in New York", "boundedAnswer": "MariTide in New York refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-north-carolina", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "MariTide in North Carolina", "boundedAnswer": "MariTide in North Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-north-dakota", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "MariTide in North Dakota", "boundedAnswer": "MariTide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-ohio", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "MariTide in Ohio", "boundedAnswer": "MariTide in Ohio refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-oklahoma", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "MariTide in Oklahoma", "boundedAnswer": "MariTide in Oklahoma refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-oregon", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "MariTide in Oregon", "boundedAnswer": "MariTide in Oregon refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-pennsylvania", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "MariTide in Pennsylvania", "boundedAnswer": "MariTide in Pennsylvania refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-rhode-island", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "MariTide in Rhode Island", "boundedAnswer": "MariTide in Rhode Island refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-south-carolina", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "MariTide in South Carolina", "boundedAnswer": "MariTide in South Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-south-dakota", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "MariTide in South Dakota", "boundedAnswer": "MariTide in South Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-tennessee", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "MariTide in Tennessee", "boundedAnswer": "MariTide in Tennessee refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-texas", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Texas", "stateSlug": "texas", "searchQuery": "MariTide in Texas", "boundedAnswer": "MariTide in Texas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-utah", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Utah", "stateSlug": "utah", "searchQuery": "MariTide in Utah", "boundedAnswer": "MariTide in Utah refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-vermont", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "MariTide in Vermont", "boundedAnswer": "MariTide in Vermont refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-virginia", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "MariTide in Virginia", "boundedAnswer": "MariTide in Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-washington", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Washington", "stateSlug": "washington", "searchQuery": "MariTide in Washington", "boundedAnswer": "MariTide in Washington refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-west-virginia", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "MariTide in West Virginia", "boundedAnswer": "MariTide in West Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-wisconsin", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "MariTide in Wisconsin", "boundedAnswer": "MariTide in Wisconsin refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-maritide-wyoming", "compound": "MariTide", "compoundSlug": "maritide", "compoundAliases": [ "maridebart cafraglutide", "AMG 133" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "MariTide in Wyoming", "boundedAnswer": "MariTide in Wyoming refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/maritide", "identitySourceLabel": "Phase 2 dose-ranging study - NCT05669599", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05669599", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/maritide/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/maritide/countries" }, { "recordId": "pl-compound-state-survodutide-alabama", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Survodutide in Alabama", "boundedAnswer": "Survodutide in Alabama refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-alaska", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Survodutide in Alaska", "boundedAnswer": "Survodutide in Alaska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-arizona", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Survodutide in Arizona", "boundedAnswer": "Survodutide in Arizona refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-arkansas", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Survodutide in Arkansas", "boundedAnswer": "Survodutide in Arkansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-california", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "California", "stateSlug": "california", "searchQuery": "Survodutide in California", "boundedAnswer": "Survodutide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-colorado", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Survodutide in Colorado", "boundedAnswer": "Survodutide in Colorado refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-connecticut", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Survodutide in Connecticut", "boundedAnswer": "Survodutide in Connecticut refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-delaware", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Survodutide in Delaware", "boundedAnswer": "Survodutide in Delaware refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-florida", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Florida", "stateSlug": "florida", "searchQuery": "Survodutide in Florida", "boundedAnswer": "Survodutide in Florida refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-georgia", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Survodutide in Georgia", "boundedAnswer": "Survodutide in Georgia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-hawaii", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Survodutide in Hawaii", "boundedAnswer": "Survodutide in Hawaii refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-idaho", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Survodutide in Idaho", "boundedAnswer": "Survodutide in Idaho refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-illinois", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Survodutide in Illinois", "boundedAnswer": "Survodutide in Illinois refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-indiana", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Survodutide in Indiana", "boundedAnswer": "Survodutide in Indiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-iowa", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Survodutide in Iowa", "boundedAnswer": "Survodutide in Iowa refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-kansas", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Survodutide in Kansas", "boundedAnswer": "Survodutide in Kansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-kentucky", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Survodutide in Kentucky", "boundedAnswer": "Survodutide in Kentucky refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-louisiana", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Survodutide in Louisiana", "boundedAnswer": "Survodutide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-maine", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maine", "stateSlug": "maine", "searchQuery": "Survodutide in Maine", "boundedAnswer": "Survodutide in Maine refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-maryland", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Survodutide in Maryland", "boundedAnswer": "Survodutide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-massachusetts", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Survodutide in Massachusetts", "boundedAnswer": "Survodutide in Massachusetts refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-michigan", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Survodutide in Michigan", "boundedAnswer": "Survodutide in Michigan refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-minnesota", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Survodutide in Minnesota", "boundedAnswer": "Survodutide in Minnesota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-mississippi", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Survodutide in Mississippi", "boundedAnswer": "Survodutide in Mississippi refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-missouri", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Survodutide in Missouri", "boundedAnswer": "Survodutide in Missouri refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-montana", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Montana", "stateSlug": "montana", "searchQuery": "Survodutide in Montana", "boundedAnswer": "Survodutide in Montana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-nebraska", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Survodutide in Nebraska", "boundedAnswer": "Survodutide in Nebraska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-nevada", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Survodutide in Nevada", "boundedAnswer": "Survodutide in Nevada refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-new-hampshire", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Survodutide in New Hampshire", "boundedAnswer": "Survodutide in New Hampshire refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-new-jersey", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Survodutide in New Jersey", "boundedAnswer": "Survodutide in New Jersey refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-new-mexico", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Survodutide in New Mexico", "boundedAnswer": "Survodutide in New Mexico refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-new-york", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New York", "stateSlug": "new-york", "searchQuery": "Survodutide in New York", "boundedAnswer": "Survodutide in New York refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-north-carolina", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Survodutide in North Carolina", "boundedAnswer": "Survodutide in North Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-north-dakota", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Survodutide in North Dakota", "boundedAnswer": "Survodutide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-ohio", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Survodutide in Ohio", "boundedAnswer": "Survodutide in Ohio refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-oklahoma", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Survodutide in Oklahoma", "boundedAnswer": "Survodutide in Oklahoma refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-oregon", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Survodutide in Oregon", "boundedAnswer": "Survodutide in Oregon refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-pennsylvania", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Survodutide in Pennsylvania", "boundedAnswer": "Survodutide in Pennsylvania refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-rhode-island", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Survodutide in Rhode Island", "boundedAnswer": "Survodutide in Rhode Island refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-south-carolina", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Survodutide in South Carolina", "boundedAnswer": "Survodutide in South Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-south-dakota", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Survodutide in South Dakota", "boundedAnswer": "Survodutide in South Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-tennessee", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Survodutide in Tennessee", "boundedAnswer": "Survodutide in Tennessee refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-texas", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Texas", "stateSlug": "texas", "searchQuery": "Survodutide in Texas", "boundedAnswer": "Survodutide in Texas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-utah", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Utah", "stateSlug": "utah", "searchQuery": "Survodutide in Utah", "boundedAnswer": "Survodutide in Utah refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-vermont", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Survodutide in Vermont", "boundedAnswer": "Survodutide in Vermont refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-virginia", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Survodutide in Virginia", "boundedAnswer": "Survodutide in Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-washington", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Washington", "stateSlug": "washington", "searchQuery": "Survodutide in Washington", "boundedAnswer": "Survodutide in Washington refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-west-virginia", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Survodutide in West Virginia", "boundedAnswer": "Survodutide in West Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-wisconsin", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Survodutide in Wisconsin", "boundedAnswer": "Survodutide in Wisconsin refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-survodutide-wyoming", "compound": "Survodutide", "compoundSlug": "survodutide", "compoundAliases": [ "BI 456906", "glucagon/GLP-1 dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Survodutide in Wyoming", "boundedAnswer": "Survodutide in Wyoming refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/survodutide", "identitySourceLabel": "SYNCHRONIZE-1 Phase 3 study - NCT06066515", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06066515", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/survodutide/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/survodutide/countries" }, { "recordId": "pl-compound-state-vk2735-alabama", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "VK2735 in Alabama", "boundedAnswer": "VK2735 in Alabama refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-alaska", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "VK2735 in Alaska", "boundedAnswer": "VK2735 in Alaska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-arizona", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "VK2735 in Arizona", "boundedAnswer": "VK2735 in Arizona refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-arkansas", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "VK2735 in Arkansas", "boundedAnswer": "VK2735 in Arkansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-california", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "California", "stateSlug": "california", "searchQuery": "VK2735 in California", "boundedAnswer": "VK2735 in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-colorado", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "VK2735 in Colorado", "boundedAnswer": "VK2735 in Colorado refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-connecticut", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "VK2735 in Connecticut", "boundedAnswer": "VK2735 in Connecticut refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-delaware", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "VK2735 in Delaware", "boundedAnswer": "VK2735 in Delaware refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-florida", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Florida", "stateSlug": "florida", "searchQuery": "VK2735 in Florida", "boundedAnswer": "VK2735 in Florida refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-georgia", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "VK2735 in Georgia", "boundedAnswer": "VK2735 in Georgia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-hawaii", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "VK2735 in Hawaii", "boundedAnswer": "VK2735 in Hawaii refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-idaho", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "VK2735 in Idaho", "boundedAnswer": "VK2735 in Idaho refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-illinois", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "VK2735 in Illinois", "boundedAnswer": "VK2735 in Illinois refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-indiana", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "VK2735 in Indiana", "boundedAnswer": "VK2735 in Indiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-iowa", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "VK2735 in Iowa", "boundedAnswer": "VK2735 in Iowa refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-kansas", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "VK2735 in Kansas", "boundedAnswer": "VK2735 in Kansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-kentucky", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "VK2735 in Kentucky", "boundedAnswer": "VK2735 in Kentucky refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-louisiana", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "VK2735 in Louisiana", "boundedAnswer": "VK2735 in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-maine", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maine", "stateSlug": "maine", "searchQuery": "VK2735 in Maine", "boundedAnswer": "VK2735 in Maine refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-maryland", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "VK2735 in Maryland", "boundedAnswer": "VK2735 in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-massachusetts", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "VK2735 in Massachusetts", "boundedAnswer": "VK2735 in Massachusetts refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-michigan", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "VK2735 in Michigan", "boundedAnswer": "VK2735 in Michigan refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-minnesota", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "VK2735 in Minnesota", "boundedAnswer": "VK2735 in Minnesota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-mississippi", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "VK2735 in Mississippi", "boundedAnswer": "VK2735 in Mississippi refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-missouri", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "VK2735 in Missouri", "boundedAnswer": "VK2735 in Missouri refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-montana", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Montana", "stateSlug": "montana", "searchQuery": "VK2735 in Montana", "boundedAnswer": "VK2735 in Montana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-nebraska", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "VK2735 in Nebraska", "boundedAnswer": "VK2735 in Nebraska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-nevada", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "VK2735 in Nevada", "boundedAnswer": "VK2735 in Nevada refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-new-hampshire", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "VK2735 in New Hampshire", "boundedAnswer": "VK2735 in New Hampshire refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-new-jersey", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "VK2735 in New Jersey", "boundedAnswer": "VK2735 in New Jersey refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-new-mexico", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "VK2735 in New Mexico", "boundedAnswer": "VK2735 in New Mexico refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-new-york", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New York", "stateSlug": "new-york", "searchQuery": "VK2735 in New York", "boundedAnswer": "VK2735 in New York refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-north-carolina", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "VK2735 in North Carolina", "boundedAnswer": "VK2735 in North Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-north-dakota", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "VK2735 in North Dakota", "boundedAnswer": "VK2735 in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-ohio", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "VK2735 in Ohio", "boundedAnswer": "VK2735 in Ohio refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-oklahoma", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "VK2735 in Oklahoma", "boundedAnswer": "VK2735 in Oklahoma refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-oregon", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "VK2735 in Oregon", "boundedAnswer": "VK2735 in Oregon refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-pennsylvania", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "VK2735 in Pennsylvania", "boundedAnswer": "VK2735 in Pennsylvania refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-rhode-island", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "VK2735 in Rhode Island", "boundedAnswer": "VK2735 in Rhode Island refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-south-carolina", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "VK2735 in South Carolina", "boundedAnswer": "VK2735 in South Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-south-dakota", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "VK2735 in South Dakota", "boundedAnswer": "VK2735 in South Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-tennessee", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "VK2735 in Tennessee", "boundedAnswer": "VK2735 in Tennessee refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-texas", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Texas", "stateSlug": "texas", "searchQuery": "VK2735 in Texas", "boundedAnswer": "VK2735 in Texas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-utah", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Utah", "stateSlug": "utah", "searchQuery": "VK2735 in Utah", "boundedAnswer": "VK2735 in Utah refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-vermont", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "VK2735 in Vermont", "boundedAnswer": "VK2735 in Vermont refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-virginia", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "VK2735 in Virginia", "boundedAnswer": "VK2735 in Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-washington", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Washington", "stateSlug": "washington", "searchQuery": "VK2735 in Washington", "boundedAnswer": "VK2735 in Washington refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-west-virginia", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "VK2735 in West Virginia", "boundedAnswer": "VK2735 in West Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-wisconsin", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "VK2735 in Wisconsin", "boundedAnswer": "VK2735 in Wisconsin refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-vk2735-wyoming", "compound": "VK2735", "compoundSlug": "vk2735", "compoundAliases": [ "Viking VK2735", "oral VK2735", "GLP-1/GIP dual agonist" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "VK2735 in Wyoming", "boundedAnswer": "VK2735 in Wyoming refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/vk2735", "identitySourceLabel": "VENTURE injectable Phase 2 study - NCT06068946", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT06068946", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vk2735/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/vk2735/countries" }, { "recordId": "pl-compound-state-pemvidutide-alabama", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Pemvidutide in Alabama", "boundedAnswer": "Pemvidutide in Alabama refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-alaska", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Pemvidutide in Alaska", "boundedAnswer": "Pemvidutide in Alaska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-arizona", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Pemvidutide in Arizona", "boundedAnswer": "Pemvidutide in Arizona refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-arkansas", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Pemvidutide in Arkansas", "boundedAnswer": "Pemvidutide in Arkansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-california", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "California", "stateSlug": "california", "searchQuery": "Pemvidutide in California", "boundedAnswer": "Pemvidutide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-colorado", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Pemvidutide in Colorado", "boundedAnswer": "Pemvidutide in Colorado refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-connecticut", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Pemvidutide in Connecticut", "boundedAnswer": "Pemvidutide in Connecticut refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-delaware", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Pemvidutide in Delaware", "boundedAnswer": "Pemvidutide in Delaware refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-florida", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Florida", "stateSlug": "florida", "searchQuery": "Pemvidutide in Florida", "boundedAnswer": "Pemvidutide in Florida refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-georgia", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Pemvidutide in Georgia", "boundedAnswer": "Pemvidutide in Georgia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-hawaii", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Pemvidutide in Hawaii", "boundedAnswer": "Pemvidutide in Hawaii refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-idaho", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Pemvidutide in Idaho", "boundedAnswer": "Pemvidutide in Idaho refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-illinois", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Pemvidutide in Illinois", "boundedAnswer": "Pemvidutide in Illinois refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-indiana", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Pemvidutide in Indiana", "boundedAnswer": "Pemvidutide in Indiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-iowa", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Pemvidutide in Iowa", "boundedAnswer": "Pemvidutide in Iowa refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-kansas", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Pemvidutide in Kansas", "boundedAnswer": "Pemvidutide in Kansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-kentucky", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Pemvidutide in Kentucky", "boundedAnswer": "Pemvidutide in Kentucky refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-louisiana", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Pemvidutide in Louisiana", "boundedAnswer": "Pemvidutide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-maine", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maine", "stateSlug": "maine", "searchQuery": "Pemvidutide in Maine", "boundedAnswer": "Pemvidutide in Maine refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-maryland", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Pemvidutide in Maryland", "boundedAnswer": "Pemvidutide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-massachusetts", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Pemvidutide in Massachusetts", "boundedAnswer": "Pemvidutide in Massachusetts refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-michigan", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Pemvidutide in Michigan", "boundedAnswer": "Pemvidutide in Michigan refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-minnesota", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Pemvidutide in Minnesota", "boundedAnswer": "Pemvidutide in Minnesota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-mississippi", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Pemvidutide in Mississippi", "boundedAnswer": "Pemvidutide in Mississippi refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-missouri", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Pemvidutide in Missouri", "boundedAnswer": "Pemvidutide in Missouri refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-montana", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Montana", "stateSlug": "montana", "searchQuery": "Pemvidutide in Montana", "boundedAnswer": "Pemvidutide in Montana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-nebraska", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Pemvidutide in Nebraska", "boundedAnswer": "Pemvidutide in Nebraska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-nevada", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Pemvidutide in Nevada", "boundedAnswer": "Pemvidutide in Nevada refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-new-hampshire", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Pemvidutide in New Hampshire", "boundedAnswer": "Pemvidutide in New Hampshire refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-new-jersey", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Pemvidutide in New Jersey", "boundedAnswer": "Pemvidutide in New Jersey refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-new-mexico", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Pemvidutide in New Mexico", "boundedAnswer": "Pemvidutide in New Mexico refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-new-york", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New York", "stateSlug": "new-york", "searchQuery": "Pemvidutide in New York", "boundedAnswer": "Pemvidutide in New York refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-north-carolina", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Pemvidutide in North Carolina", "boundedAnswer": "Pemvidutide in North Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-north-dakota", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Pemvidutide in North Dakota", "boundedAnswer": "Pemvidutide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-ohio", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Pemvidutide in Ohio", "boundedAnswer": "Pemvidutide in Ohio refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-oklahoma", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Pemvidutide in Oklahoma", "boundedAnswer": "Pemvidutide in Oklahoma refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-oregon", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Pemvidutide in Oregon", "boundedAnswer": "Pemvidutide in Oregon refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-pennsylvania", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Pemvidutide in Pennsylvania", "boundedAnswer": "Pemvidutide in Pennsylvania refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-rhode-island", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Pemvidutide in Rhode Island", "boundedAnswer": "Pemvidutide in Rhode Island refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-south-carolina", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Pemvidutide in South Carolina", "boundedAnswer": "Pemvidutide in South Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-south-dakota", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Pemvidutide in South Dakota", "boundedAnswer": "Pemvidutide in South Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-tennessee", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Pemvidutide in Tennessee", "boundedAnswer": "Pemvidutide in Tennessee refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-texas", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Texas", "stateSlug": "texas", "searchQuery": "Pemvidutide in Texas", "boundedAnswer": "Pemvidutide in Texas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-utah", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Utah", "stateSlug": "utah", "searchQuery": "Pemvidutide in Utah", "boundedAnswer": "Pemvidutide in Utah refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-vermont", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Pemvidutide in Vermont", "boundedAnswer": "Pemvidutide in Vermont refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-virginia", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Pemvidutide in Virginia", "boundedAnswer": "Pemvidutide in Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-washington", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Washington", "stateSlug": "washington", "searchQuery": "Pemvidutide in Washington", "boundedAnswer": "Pemvidutide in Washington refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-west-virginia", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Pemvidutide in West Virginia", "boundedAnswer": "Pemvidutide in West Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-wisconsin", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Pemvidutide in Wisconsin", "boundedAnswer": "Pemvidutide in Wisconsin refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-pemvidutide-wyoming", "compound": "Pemvidutide", "compoundSlug": "pemvidutide", "compoundAliases": [ "ALT-801", "balanced GLP-1/glucagon dual agonist", "Altimmune pemvidutide" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Pemvidutide in Wyoming", "boundedAnswer": "Pemvidutide in Wyoming refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/pemvidutide", "identitySourceLabel": "IMPACT Phase 2b MASH study - NCT05989711", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT05989711", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/pemvidutide/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/pemvidutide/countries" }, { "recordId": "pl-compound-state-amycretin-alabama", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Amycretin / Zenagamtide in Alabama", "boundedAnswer": "Amycretin / Zenagamtide in Alabama refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-alaska", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Amycretin / Zenagamtide in Alaska", "boundedAnswer": "Amycretin / Zenagamtide in Alaska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-arizona", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Amycretin / Zenagamtide in Arizona", "boundedAnswer": "Amycretin / Zenagamtide in Arizona refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-arkansas", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Amycretin / Zenagamtide in Arkansas", "boundedAnswer": "Amycretin / Zenagamtide in Arkansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-california", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "California", "stateSlug": "california", "searchQuery": "Amycretin / Zenagamtide in California", "boundedAnswer": "Amycretin / Zenagamtide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-colorado", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Amycretin / Zenagamtide in Colorado", "boundedAnswer": "Amycretin / Zenagamtide in Colorado refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-connecticut", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Amycretin / Zenagamtide in Connecticut", "boundedAnswer": "Amycretin / Zenagamtide in Connecticut refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-delaware", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Amycretin / Zenagamtide in Delaware", "boundedAnswer": "Amycretin / Zenagamtide in Delaware refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-florida", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Florida", "stateSlug": "florida", "searchQuery": "Amycretin / Zenagamtide in Florida", "boundedAnswer": "Amycretin / Zenagamtide in Florida refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-georgia", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Amycretin / Zenagamtide in Georgia", "boundedAnswer": "Amycretin / Zenagamtide in Georgia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-hawaii", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Amycretin / Zenagamtide in Hawaii", "boundedAnswer": "Amycretin / Zenagamtide in Hawaii refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-idaho", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Amycretin / Zenagamtide in Idaho", "boundedAnswer": "Amycretin / Zenagamtide in Idaho refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-illinois", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Amycretin / Zenagamtide in Illinois", "boundedAnswer": "Amycretin / Zenagamtide in Illinois refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-indiana", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Amycretin / Zenagamtide in Indiana", "boundedAnswer": "Amycretin / Zenagamtide in Indiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-iowa", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Amycretin / Zenagamtide in Iowa", "boundedAnswer": "Amycretin / Zenagamtide in Iowa refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-kansas", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Amycretin / Zenagamtide in Kansas", "boundedAnswer": "Amycretin / Zenagamtide in Kansas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-kentucky", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Amycretin / Zenagamtide in Kentucky", "boundedAnswer": "Amycretin / Zenagamtide in Kentucky refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-louisiana", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Amycretin / Zenagamtide in Louisiana", "boundedAnswer": "Amycretin / Zenagamtide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-maine", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maine", "stateSlug": "maine", "searchQuery": "Amycretin / Zenagamtide in Maine", "boundedAnswer": "Amycretin / Zenagamtide in Maine refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-maryland", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Amycretin / Zenagamtide in Maryland", "boundedAnswer": "Amycretin / Zenagamtide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-massachusetts", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Amycretin / Zenagamtide in Massachusetts", "boundedAnswer": "Amycretin / Zenagamtide in Massachusetts refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-michigan", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Amycretin / Zenagamtide in Michigan", "boundedAnswer": "Amycretin / Zenagamtide in Michigan refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-minnesota", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Amycretin / Zenagamtide in Minnesota", "boundedAnswer": "Amycretin / Zenagamtide in Minnesota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-mississippi", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Amycretin / Zenagamtide in Mississippi", "boundedAnswer": "Amycretin / Zenagamtide in Mississippi refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-missouri", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Amycretin / Zenagamtide in Missouri", "boundedAnswer": "Amycretin / Zenagamtide in Missouri refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-montana", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Montana", "stateSlug": "montana", "searchQuery": "Amycretin / Zenagamtide in Montana", "boundedAnswer": "Amycretin / Zenagamtide in Montana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-nebraska", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Amycretin / Zenagamtide in Nebraska", "boundedAnswer": "Amycretin / Zenagamtide in Nebraska refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-nevada", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Amycretin / Zenagamtide in Nevada", "boundedAnswer": "Amycretin / Zenagamtide in Nevada refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-new-hampshire", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Amycretin / Zenagamtide in New Hampshire", "boundedAnswer": "Amycretin / Zenagamtide in New Hampshire refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-new-jersey", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Amycretin / Zenagamtide in New Jersey", "boundedAnswer": "Amycretin / Zenagamtide in New Jersey refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-new-mexico", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Amycretin / Zenagamtide in New Mexico", "boundedAnswer": "Amycretin / Zenagamtide in New Mexico refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-new-york", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "New York", "stateSlug": "new-york", "searchQuery": "Amycretin / Zenagamtide in New York", "boundedAnswer": "Amycretin / Zenagamtide in New York refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-north-carolina", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Amycretin / Zenagamtide in North Carolina", "boundedAnswer": "Amycretin / Zenagamtide in North Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-north-dakota", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Amycretin / Zenagamtide in North Dakota", "boundedAnswer": "Amycretin / Zenagamtide in North Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-ohio", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Amycretin / Zenagamtide in Ohio", "boundedAnswer": "Amycretin / Zenagamtide in Ohio refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-oklahoma", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Amycretin / Zenagamtide in Oklahoma", "boundedAnswer": "Amycretin / Zenagamtide in Oklahoma refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-oregon", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Amycretin / Zenagamtide in Oregon", "boundedAnswer": "Amycretin / Zenagamtide in Oregon refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-pennsylvania", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Amycretin / Zenagamtide in Pennsylvania", "boundedAnswer": "Amycretin / Zenagamtide in Pennsylvania refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-rhode-island", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Amycretin / Zenagamtide in Rhode Island", "boundedAnswer": "Amycretin / Zenagamtide in Rhode Island refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-south-carolina", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Amycretin / Zenagamtide in South Carolina", "boundedAnswer": "Amycretin / Zenagamtide in South Carolina refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-south-dakota", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Amycretin / Zenagamtide in South Dakota", "boundedAnswer": "Amycretin / Zenagamtide in South Dakota refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-tennessee", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Amycretin / Zenagamtide in Tennessee", "boundedAnswer": "Amycretin / Zenagamtide in Tennessee refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-texas", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Texas", "stateSlug": "texas", "searchQuery": "Amycretin / Zenagamtide in Texas", "boundedAnswer": "Amycretin / Zenagamtide in Texas refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-utah", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Utah", "stateSlug": "utah", "searchQuery": "Amycretin / Zenagamtide in Utah", "boundedAnswer": "Amycretin / Zenagamtide in Utah refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-vermont", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Amycretin / Zenagamtide in Vermont", "boundedAnswer": "Amycretin / Zenagamtide in Vermont refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-virginia", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Amycretin / Zenagamtide in Virginia", "boundedAnswer": "Amycretin / Zenagamtide in Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-washington", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Washington", "stateSlug": "washington", "searchQuery": "Amycretin / Zenagamtide in Washington", "boundedAnswer": "Amycretin / Zenagamtide in Washington refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-west-virginia", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Amycretin / Zenagamtide in West Virginia", "boundedAnswer": "Amycretin / Zenagamtide in West Virginia refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-wisconsin", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Amycretin / Zenagamtide in Wisconsin", "boundedAnswer": "Amycretin / Zenagamtide in Wisconsin refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-amycretin-wyoming", "compound": "Amycretin / Zenagamtide", "compoundSlug": "amycretin", "compoundAliases": [ "amycretin", "NNC0487-0111", "AMAZE 7" ], "evidenceLane": "Clinical pipeline profile", "identityStatus": "Investigational clinical program", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Amycretin / Zenagamtide in Wyoming", "boundedAnswer": "Amycretin / Zenagamtide in Wyoming refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/pipeline/amycretin", "identitySourceLabel": "AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414", "identitySourcePublisher": "ClinicalTrials.gov", "identitySourceUrl": "https://clinicaltrials.gov/study/NCT07668414", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/amycretin/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/amycretin/countries" }, { "recordId": "pl-compound-state-tirzepatide-alabama", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Tirzepatide in Alabama", "boundedAnswer": "Tirzepatide in Alabama begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-alaska", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Tirzepatide in Alaska", "boundedAnswer": "Tirzepatide in Alaska begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-arizona", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Tirzepatide in Arizona", "boundedAnswer": "Tirzepatide in Arizona begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-arkansas", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Tirzepatide in Arkansas", "boundedAnswer": "Tirzepatide in Arkansas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-california", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "California", "stateSlug": "california", "searchQuery": "Tirzepatide in California", "boundedAnswer": "Tirzepatide in California begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-colorado", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Tirzepatide in Colorado", "boundedAnswer": "Tirzepatide in Colorado begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-connecticut", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Tirzepatide in Connecticut", "boundedAnswer": "Tirzepatide in Connecticut begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-delaware", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Tirzepatide in Delaware", "boundedAnswer": "Tirzepatide in Delaware begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-florida", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Florida", "stateSlug": "florida", "searchQuery": "Tirzepatide in Florida", "boundedAnswer": "Tirzepatide in Florida begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-georgia", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Tirzepatide in Georgia", "boundedAnswer": "Tirzepatide in Georgia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-hawaii", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Tirzepatide in Hawaii", "boundedAnswer": "Tirzepatide in Hawaii begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-idaho", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Tirzepatide in Idaho", "boundedAnswer": "Tirzepatide in Idaho begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-illinois", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Tirzepatide in Illinois", "boundedAnswer": "Tirzepatide in Illinois begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-indiana", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Tirzepatide in Indiana", "boundedAnswer": "Tirzepatide in Indiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-iowa", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Tirzepatide in Iowa", "boundedAnswer": "Tirzepatide in Iowa begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-kansas", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Tirzepatide in Kansas", "boundedAnswer": "Tirzepatide in Kansas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-kentucky", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Tirzepatide in Kentucky", "boundedAnswer": "Tirzepatide in Kentucky begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-louisiana", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Tirzepatide in Louisiana", "boundedAnswer": "Tirzepatide in Louisiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-maine", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Maine", "stateSlug": "maine", "searchQuery": "Tirzepatide in Maine", "boundedAnswer": "Tirzepatide in Maine begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-maryland", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Tirzepatide in Maryland", "boundedAnswer": "Tirzepatide in Maryland begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-massachusetts", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Tirzepatide in Massachusetts", "boundedAnswer": "Tirzepatide in Massachusetts begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-michigan", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Tirzepatide in Michigan", "boundedAnswer": "Tirzepatide in Michigan begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-minnesota", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Tirzepatide in Minnesota", "boundedAnswer": "Tirzepatide in Minnesota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-mississippi", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Tirzepatide in Mississippi", "boundedAnswer": "Tirzepatide in Mississippi begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-missouri", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Tirzepatide in Missouri", "boundedAnswer": "Tirzepatide in Missouri begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-montana", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Montana", "stateSlug": "montana", "searchQuery": "Tirzepatide in Montana", "boundedAnswer": "Tirzepatide in Montana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-nebraska", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Tirzepatide in Nebraska", "boundedAnswer": "Tirzepatide in Nebraska begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-nevada", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Tirzepatide in Nevada", "boundedAnswer": "Tirzepatide in Nevada begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-new-hampshire", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Tirzepatide in New Hampshire", "boundedAnswer": "Tirzepatide in New Hampshire begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-new-jersey", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Tirzepatide in New Jersey", "boundedAnswer": "Tirzepatide in New Jersey begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-new-mexico", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Tirzepatide in New Mexico", "boundedAnswer": "Tirzepatide in New Mexico begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-new-york", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "New York", "stateSlug": "new-york", "searchQuery": "Tirzepatide in New York", "boundedAnswer": "Tirzepatide in New York begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-north-carolina", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Tirzepatide in North Carolina", "boundedAnswer": "Tirzepatide in North Carolina begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-north-dakota", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Tirzepatide in North Dakota", "boundedAnswer": "Tirzepatide in North Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-ohio", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Tirzepatide in Ohio", "boundedAnswer": "Tirzepatide in Ohio begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-oklahoma", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Tirzepatide in Oklahoma", "boundedAnswer": "Tirzepatide in Oklahoma begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-oregon", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Tirzepatide in Oregon", "boundedAnswer": "Tirzepatide in Oregon begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-pennsylvania", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Tirzepatide in Pennsylvania", "boundedAnswer": "Tirzepatide in Pennsylvania begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-rhode-island", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Tirzepatide in Rhode Island", "boundedAnswer": "Tirzepatide in Rhode Island begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-south-carolina", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Tirzepatide in South Carolina", "boundedAnswer": "Tirzepatide in South Carolina begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-south-dakota", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Tirzepatide in South Dakota", "boundedAnswer": "Tirzepatide in South Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-tennessee", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Tirzepatide in Tennessee", "boundedAnswer": "Tirzepatide in Tennessee begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-texas", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Texas", "stateSlug": "texas", "searchQuery": "Tirzepatide in Texas", "boundedAnswer": "Tirzepatide in Texas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-utah", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Utah", "stateSlug": "utah", "searchQuery": "Tirzepatide in Utah", "boundedAnswer": "Tirzepatide in Utah begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-vermont", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Tirzepatide in Vermont", "boundedAnswer": "Tirzepatide in Vermont begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-virginia", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Tirzepatide in Virginia", "boundedAnswer": "Tirzepatide in Virginia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-washington", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Washington", "stateSlug": "washington", "searchQuery": "Tirzepatide in Washington", "boundedAnswer": "Tirzepatide in Washington begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-west-virginia", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Tirzepatide in West Virginia", "boundedAnswer": "Tirzepatide in West Virginia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-wisconsin", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Tirzepatide in Wisconsin", "boundedAnswer": "Tirzepatide in Wisconsin begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-tirzepatide-wyoming", "compound": "Tirzepatide", "compoundSlug": "tirzepatide", "compoundAliases": [ "tirzepatide", "Zepbound", "LY3298176", "NDA 217806", "GIP and GLP-1 receptor agonist" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "US FDA medicine reference", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Tirzepatide in Wyoming", "boundedAnswer": "Tirzepatide in Wyoming begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/zepbound", "identitySourceLabel": "Current ZEPBOUND prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/tirzepatide/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/tirzepatide/countries" }, { "recordId": "pl-compound-state-orforglipron-alabama", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Orforglipron / Foundayo in Alabama", "boundedAnswer": "Orforglipron / Foundayo in Alabama begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-alaska", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Orforglipron / Foundayo in Alaska", "boundedAnswer": "Orforglipron / Foundayo in Alaska begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-arizona", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Orforglipron / Foundayo in Arizona", "boundedAnswer": "Orforglipron / Foundayo in Arizona begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-arkansas", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Orforglipron / Foundayo in Arkansas", "boundedAnswer": "Orforglipron / Foundayo in Arkansas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-california", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "California", "stateSlug": "california", "searchQuery": "Orforglipron / Foundayo in California", "boundedAnswer": "Orforglipron / Foundayo in California begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-colorado", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Orforglipron / Foundayo in Colorado", "boundedAnswer": "Orforglipron / Foundayo in Colorado begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-connecticut", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Orforglipron / Foundayo in Connecticut", "boundedAnswer": "Orforglipron / Foundayo in Connecticut begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-delaware", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Orforglipron / Foundayo in Delaware", "boundedAnswer": "Orforglipron / Foundayo in Delaware begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-florida", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Florida", "stateSlug": "florida", "searchQuery": "Orforglipron / Foundayo in Florida", "boundedAnswer": "Orforglipron / Foundayo in Florida begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-georgia", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Orforglipron / Foundayo in Georgia", "boundedAnswer": "Orforglipron / Foundayo in Georgia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-hawaii", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Orforglipron / Foundayo in Hawaii", "boundedAnswer": "Orforglipron / Foundayo in Hawaii begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-idaho", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Orforglipron / Foundayo in Idaho", "boundedAnswer": "Orforglipron / Foundayo in Idaho begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-illinois", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Orforglipron / Foundayo in Illinois", "boundedAnswer": "Orforglipron / Foundayo in Illinois begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-indiana", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Orforglipron / Foundayo in Indiana", "boundedAnswer": "Orforglipron / Foundayo in Indiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-iowa", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Orforglipron / Foundayo in Iowa", "boundedAnswer": "Orforglipron / Foundayo in Iowa begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-kansas", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Orforglipron / Foundayo in Kansas", "boundedAnswer": "Orforglipron / Foundayo in Kansas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-kentucky", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Orforglipron / Foundayo in Kentucky", "boundedAnswer": "Orforglipron / Foundayo in Kentucky begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-louisiana", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Orforglipron / Foundayo in Louisiana", "boundedAnswer": "Orforglipron / Foundayo in Louisiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-maine", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Maine", "stateSlug": "maine", "searchQuery": "Orforglipron / Foundayo in Maine", "boundedAnswer": "Orforglipron / Foundayo in Maine begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-maryland", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Orforglipron / Foundayo in Maryland", "boundedAnswer": "Orforglipron / Foundayo in Maryland begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-massachusetts", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Orforglipron / Foundayo in Massachusetts", "boundedAnswer": "Orforglipron / Foundayo in Massachusetts begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-michigan", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Orforglipron / Foundayo in Michigan", "boundedAnswer": "Orforglipron / Foundayo in Michigan begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-minnesota", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Orforglipron / Foundayo in Minnesota", "boundedAnswer": "Orforglipron / Foundayo in Minnesota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-mississippi", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Orforglipron / Foundayo in Mississippi", "boundedAnswer": "Orforglipron / Foundayo in Mississippi begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-missouri", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Orforglipron / Foundayo in Missouri", "boundedAnswer": "Orforglipron / Foundayo in Missouri begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-montana", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Montana", "stateSlug": "montana", "searchQuery": "Orforglipron / Foundayo in Montana", "boundedAnswer": "Orforglipron / Foundayo in Montana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-nebraska", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Orforglipron / Foundayo in Nebraska", "boundedAnswer": "Orforglipron / Foundayo in Nebraska begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-nevada", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Orforglipron / Foundayo in Nevada", "boundedAnswer": "Orforglipron / Foundayo in Nevada begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-new-hampshire", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Orforglipron / Foundayo in New Hampshire", "boundedAnswer": "Orforglipron / Foundayo in New Hampshire begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-new-jersey", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Orforglipron / Foundayo in New Jersey", "boundedAnswer": "Orforglipron / Foundayo in New Jersey begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-new-mexico", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Orforglipron / Foundayo in New Mexico", "boundedAnswer": "Orforglipron / Foundayo in New Mexico begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-new-york", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "New York", "stateSlug": "new-york", "searchQuery": "Orforglipron / Foundayo in New York", "boundedAnswer": "Orforglipron / Foundayo in New York begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-north-carolina", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Orforglipron / Foundayo in North Carolina", "boundedAnswer": "Orforglipron / Foundayo in North Carolina begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-north-dakota", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Orforglipron / Foundayo in North Dakota", "boundedAnswer": "Orforglipron / Foundayo in North Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-ohio", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Orforglipron / Foundayo in Ohio", "boundedAnswer": "Orforglipron / Foundayo in Ohio begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-oklahoma", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Orforglipron / Foundayo in Oklahoma", "boundedAnswer": "Orforglipron / Foundayo in Oklahoma begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-oregon", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Orforglipron / Foundayo in Oregon", "boundedAnswer": "Orforglipron / Foundayo in Oregon begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-pennsylvania", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Orforglipron / Foundayo in Pennsylvania", "boundedAnswer": "Orforglipron / Foundayo in Pennsylvania begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-rhode-island", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Orforglipron / Foundayo in Rhode Island", "boundedAnswer": "Orforglipron / Foundayo in Rhode Island begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-south-carolina", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Orforglipron / Foundayo in South Carolina", "boundedAnswer": "Orforglipron / Foundayo in South Carolina begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-south-dakota", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Orforglipron / Foundayo in South Dakota", "boundedAnswer": "Orforglipron / Foundayo in South Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-tennessee", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Orforglipron / Foundayo in Tennessee", "boundedAnswer": "Orforglipron / Foundayo in Tennessee begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-texas", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Texas", "stateSlug": "texas", "searchQuery": "Orforglipron / Foundayo in Texas", "boundedAnswer": "Orforglipron / Foundayo in Texas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-utah", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Utah", "stateSlug": "utah", "searchQuery": "Orforglipron / Foundayo in Utah", "boundedAnswer": "Orforglipron / Foundayo in Utah begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-vermont", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Orforglipron / Foundayo in Vermont", "boundedAnswer": "Orforglipron / Foundayo in Vermont begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-virginia", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Orforglipron / Foundayo in Virginia", "boundedAnswer": "Orforglipron / Foundayo in Virginia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-washington", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Washington", "stateSlug": "washington", "searchQuery": "Orforglipron / Foundayo in Washington", "boundedAnswer": "Orforglipron / Foundayo in Washington begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-west-virginia", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Orforglipron / Foundayo in West Virginia", "boundedAnswer": "Orforglipron / Foundayo in West Virginia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-wisconsin", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Orforglipron / Foundayo in Wisconsin", "boundedAnswer": "Orforglipron / Foundayo in Wisconsin begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-orforglipron-wyoming", "compound": "Orforglipron / Foundayo", "compoundSlug": "orforglipron", "compoundAliases": [ "orforglipron", "Foundayo", "LY3502970", "NDA 220934", "oral GLP-1", "nonpeptide GLP-1", "non-peptide GLP-1", "weight loss pill" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with country-specific status elsewhere", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Orforglipron / Foundayo in Wyoming", "boundedAnswer": "Orforglipron / Foundayo in Wyoming begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/foundayo", "identitySourceLabel": "Current FOUNDAYO prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/orforglipron/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/orforglipron/countries" }, { "recordId": "pl-compound-state-semaglutide-alabama", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Semaglutide in Alabama", "boundedAnswer": "Semaglutide in Alabama begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-alaska", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Semaglutide in Alaska", "boundedAnswer": "Semaglutide in Alaska begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-arizona", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Semaglutide in Arizona", "boundedAnswer": "Semaglutide in Arizona begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-arkansas", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Semaglutide in Arkansas", "boundedAnswer": "Semaglutide in Arkansas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-california", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "California", "stateSlug": "california", "searchQuery": "Semaglutide in California", "boundedAnswer": "Semaglutide in California begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-colorado", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Semaglutide in Colorado", "boundedAnswer": "Semaglutide in Colorado begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-connecticut", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Semaglutide in Connecticut", "boundedAnswer": "Semaglutide in Connecticut begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-delaware", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Semaglutide in Delaware", "boundedAnswer": "Semaglutide in Delaware begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-florida", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Florida", "stateSlug": "florida", "searchQuery": "Semaglutide in Florida", "boundedAnswer": "Semaglutide in Florida begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-georgia", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Semaglutide in Georgia", "boundedAnswer": "Semaglutide in Georgia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-hawaii", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Semaglutide in Hawaii", "boundedAnswer": "Semaglutide in Hawaii begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-idaho", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Semaglutide in Idaho", "boundedAnswer": "Semaglutide in Idaho begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-illinois", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Semaglutide in Illinois", "boundedAnswer": "Semaglutide in Illinois begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-indiana", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Semaglutide in Indiana", "boundedAnswer": "Semaglutide in Indiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-iowa", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Semaglutide in Iowa", "boundedAnswer": "Semaglutide in Iowa begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-kansas", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Semaglutide in Kansas", "boundedAnswer": "Semaglutide in Kansas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-kentucky", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Semaglutide in Kentucky", "boundedAnswer": "Semaglutide in Kentucky begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-louisiana", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Semaglutide in Louisiana", "boundedAnswer": "Semaglutide in Louisiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-maine", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Maine", "stateSlug": "maine", "searchQuery": "Semaglutide in Maine", "boundedAnswer": "Semaglutide in Maine begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-maryland", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Semaglutide in Maryland", "boundedAnswer": "Semaglutide in Maryland begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-massachusetts", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Semaglutide in Massachusetts", "boundedAnswer": "Semaglutide in Massachusetts begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-michigan", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Semaglutide in Michigan", "boundedAnswer": "Semaglutide in Michigan begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-minnesota", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Semaglutide in Minnesota", "boundedAnswer": "Semaglutide in Minnesota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-mississippi", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Semaglutide in Mississippi", "boundedAnswer": "Semaglutide in Mississippi begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-missouri", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Semaglutide in Missouri", "boundedAnswer": "Semaglutide in Missouri begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-montana", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Montana", "stateSlug": "montana", "searchQuery": "Semaglutide in Montana", "boundedAnswer": "Semaglutide in Montana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-nebraska", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Semaglutide in Nebraska", "boundedAnswer": "Semaglutide in Nebraska begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-nevada", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Semaglutide in Nevada", "boundedAnswer": "Semaglutide in Nevada begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-new-hampshire", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Semaglutide in New Hampshire", "boundedAnswer": "Semaglutide in New Hampshire begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-new-jersey", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Semaglutide in New Jersey", "boundedAnswer": "Semaglutide in New Jersey begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-new-mexico", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Semaglutide in New Mexico", "boundedAnswer": "Semaglutide in New Mexico begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-new-york", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "New York", "stateSlug": "new-york", "searchQuery": "Semaglutide in New York", "boundedAnswer": "Semaglutide in New York begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-north-carolina", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Semaglutide in North Carolina", "boundedAnswer": "Semaglutide in North Carolina begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-north-dakota", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Semaglutide in North Dakota", "boundedAnswer": "Semaglutide in North Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-ohio", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Semaglutide in Ohio", "boundedAnswer": "Semaglutide in Ohio begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-oklahoma", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Semaglutide in Oklahoma", "boundedAnswer": "Semaglutide in Oklahoma begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-oregon", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Semaglutide in Oregon", "boundedAnswer": "Semaglutide in Oregon begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-pennsylvania", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Semaglutide in Pennsylvania", "boundedAnswer": "Semaglutide in Pennsylvania begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-rhode-island", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Semaglutide in Rhode Island", "boundedAnswer": "Semaglutide in Rhode Island begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-south-carolina", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Semaglutide in South Carolina", "boundedAnswer": "Semaglutide in South Carolina begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-south-dakota", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Semaglutide in South Dakota", "boundedAnswer": "Semaglutide in South Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-tennessee", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Semaglutide in Tennessee", "boundedAnswer": "Semaglutide in Tennessee begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-texas", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Texas", "stateSlug": "texas", "searchQuery": "Semaglutide in Texas", "boundedAnswer": "Semaglutide in Texas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-utah", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Utah", "stateSlug": "utah", "searchQuery": "Semaglutide in Utah", "boundedAnswer": "Semaglutide in Utah begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-vermont", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Semaglutide in Vermont", "boundedAnswer": "Semaglutide in Vermont begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-virginia", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Semaglutide in Virginia", "boundedAnswer": "Semaglutide in Virginia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-washington", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Washington", "stateSlug": "washington", "searchQuery": "Semaglutide in Washington", "boundedAnswer": "Semaglutide in Washington begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-west-virginia", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Semaglutide in West Virginia", "boundedAnswer": "Semaglutide in West Virginia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-wisconsin", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Semaglutide in Wisconsin", "boundedAnswer": "Semaglutide in Wisconsin begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-semaglutide-wyoming", "compound": "Semaglutide", "compoundSlug": "semaglutide", "compoundAliases": [ "semaglutide", "Wegovy", "NDA 215256", "GLP-1 receptor agonist", "semaglutide injection", "semaglutide tablets", "oral Wegovy", "Wegovy pill", "sémaglutide", "semaglutida", "Semaglutid", "司美格鲁肽", "semaglutyd", "semaglutid", "Ozempic by country", "Rybelsus by country" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific approved medicine records in multiple jurisdictions", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Semaglutide in Wyoming", "boundedAnswer": "Semaglutide in Wyoming begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/wegovy", "identitySourceLabel": "Current WEGOVY prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/semaglutide/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/semaglutide/countries" }, { "recordId": "pl-compound-state-dsip-alabama", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "DSIP / Emideltide in Alabama", "boundedAnswer": "DSIP / Emideltide in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-alaska", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "DSIP / Emideltide in Alaska", "boundedAnswer": "DSIP / Emideltide in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-arizona", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "DSIP / Emideltide in Arizona", "boundedAnswer": "DSIP / Emideltide in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-arkansas", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "DSIP / Emideltide in Arkansas", "boundedAnswer": "DSIP / Emideltide in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-california", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "California", "stateSlug": "california", "searchQuery": "DSIP / Emideltide in California", "boundedAnswer": "DSIP / Emideltide in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-colorado", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "DSIP / Emideltide in Colorado", "boundedAnswer": "DSIP / Emideltide in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-connecticut", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "DSIP / Emideltide in Connecticut", "boundedAnswer": "DSIP / Emideltide in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-delaware", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "DSIP / Emideltide in Delaware", "boundedAnswer": "DSIP / Emideltide in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-florida", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Florida", "stateSlug": "florida", "searchQuery": "DSIP / Emideltide in Florida", "boundedAnswer": "DSIP / Emideltide in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-georgia", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "DSIP / Emideltide in Georgia", "boundedAnswer": "DSIP / Emideltide in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-hawaii", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "DSIP / Emideltide in Hawaii", "boundedAnswer": "DSIP / Emideltide in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-idaho", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "DSIP / Emideltide in Idaho", "boundedAnswer": "DSIP / Emideltide in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-illinois", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "DSIP / Emideltide in Illinois", "boundedAnswer": "DSIP / Emideltide in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-indiana", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "DSIP / Emideltide in Indiana", "boundedAnswer": "DSIP / Emideltide in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-iowa", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "DSIP / Emideltide in Iowa", "boundedAnswer": "DSIP / Emideltide in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-kansas", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "DSIP / Emideltide in Kansas", "boundedAnswer": "DSIP / Emideltide in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-kentucky", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "DSIP / Emideltide in Kentucky", "boundedAnswer": "DSIP / Emideltide in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-louisiana", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "DSIP / Emideltide in Louisiana", "boundedAnswer": "DSIP / Emideltide in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-maine", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Maine", "stateSlug": "maine", "searchQuery": "DSIP / Emideltide in Maine", "boundedAnswer": "DSIP / Emideltide in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-maryland", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "DSIP / Emideltide in Maryland", "boundedAnswer": "DSIP / Emideltide in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-massachusetts", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "DSIP / Emideltide in Massachusetts", "boundedAnswer": "DSIP / Emideltide in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-michigan", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "DSIP / Emideltide in Michigan", "boundedAnswer": "DSIP / Emideltide in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-minnesota", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "DSIP / Emideltide in Minnesota", "boundedAnswer": "DSIP / Emideltide in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-mississippi", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "DSIP / Emideltide in Mississippi", "boundedAnswer": "DSIP / Emideltide in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-missouri", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "DSIP / Emideltide in Missouri", "boundedAnswer": "DSIP / Emideltide in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-montana", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Montana", "stateSlug": "montana", "searchQuery": "DSIP / Emideltide in Montana", "boundedAnswer": "DSIP / Emideltide in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-nebraska", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "DSIP / Emideltide in Nebraska", "boundedAnswer": "DSIP / Emideltide in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-nevada", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "DSIP / Emideltide in Nevada", "boundedAnswer": "DSIP / Emideltide in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-new-hampshire", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "DSIP / Emideltide in New Hampshire", "boundedAnswer": "DSIP / Emideltide in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-new-jersey", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "DSIP / Emideltide in New Jersey", "boundedAnswer": "DSIP / Emideltide in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-new-mexico", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "DSIP / Emideltide in New Mexico", "boundedAnswer": "DSIP / Emideltide in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-new-york", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "New York", "stateSlug": "new-york", "searchQuery": "DSIP / Emideltide in New York", "boundedAnswer": "DSIP / Emideltide in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-north-carolina", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "DSIP / Emideltide in North Carolina", "boundedAnswer": "DSIP / Emideltide in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-north-dakota", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "DSIP / Emideltide in North Dakota", "boundedAnswer": "DSIP / Emideltide in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-ohio", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "DSIP / Emideltide in Ohio", "boundedAnswer": "DSIP / Emideltide in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-oklahoma", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "DSIP / Emideltide in Oklahoma", "boundedAnswer": "DSIP / Emideltide in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-oregon", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "DSIP / Emideltide in Oregon", "boundedAnswer": "DSIP / Emideltide in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-pennsylvania", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "DSIP / Emideltide in Pennsylvania", "boundedAnswer": "DSIP / Emideltide in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-rhode-island", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "DSIP / Emideltide in Rhode Island", "boundedAnswer": "DSIP / Emideltide in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-south-carolina", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "DSIP / Emideltide in South Carolina", "boundedAnswer": "DSIP / Emideltide in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-south-dakota", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "DSIP / Emideltide in South Dakota", "boundedAnswer": "DSIP / Emideltide in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-tennessee", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "DSIP / Emideltide in Tennessee", "boundedAnswer": "DSIP / Emideltide in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-texas", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Texas", "stateSlug": "texas", "searchQuery": "DSIP / Emideltide in Texas", "boundedAnswer": "DSIP / Emideltide in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-utah", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Utah", "stateSlug": "utah", "searchQuery": "DSIP / Emideltide in Utah", "boundedAnswer": "DSIP / Emideltide in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-vermont", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "DSIP / Emideltide in Vermont", "boundedAnswer": "DSIP / Emideltide in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-virginia", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "DSIP / Emideltide in Virginia", "boundedAnswer": "DSIP / Emideltide in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-washington", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Washington", "stateSlug": "washington", "searchQuery": "DSIP / Emideltide in Washington", "boundedAnswer": "DSIP / Emideltide in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-west-virginia", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "DSIP / Emideltide in West Virginia", "boundedAnswer": "DSIP / Emideltide in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-wisconsin", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "DSIP / Emideltide in Wisconsin", "boundedAnswer": "DSIP / Emideltide in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-dsip-wyoming", "compound": "DSIP / Emideltide", "compoundSlug": "dsip", "compoundAliases": [ "Delta sleep-inducing peptide", "Emideltide", "DSIP nonapeptide", "delta sleep-inducing peptide", "delta sleep inducing peptide", "DSIP peptide" ], "evidenceLane": "Research price board", "identityStatus": "FDA-flagged unapproved research-market peptide identity", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "DSIP / Emideltide in Wyoming", "boundedAnswer": "DSIP / Emideltide in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/dsip", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/dsip/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/dsip/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-alabama", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "IGF-1 LR3 in Alabama", "boundedAnswer": "IGF-1 LR3 in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-alaska", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "IGF-1 LR3 in Alaska", "boundedAnswer": "IGF-1 LR3 in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-arizona", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "IGF-1 LR3 in Arizona", "boundedAnswer": "IGF-1 LR3 in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-arkansas", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "IGF-1 LR3 in Arkansas", "boundedAnswer": "IGF-1 LR3 in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-california", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "California", "stateSlug": "california", "searchQuery": "IGF-1 LR3 in California", "boundedAnswer": "IGF-1 LR3 in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-colorado", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "IGF-1 LR3 in Colorado", "boundedAnswer": "IGF-1 LR3 in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-connecticut", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "IGF-1 LR3 in Connecticut", "boundedAnswer": "IGF-1 LR3 in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-delaware", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "IGF-1 LR3 in Delaware", "boundedAnswer": "IGF-1 LR3 in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-florida", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Florida", "stateSlug": "florida", "searchQuery": "IGF-1 LR3 in Florida", "boundedAnswer": "IGF-1 LR3 in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-georgia", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "IGF-1 LR3 in Georgia", "boundedAnswer": "IGF-1 LR3 in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-hawaii", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "IGF-1 LR3 in Hawaii", "boundedAnswer": "IGF-1 LR3 in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-idaho", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "IGF-1 LR3 in Idaho", "boundedAnswer": "IGF-1 LR3 in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-illinois", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "IGF-1 LR3 in Illinois", "boundedAnswer": "IGF-1 LR3 in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-indiana", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "IGF-1 LR3 in Indiana", "boundedAnswer": "IGF-1 LR3 in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-iowa", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "IGF-1 LR3 in Iowa", "boundedAnswer": "IGF-1 LR3 in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-kansas", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "IGF-1 LR3 in Kansas", "boundedAnswer": "IGF-1 LR3 in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-kentucky", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "IGF-1 LR3 in Kentucky", "boundedAnswer": "IGF-1 LR3 in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-louisiana", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "IGF-1 LR3 in Louisiana", "boundedAnswer": "IGF-1 LR3 in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-maine", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maine", "stateSlug": "maine", "searchQuery": "IGF-1 LR3 in Maine", "boundedAnswer": "IGF-1 LR3 in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-maryland", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "IGF-1 LR3 in Maryland", "boundedAnswer": "IGF-1 LR3 in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-massachusetts", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "IGF-1 LR3 in Massachusetts", "boundedAnswer": "IGF-1 LR3 in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-michigan", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "IGF-1 LR3 in Michigan", "boundedAnswer": "IGF-1 LR3 in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-minnesota", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "IGF-1 LR3 in Minnesota", "boundedAnswer": "IGF-1 LR3 in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-mississippi", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "IGF-1 LR3 in Mississippi", "boundedAnswer": "IGF-1 LR3 in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-missouri", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "IGF-1 LR3 in Missouri", "boundedAnswer": "IGF-1 LR3 in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-montana", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Montana", "stateSlug": "montana", "searchQuery": "IGF-1 LR3 in Montana", "boundedAnswer": "IGF-1 LR3 in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-nebraska", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "IGF-1 LR3 in Nebraska", "boundedAnswer": "IGF-1 LR3 in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-nevada", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "IGF-1 LR3 in Nevada", "boundedAnswer": "IGF-1 LR3 in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-new-hampshire", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "IGF-1 LR3 in New Hampshire", "boundedAnswer": "IGF-1 LR3 in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-new-jersey", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "IGF-1 LR3 in New Jersey", "boundedAnswer": "IGF-1 LR3 in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-new-mexico", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "IGF-1 LR3 in New Mexico", "boundedAnswer": "IGF-1 LR3 in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-new-york", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New York", "stateSlug": "new-york", "searchQuery": "IGF-1 LR3 in New York", "boundedAnswer": "IGF-1 LR3 in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-north-carolina", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "IGF-1 LR3 in North Carolina", "boundedAnswer": "IGF-1 LR3 in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-north-dakota", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "IGF-1 LR3 in North Dakota", "boundedAnswer": "IGF-1 LR3 in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-ohio", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "IGF-1 LR3 in Ohio", "boundedAnswer": "IGF-1 LR3 in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-oklahoma", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "IGF-1 LR3 in Oklahoma", "boundedAnswer": "IGF-1 LR3 in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-oregon", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "IGF-1 LR3 in Oregon", "boundedAnswer": "IGF-1 LR3 in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-pennsylvania", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "IGF-1 LR3 in Pennsylvania", "boundedAnswer": "IGF-1 LR3 in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-rhode-island", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "IGF-1 LR3 in Rhode Island", "boundedAnswer": "IGF-1 LR3 in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-south-carolina", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "IGF-1 LR3 in South Carolina", "boundedAnswer": "IGF-1 LR3 in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-south-dakota", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "IGF-1 LR3 in South Dakota", "boundedAnswer": "IGF-1 LR3 in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-tennessee", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "IGF-1 LR3 in Tennessee", "boundedAnswer": "IGF-1 LR3 in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-texas", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Texas", "stateSlug": "texas", "searchQuery": "IGF-1 LR3 in Texas", "boundedAnswer": "IGF-1 LR3 in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-utah", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Utah", "stateSlug": "utah", "searchQuery": "IGF-1 LR3 in Utah", "boundedAnswer": "IGF-1 LR3 in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-vermont", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "IGF-1 LR3 in Vermont", "boundedAnswer": "IGF-1 LR3 in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-virginia", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "IGF-1 LR3 in Virginia", "boundedAnswer": "IGF-1 LR3 in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-washington", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Washington", "stateSlug": "washington", "searchQuery": "IGF-1 LR3 in Washington", "boundedAnswer": "IGF-1 LR3 in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-west-virginia", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "IGF-1 LR3 in West Virginia", "boundedAnswer": "IGF-1 LR3 in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-wisconsin", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "IGF-1 LR3 in Wisconsin", "boundedAnswer": "IGF-1 LR3 in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-igf-1-lr3-wyoming", "compound": "IGF-1 LR3", "compoundSlug": "igf-1-lr3", "compoundAliases": [ "Long R3 IGF-1", "Insulin-like growth factor long chain R3", "100 mcg IGF-1 LR3", "IGF1 LR3", "IGF-1 long R3" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "IGF-1 LR3 in Wyoming", "boundedAnswer": "IGF-1 LR3 in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/igf-1-lr3", "identitySourceLabel": "Read the PubChem substance record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/substance/381123731", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/igf-1-lr3/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/igf-1-lr3/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-alabama", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Kisspeptin-10 / KP-10 in Alabama", "boundedAnswer": "Kisspeptin-10 / KP-10 in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-alaska", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Kisspeptin-10 / KP-10 in Alaska", "boundedAnswer": "Kisspeptin-10 / KP-10 in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-arizona", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Kisspeptin-10 / KP-10 in Arizona", "boundedAnswer": "Kisspeptin-10 / KP-10 in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-arkansas", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Kisspeptin-10 / KP-10 in Arkansas", "boundedAnswer": "Kisspeptin-10 / KP-10 in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-california", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "California", "stateSlug": "california", "searchQuery": "Kisspeptin-10 / KP-10 in California", "boundedAnswer": "Kisspeptin-10 / KP-10 in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-colorado", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Kisspeptin-10 / KP-10 in Colorado", "boundedAnswer": "Kisspeptin-10 / KP-10 in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-connecticut", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Kisspeptin-10 / KP-10 in Connecticut", "boundedAnswer": "Kisspeptin-10 / KP-10 in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-delaware", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Kisspeptin-10 / KP-10 in Delaware", "boundedAnswer": "Kisspeptin-10 / KP-10 in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-florida", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Florida", "stateSlug": "florida", "searchQuery": "Kisspeptin-10 / KP-10 in Florida", "boundedAnswer": "Kisspeptin-10 / KP-10 in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-georgia", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Kisspeptin-10 / KP-10 in Georgia", "boundedAnswer": "Kisspeptin-10 / KP-10 in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-hawaii", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Kisspeptin-10 / KP-10 in Hawaii", "boundedAnswer": "Kisspeptin-10 / KP-10 in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-idaho", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Kisspeptin-10 / KP-10 in Idaho", "boundedAnswer": "Kisspeptin-10 / KP-10 in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-illinois", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Kisspeptin-10 / KP-10 in Illinois", "boundedAnswer": "Kisspeptin-10 / KP-10 in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-indiana", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Kisspeptin-10 / KP-10 in Indiana", "boundedAnswer": "Kisspeptin-10 / KP-10 in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-iowa", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Kisspeptin-10 / KP-10 in Iowa", "boundedAnswer": "Kisspeptin-10 / KP-10 in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-kansas", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Kisspeptin-10 / KP-10 in Kansas", "boundedAnswer": "Kisspeptin-10 / KP-10 in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-kentucky", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Kisspeptin-10 / KP-10 in Kentucky", "boundedAnswer": "Kisspeptin-10 / KP-10 in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-louisiana", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Kisspeptin-10 / KP-10 in Louisiana", "boundedAnswer": "Kisspeptin-10 / KP-10 in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-maine", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maine", "stateSlug": "maine", "searchQuery": "Kisspeptin-10 / KP-10 in Maine", "boundedAnswer": "Kisspeptin-10 / KP-10 in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-maryland", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Kisspeptin-10 / KP-10 in Maryland", "boundedAnswer": "Kisspeptin-10 / KP-10 in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-massachusetts", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Kisspeptin-10 / KP-10 in Massachusetts", "boundedAnswer": "Kisspeptin-10 / KP-10 in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-michigan", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Kisspeptin-10 / KP-10 in Michigan", "boundedAnswer": "Kisspeptin-10 / KP-10 in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-minnesota", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Kisspeptin-10 / KP-10 in Minnesota", "boundedAnswer": "Kisspeptin-10 / KP-10 in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-mississippi", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Kisspeptin-10 / KP-10 in Mississippi", "boundedAnswer": "Kisspeptin-10 / KP-10 in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-missouri", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Kisspeptin-10 / KP-10 in Missouri", "boundedAnswer": "Kisspeptin-10 / KP-10 in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-montana", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Montana", "stateSlug": "montana", "searchQuery": "Kisspeptin-10 / KP-10 in Montana", "boundedAnswer": "Kisspeptin-10 / KP-10 in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-nebraska", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Kisspeptin-10 / KP-10 in Nebraska", "boundedAnswer": "Kisspeptin-10 / KP-10 in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-nevada", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Kisspeptin-10 / KP-10 in Nevada", "boundedAnswer": "Kisspeptin-10 / KP-10 in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-new-hampshire", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Kisspeptin-10 / KP-10 in New Hampshire", "boundedAnswer": "Kisspeptin-10 / KP-10 in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-new-jersey", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Kisspeptin-10 / KP-10 in New Jersey", "boundedAnswer": "Kisspeptin-10 / KP-10 in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-new-mexico", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Kisspeptin-10 / KP-10 in New Mexico", "boundedAnswer": "Kisspeptin-10 / KP-10 in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-new-york", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "New York", "stateSlug": "new-york", "searchQuery": "Kisspeptin-10 / KP-10 in New York", "boundedAnswer": "Kisspeptin-10 / KP-10 in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-north-carolina", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Kisspeptin-10 / KP-10 in North Carolina", "boundedAnswer": "Kisspeptin-10 / KP-10 in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-north-dakota", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Kisspeptin-10 / KP-10 in North Dakota", "boundedAnswer": "Kisspeptin-10 / KP-10 in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-ohio", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Kisspeptin-10 / KP-10 in Ohio", "boundedAnswer": "Kisspeptin-10 / KP-10 in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-oklahoma", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Kisspeptin-10 / KP-10 in Oklahoma", "boundedAnswer": "Kisspeptin-10 / KP-10 in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-oregon", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Kisspeptin-10 / KP-10 in Oregon", "boundedAnswer": "Kisspeptin-10 / KP-10 in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-pennsylvania", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Kisspeptin-10 / KP-10 in Pennsylvania", "boundedAnswer": "Kisspeptin-10 / KP-10 in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-rhode-island", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Kisspeptin-10 / KP-10 in Rhode Island", "boundedAnswer": "Kisspeptin-10 / KP-10 in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-south-carolina", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Kisspeptin-10 / KP-10 in South Carolina", "boundedAnswer": "Kisspeptin-10 / KP-10 in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-south-dakota", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Kisspeptin-10 / KP-10 in South Dakota", "boundedAnswer": "Kisspeptin-10 / KP-10 in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-tennessee", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Kisspeptin-10 / KP-10 in Tennessee", "boundedAnswer": "Kisspeptin-10 / KP-10 in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-texas", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Texas", "stateSlug": "texas", "searchQuery": "Kisspeptin-10 / KP-10 in Texas", "boundedAnswer": "Kisspeptin-10 / KP-10 in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-utah", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Utah", "stateSlug": "utah", "searchQuery": "Kisspeptin-10 / KP-10 in Utah", "boundedAnswer": "Kisspeptin-10 / KP-10 in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-vermont", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Kisspeptin-10 / KP-10 in Vermont", "boundedAnswer": "Kisspeptin-10 / KP-10 in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-virginia", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Kisspeptin-10 / KP-10 in Virginia", "boundedAnswer": "Kisspeptin-10 / KP-10 in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-washington", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Washington", "stateSlug": "washington", "searchQuery": "Kisspeptin-10 / KP-10 in Washington", "boundedAnswer": "Kisspeptin-10 / KP-10 in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-west-virginia", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Kisspeptin-10 / KP-10 in West Virginia", "boundedAnswer": "Kisspeptin-10 / KP-10 in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-wisconsin", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Kisspeptin-10 / KP-10 in Wisconsin", "boundedAnswer": "Kisspeptin-10 / KP-10 in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-kisspeptin-10-wyoming", "compound": "Kisspeptin-10 / KP-10", "compoundSlug": "kisspeptin-10", "compoundAliases": [ "Kisspeptin 10", "Kp-10", "Metastin fragment", "KISS1 decapeptide", "kisspeptin 10", "KP-10", "Kp10" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Kisspeptin-10 / KP-10 in Wyoming", "boundedAnswer": "Kisspeptin-10 / KP-10 in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/kisspeptin-10", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/25240297", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/kisspeptin-10/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/kisspeptin-10/countries" }, { "recordId": "pl-compound-state-melanotan-i-alabama", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Melanotan I in Alabama", "boundedAnswer": "Melanotan I in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-alaska", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Melanotan I in Alaska", "boundedAnswer": "Melanotan I in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-arizona", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Melanotan I in Arizona", "boundedAnswer": "Melanotan I in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-arkansas", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Melanotan I in Arkansas", "boundedAnswer": "Melanotan I in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-california", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "California", "stateSlug": "california", "searchQuery": "Melanotan I in California", "boundedAnswer": "Melanotan I in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-colorado", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Melanotan I in Colorado", "boundedAnswer": "Melanotan I in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-connecticut", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Melanotan I in Connecticut", "boundedAnswer": "Melanotan I in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-delaware", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Melanotan I in Delaware", "boundedAnswer": "Melanotan I in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-florida", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Florida", "stateSlug": "florida", "searchQuery": "Melanotan I in Florida", "boundedAnswer": "Melanotan I in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-georgia", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Melanotan I in Georgia", "boundedAnswer": "Melanotan I in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-hawaii", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Melanotan I in Hawaii", "boundedAnswer": "Melanotan I in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-idaho", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Melanotan I in Idaho", "boundedAnswer": "Melanotan I in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-illinois", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Melanotan I in Illinois", "boundedAnswer": "Melanotan I in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-indiana", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Melanotan I in Indiana", "boundedAnswer": "Melanotan I in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-iowa", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Melanotan I in Iowa", "boundedAnswer": "Melanotan I in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-kansas", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Melanotan I in Kansas", "boundedAnswer": "Melanotan I in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-kentucky", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Melanotan I in Kentucky", "boundedAnswer": "Melanotan I in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-louisiana", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Melanotan I in Louisiana", "boundedAnswer": "Melanotan I in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-maine", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Maine", "stateSlug": "maine", "searchQuery": "Melanotan I in Maine", "boundedAnswer": "Melanotan I in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-maryland", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Melanotan I in Maryland", "boundedAnswer": "Melanotan I in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-massachusetts", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Melanotan I in Massachusetts", "boundedAnswer": "Melanotan I in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-michigan", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Melanotan I in Michigan", "boundedAnswer": "Melanotan I in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-minnesota", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Melanotan I in Minnesota", "boundedAnswer": "Melanotan I in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-mississippi", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Melanotan I in Mississippi", "boundedAnswer": "Melanotan I in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-missouri", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Melanotan I in Missouri", "boundedAnswer": "Melanotan I in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-montana", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Montana", "stateSlug": "montana", "searchQuery": "Melanotan I in Montana", "boundedAnswer": "Melanotan I in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-nebraska", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Melanotan I in Nebraska", "boundedAnswer": "Melanotan I in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-nevada", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Melanotan I in Nevada", "boundedAnswer": "Melanotan I in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-new-hampshire", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Melanotan I in New Hampshire", "boundedAnswer": "Melanotan I in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-new-jersey", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Melanotan I in New Jersey", "boundedAnswer": "Melanotan I in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-new-mexico", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Melanotan I in New Mexico", "boundedAnswer": "Melanotan I in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-new-york", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "New York", "stateSlug": "new-york", "searchQuery": "Melanotan I in New York", "boundedAnswer": "Melanotan I in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-north-carolina", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Melanotan I in North Carolina", "boundedAnswer": "Melanotan I in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-north-dakota", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Melanotan I in North Dakota", "boundedAnswer": "Melanotan I in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-ohio", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Melanotan I in Ohio", "boundedAnswer": "Melanotan I in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-oklahoma", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Melanotan I in Oklahoma", "boundedAnswer": "Melanotan I in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-oregon", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Melanotan I in Oregon", "boundedAnswer": "Melanotan I in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-pennsylvania", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Melanotan I in Pennsylvania", "boundedAnswer": "Melanotan I in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-rhode-island", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Melanotan I in Rhode Island", "boundedAnswer": "Melanotan I in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-south-carolina", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Melanotan I in South Carolina", "boundedAnswer": "Melanotan I in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-south-dakota", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Melanotan I in South Dakota", "boundedAnswer": "Melanotan I in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-tennessee", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Melanotan I in Tennessee", "boundedAnswer": "Melanotan I in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-texas", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Texas", "stateSlug": "texas", "searchQuery": "Melanotan I in Texas", "boundedAnswer": "Melanotan I in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-utah", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Utah", "stateSlug": "utah", "searchQuery": "Melanotan I in Utah", "boundedAnswer": "Melanotan I in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-vermont", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Melanotan I in Vermont", "boundedAnswer": "Melanotan I in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-virginia", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Melanotan I in Virginia", "boundedAnswer": "Melanotan I in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-washington", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Washington", "stateSlug": "washington", "searchQuery": "Melanotan I in Washington", "boundedAnswer": "Melanotan I in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-west-virginia", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Melanotan I in West Virginia", "boundedAnswer": "Melanotan I in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-wisconsin", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Melanotan I in Wisconsin", "boundedAnswer": "Melanotan I in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-melanotan-i-wyoming", "compound": "Melanotan I", "compoundSlug": "melanotan-i", "compoundAliases": [ "MT-I", "MT1", "Afamelanotide", "Melanotan 1" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity separated from SCENESSE", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Melanotan I in Wyoming", "boundedAnswer": "Melanotan I in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/melanotan-i", "identitySourceLabel": "Read the current SCENESSE label", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/melanotan-i/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/melanotan-i/countries" }, { "recordId": "pl-compound-state-nad-plus-alabama", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "NAD+ in Alabama", "boundedAnswer": "NAD+ in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-alaska", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "NAD+ in Alaska", "boundedAnswer": "NAD+ in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-arizona", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "NAD+ in Arizona", "boundedAnswer": "NAD+ in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-arkansas", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "NAD+ in Arkansas", "boundedAnswer": "NAD+ in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-california", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "California", "stateSlug": "california", "searchQuery": "NAD+ in California", "boundedAnswer": "NAD+ in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-colorado", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "NAD+ in Colorado", "boundedAnswer": "NAD+ in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-connecticut", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "NAD+ in Connecticut", "boundedAnswer": "NAD+ in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-delaware", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "NAD+ in Delaware", "boundedAnswer": "NAD+ in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-florida", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Florida", "stateSlug": "florida", "searchQuery": "NAD+ in Florida", "boundedAnswer": "NAD+ in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-georgia", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "NAD+ in Georgia", "boundedAnswer": "NAD+ in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-hawaii", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "NAD+ in Hawaii", "boundedAnswer": "NAD+ in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-idaho", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "NAD+ in Idaho", "boundedAnswer": "NAD+ in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-illinois", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "NAD+ in Illinois", "boundedAnswer": "NAD+ in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-indiana", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "NAD+ in Indiana", "boundedAnswer": "NAD+ in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-iowa", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "NAD+ in Iowa", "boundedAnswer": "NAD+ in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-kansas", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "NAD+ in Kansas", "boundedAnswer": "NAD+ in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-kentucky", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "NAD+ in Kentucky", "boundedAnswer": "NAD+ in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-louisiana", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "NAD+ in Louisiana", "boundedAnswer": "NAD+ in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-maine", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Maine", "stateSlug": "maine", "searchQuery": "NAD+ in Maine", "boundedAnswer": "NAD+ in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-maryland", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "NAD+ in Maryland", "boundedAnswer": "NAD+ in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-massachusetts", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "NAD+ in Massachusetts", "boundedAnswer": "NAD+ in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-michigan", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "NAD+ in Michigan", "boundedAnswer": "NAD+ in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-minnesota", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "NAD+ in Minnesota", "boundedAnswer": "NAD+ in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-mississippi", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "NAD+ in Mississippi", "boundedAnswer": "NAD+ in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-missouri", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "NAD+ in Missouri", "boundedAnswer": "NAD+ in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-montana", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Montana", "stateSlug": "montana", "searchQuery": "NAD+ in Montana", "boundedAnswer": "NAD+ in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-nebraska", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "NAD+ in Nebraska", "boundedAnswer": "NAD+ in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-nevada", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "NAD+ in Nevada", "boundedAnswer": "NAD+ in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-new-hampshire", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "NAD+ in New Hampshire", "boundedAnswer": "NAD+ in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-new-jersey", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "NAD+ in New Jersey", "boundedAnswer": "NAD+ in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-new-mexico", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "NAD+ in New Mexico", "boundedAnswer": "NAD+ in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-new-york", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "New York", "stateSlug": "new-york", "searchQuery": "NAD+ in New York", "boundedAnswer": "NAD+ in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-north-carolina", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "NAD+ in North Carolina", "boundedAnswer": "NAD+ in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-north-dakota", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "NAD+ in North Dakota", "boundedAnswer": "NAD+ in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-ohio", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "NAD+ in Ohio", "boundedAnswer": "NAD+ in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-oklahoma", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "NAD+ in Oklahoma", "boundedAnswer": "NAD+ in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-oregon", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "NAD+ in Oregon", "boundedAnswer": "NAD+ in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-pennsylvania", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "NAD+ in Pennsylvania", "boundedAnswer": "NAD+ in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-rhode-island", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "NAD+ in Rhode Island", "boundedAnswer": "NAD+ in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-south-carolina", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "NAD+ in South Carolina", "boundedAnswer": "NAD+ in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-south-dakota", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "NAD+ in South Dakota", "boundedAnswer": "NAD+ in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-tennessee", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "NAD+ in Tennessee", "boundedAnswer": "NAD+ in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-texas", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Texas", "stateSlug": "texas", "searchQuery": "NAD+ in Texas", "boundedAnswer": "NAD+ in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-utah", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Utah", "stateSlug": "utah", "searchQuery": "NAD+ in Utah", "boundedAnswer": "NAD+ in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-vermont", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "NAD+ in Vermont", "boundedAnswer": "NAD+ in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-virginia", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "NAD+ in Virginia", "boundedAnswer": "NAD+ in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-washington", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Washington", "stateSlug": "washington", "searchQuery": "NAD+ in Washington", "boundedAnswer": "NAD+ in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-west-virginia", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "NAD+ in West Virginia", "boundedAnswer": "NAD+ in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-wisconsin", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "NAD+ in Wisconsin", "boundedAnswer": "NAD+ in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-nad-plus-wyoming", "compound": "NAD+", "compoundSlug": "nad-plus", "compoundAliases": [ "Nicotinamide adenine dinucleotide", "NAD plus", "nicotinamide adenine dinucleotide", "NAD peptide" ], "evidenceLane": "Research price board", "identityStatus": "US research-market non-peptide coenzyme identity", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "NAD+ in Wyoming", "boundedAnswer": "NAD+ in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/nad-plus", "identitySourceLabel": "Read the PubChem compound record", "identitySourcePublisher": "National Library of Medicine, PubChem", "identitySourceUrl": "https://pubchem.ncbi.nlm.nih.gov/compound/Nadide-_JAN_USAN_INN", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/nad-plus/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/nad-plus/countries" }, { "recordId": "pl-compound-state-sermorelin-alabama", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Sermorelin in Alabama", "boundedAnswer": "Sermorelin in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-alaska", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Sermorelin in Alaska", "boundedAnswer": "Sermorelin in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-arizona", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Sermorelin in Arizona", "boundedAnswer": "Sermorelin in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-arkansas", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Sermorelin in Arkansas", "boundedAnswer": "Sermorelin in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-california", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "California", "stateSlug": "california", "searchQuery": "Sermorelin in California", "boundedAnswer": "Sermorelin in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-colorado", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Sermorelin in Colorado", "boundedAnswer": "Sermorelin in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-connecticut", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Sermorelin in Connecticut", "boundedAnswer": "Sermorelin in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-delaware", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Sermorelin in Delaware", "boundedAnswer": "Sermorelin in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-florida", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Florida", "stateSlug": "florida", "searchQuery": "Sermorelin in Florida", "boundedAnswer": "Sermorelin in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-georgia", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Sermorelin in Georgia", "boundedAnswer": "Sermorelin in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-hawaii", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Sermorelin in Hawaii", "boundedAnswer": "Sermorelin in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-idaho", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Sermorelin in Idaho", "boundedAnswer": "Sermorelin in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-illinois", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Sermorelin in Illinois", "boundedAnswer": "Sermorelin in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-indiana", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Sermorelin in Indiana", "boundedAnswer": "Sermorelin in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-iowa", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Sermorelin in Iowa", "boundedAnswer": "Sermorelin in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-kansas", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Sermorelin in Kansas", "boundedAnswer": "Sermorelin in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-kentucky", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Sermorelin in Kentucky", "boundedAnswer": "Sermorelin in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-louisiana", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Sermorelin in Louisiana", "boundedAnswer": "Sermorelin in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-maine", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Maine", "stateSlug": "maine", "searchQuery": "Sermorelin in Maine", "boundedAnswer": "Sermorelin in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-maryland", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Sermorelin in Maryland", "boundedAnswer": "Sermorelin in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-massachusetts", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Sermorelin in Massachusetts", "boundedAnswer": "Sermorelin in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-michigan", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Sermorelin in Michigan", "boundedAnswer": "Sermorelin in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-minnesota", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Sermorelin in Minnesota", "boundedAnswer": "Sermorelin in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-mississippi", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Sermorelin in Mississippi", "boundedAnswer": "Sermorelin in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-missouri", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Sermorelin in Missouri", "boundedAnswer": "Sermorelin in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-montana", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Montana", "stateSlug": "montana", "searchQuery": "Sermorelin in Montana", "boundedAnswer": "Sermorelin in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-nebraska", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Sermorelin in Nebraska", "boundedAnswer": "Sermorelin in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-nevada", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Sermorelin in Nevada", "boundedAnswer": "Sermorelin in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-new-hampshire", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Sermorelin in New Hampshire", "boundedAnswer": "Sermorelin in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-new-jersey", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Sermorelin in New Jersey", "boundedAnswer": "Sermorelin in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-new-mexico", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Sermorelin in New Mexico", "boundedAnswer": "Sermorelin in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-new-york", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "New York", "stateSlug": "new-york", "searchQuery": "Sermorelin in New York", "boundedAnswer": "Sermorelin in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-north-carolina", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Sermorelin in North Carolina", "boundedAnswer": "Sermorelin in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-north-dakota", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Sermorelin in North Dakota", "boundedAnswer": "Sermorelin in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-ohio", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Sermorelin in Ohio", "boundedAnswer": "Sermorelin in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-oklahoma", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Sermorelin in Oklahoma", "boundedAnswer": "Sermorelin in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-oregon", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Sermorelin in Oregon", "boundedAnswer": "Sermorelin in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-pennsylvania", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Sermorelin in Pennsylvania", "boundedAnswer": "Sermorelin in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-rhode-island", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Sermorelin in Rhode Island", "boundedAnswer": "Sermorelin in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-south-carolina", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Sermorelin in South Carolina", "boundedAnswer": "Sermorelin in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-south-dakota", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Sermorelin in South Dakota", "boundedAnswer": "Sermorelin in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-tennessee", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Sermorelin in Tennessee", "boundedAnswer": "Sermorelin in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-texas", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Texas", "stateSlug": "texas", "searchQuery": "Sermorelin in Texas", "boundedAnswer": "Sermorelin in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-utah", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Utah", "stateSlug": "utah", "searchQuery": "Sermorelin in Utah", "boundedAnswer": "Sermorelin in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-vermont", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Sermorelin in Vermont", "boundedAnswer": "Sermorelin in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-virginia", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Sermorelin in Virginia", "boundedAnswer": "Sermorelin in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-washington", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Washington", "stateSlug": "washington", "searchQuery": "Sermorelin in Washington", "boundedAnswer": "Sermorelin in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-west-virginia", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Sermorelin in West Virginia", "boundedAnswer": "Sermorelin in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-wisconsin", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Sermorelin in Wisconsin", "boundedAnswer": "Sermorelin in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-sermorelin-wyoming", "compound": "Sermorelin", "compoundSlug": "sermorelin", "compoundAliases": [ "GHRH 1-29", "Sermorelin acetate", "Geref" ], "evidenceLane": "Research price board", "identityStatus": "US research-market identity with a withdrawn historical medicine record", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Sermorelin in Wyoming", "boundedAnswer": "Sermorelin in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/sermorelin", "identitySourceLabel": "Read the FDA orphan-drug record", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=24687", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/sermorelin/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/sermorelin/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-alabama", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Thymosin Alpha-1 in Alabama", "boundedAnswer": "Thymosin Alpha-1 in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-alaska", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Thymosin Alpha-1 in Alaska", "boundedAnswer": "Thymosin Alpha-1 in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-arizona", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Thymosin Alpha-1 in Arizona", "boundedAnswer": "Thymosin Alpha-1 in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-arkansas", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Thymosin Alpha-1 in Arkansas", "boundedAnswer": "Thymosin Alpha-1 in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-california", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "California", "stateSlug": "california", "searchQuery": "Thymosin Alpha-1 in California", "boundedAnswer": "Thymosin Alpha-1 in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-colorado", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Thymosin Alpha-1 in Colorado", "boundedAnswer": "Thymosin Alpha-1 in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-connecticut", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Thymosin Alpha-1 in Connecticut", "boundedAnswer": "Thymosin Alpha-1 in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-delaware", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Thymosin Alpha-1 in Delaware", "boundedAnswer": "Thymosin Alpha-1 in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-florida", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Florida", "stateSlug": "florida", "searchQuery": "Thymosin Alpha-1 in Florida", "boundedAnswer": "Thymosin Alpha-1 in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-georgia", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Thymosin Alpha-1 in Georgia", "boundedAnswer": "Thymosin Alpha-1 in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-hawaii", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Thymosin Alpha-1 in Hawaii", "boundedAnswer": "Thymosin Alpha-1 in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-idaho", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Thymosin Alpha-1 in Idaho", "boundedAnswer": "Thymosin Alpha-1 in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-illinois", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Thymosin Alpha-1 in Illinois", "boundedAnswer": "Thymosin Alpha-1 in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-indiana", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Thymosin Alpha-1 in Indiana", "boundedAnswer": "Thymosin Alpha-1 in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-iowa", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Thymosin Alpha-1 in Iowa", "boundedAnswer": "Thymosin Alpha-1 in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-kansas", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Thymosin Alpha-1 in Kansas", "boundedAnswer": "Thymosin Alpha-1 in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-kentucky", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Thymosin Alpha-1 in Kentucky", "boundedAnswer": "Thymosin Alpha-1 in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-louisiana", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Thymosin Alpha-1 in Louisiana", "boundedAnswer": "Thymosin Alpha-1 in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-maine", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Maine", "stateSlug": "maine", "searchQuery": "Thymosin Alpha-1 in Maine", "boundedAnswer": "Thymosin Alpha-1 in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-maryland", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Thymosin Alpha-1 in Maryland", "boundedAnswer": "Thymosin Alpha-1 in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-massachusetts", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Thymosin Alpha-1 in Massachusetts", "boundedAnswer": "Thymosin Alpha-1 in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-michigan", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Thymosin Alpha-1 in Michigan", "boundedAnswer": "Thymosin Alpha-1 in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-minnesota", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Thymosin Alpha-1 in Minnesota", "boundedAnswer": "Thymosin Alpha-1 in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-mississippi", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Thymosin Alpha-1 in Mississippi", "boundedAnswer": "Thymosin Alpha-1 in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-missouri", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Thymosin Alpha-1 in Missouri", "boundedAnswer": "Thymosin Alpha-1 in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-montana", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Montana", "stateSlug": "montana", "searchQuery": "Thymosin Alpha-1 in Montana", "boundedAnswer": "Thymosin Alpha-1 in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-nebraska", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Thymosin Alpha-1 in Nebraska", "boundedAnswer": "Thymosin Alpha-1 in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-nevada", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Thymosin Alpha-1 in Nevada", "boundedAnswer": "Thymosin Alpha-1 in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-new-hampshire", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Thymosin Alpha-1 in New Hampshire", "boundedAnswer": "Thymosin Alpha-1 in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-new-jersey", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Thymosin Alpha-1 in New Jersey", "boundedAnswer": "Thymosin Alpha-1 in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-new-mexico", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Thymosin Alpha-1 in New Mexico", "boundedAnswer": "Thymosin Alpha-1 in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-new-york", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "New York", "stateSlug": "new-york", "searchQuery": "Thymosin Alpha-1 in New York", "boundedAnswer": "Thymosin Alpha-1 in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-north-carolina", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Thymosin Alpha-1 in North Carolina", "boundedAnswer": "Thymosin Alpha-1 in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-north-dakota", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Thymosin Alpha-1 in North Dakota", "boundedAnswer": "Thymosin Alpha-1 in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-ohio", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Thymosin Alpha-1 in Ohio", "boundedAnswer": "Thymosin Alpha-1 in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-oklahoma", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Thymosin Alpha-1 in Oklahoma", "boundedAnswer": "Thymosin Alpha-1 in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-oregon", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Thymosin Alpha-1 in Oregon", "boundedAnswer": "Thymosin Alpha-1 in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-pennsylvania", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Thymosin Alpha-1 in Pennsylvania", "boundedAnswer": "Thymosin Alpha-1 in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-rhode-island", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Thymosin Alpha-1 in Rhode Island", "boundedAnswer": "Thymosin Alpha-1 in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-south-carolina", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Thymosin Alpha-1 in South Carolina", "boundedAnswer": "Thymosin Alpha-1 in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-south-dakota", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Thymosin Alpha-1 in South Dakota", "boundedAnswer": "Thymosin Alpha-1 in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-tennessee", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Thymosin Alpha-1 in Tennessee", "boundedAnswer": "Thymosin Alpha-1 in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-texas", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Texas", "stateSlug": "texas", "searchQuery": "Thymosin Alpha-1 in Texas", "boundedAnswer": "Thymosin Alpha-1 in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-utah", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Utah", "stateSlug": "utah", "searchQuery": "Thymosin Alpha-1 in Utah", "boundedAnswer": "Thymosin Alpha-1 in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-vermont", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Thymosin Alpha-1 in Vermont", "boundedAnswer": "Thymosin Alpha-1 in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-virginia", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Thymosin Alpha-1 in Virginia", "boundedAnswer": "Thymosin Alpha-1 in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-washington", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Washington", "stateSlug": "washington", "searchQuery": "Thymosin Alpha-1 in Washington", "boundedAnswer": "Thymosin Alpha-1 in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-west-virginia", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Thymosin Alpha-1 in West Virginia", "boundedAnswer": "Thymosin Alpha-1 in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-wisconsin", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Thymosin Alpha-1 in Wisconsin", "boundedAnswer": "Thymosin Alpha-1 in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-thymosin-alpha-1-wyoming", "compound": "Thymosin Alpha-1", "compoundSlug": "thymosin-alpha-1", "compoundAliases": [ "Thymalfasin", "TA1", "Thymosin alpha 1", "thymosin alpha 1", "TA-1", "Tα1", "thymalfasin" ], "evidenceLane": "Research price board", "identityStatus": "No FDA-approved US product; exact foreign prescription products exist", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Thymosin Alpha-1 in Wyoming", "boundedAnswer": "Thymosin Alpha-1 in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/products/thymosin-alpha-1", "identitySourceLabel": "Read the FDA source", "identitySourcePublisher": "U.S. Food and Drug Administration", "identitySourceUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/thymosin-alpha-1/countries" }, { "recordId": "pl-compound-state-egrifta-wr-alabama", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "EGRIFTA WR in Alabama", "boundedAnswer": "EGRIFTA WR in Alabama begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-alaska", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "EGRIFTA WR in Alaska", "boundedAnswer": "EGRIFTA WR in Alaska begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-arizona", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "EGRIFTA WR in Arizona", "boundedAnswer": "EGRIFTA WR in Arizona begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-arkansas", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "EGRIFTA WR in Arkansas", "boundedAnswer": "EGRIFTA WR in Arkansas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-california", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "California", "stateSlug": "california", "searchQuery": "EGRIFTA WR in California", "boundedAnswer": "EGRIFTA WR in California begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-colorado", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "EGRIFTA WR in Colorado", "boundedAnswer": "EGRIFTA WR in Colorado begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-connecticut", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "EGRIFTA WR in Connecticut", "boundedAnswer": "EGRIFTA WR in Connecticut begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-delaware", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "EGRIFTA WR in Delaware", "boundedAnswer": "EGRIFTA WR in Delaware begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-florida", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Florida", "stateSlug": "florida", "searchQuery": "EGRIFTA WR in Florida", "boundedAnswer": "EGRIFTA WR in Florida begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-georgia", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "EGRIFTA WR in Georgia", "boundedAnswer": "EGRIFTA WR in Georgia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-hawaii", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "EGRIFTA WR in Hawaii", "boundedAnswer": "EGRIFTA WR in Hawaii begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-idaho", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "EGRIFTA WR in Idaho", "boundedAnswer": "EGRIFTA WR in Idaho begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-illinois", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "EGRIFTA WR in Illinois", "boundedAnswer": "EGRIFTA WR in Illinois begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-indiana", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "EGRIFTA WR in Indiana", "boundedAnswer": "EGRIFTA WR in Indiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-iowa", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "EGRIFTA WR in Iowa", "boundedAnswer": "EGRIFTA WR in Iowa begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-kansas", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "EGRIFTA WR in Kansas", "boundedAnswer": "EGRIFTA WR in Kansas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-kentucky", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "EGRIFTA WR in Kentucky", "boundedAnswer": "EGRIFTA WR in Kentucky begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-louisiana", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "EGRIFTA WR in Louisiana", "boundedAnswer": "EGRIFTA WR in Louisiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-maine", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Maine", "stateSlug": "maine", "searchQuery": "EGRIFTA WR in Maine", "boundedAnswer": "EGRIFTA WR in Maine begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-maryland", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "EGRIFTA WR in Maryland", "boundedAnswer": "EGRIFTA WR in Maryland begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-massachusetts", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "EGRIFTA WR in Massachusetts", "boundedAnswer": "EGRIFTA WR in Massachusetts begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-michigan", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "EGRIFTA WR in Michigan", "boundedAnswer": "EGRIFTA WR in Michigan begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-minnesota", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "EGRIFTA WR in Minnesota", "boundedAnswer": "EGRIFTA WR in Minnesota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-mississippi", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "EGRIFTA WR in Mississippi", "boundedAnswer": "EGRIFTA WR in Mississippi begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-missouri", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "EGRIFTA WR in Missouri", "boundedAnswer": "EGRIFTA WR in Missouri begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-montana", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Montana", "stateSlug": "montana", "searchQuery": "EGRIFTA WR in Montana", "boundedAnswer": "EGRIFTA WR in Montana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-nebraska", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "EGRIFTA WR in Nebraska", "boundedAnswer": "EGRIFTA WR in Nebraska begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-nevada", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "EGRIFTA WR in Nevada", "boundedAnswer": "EGRIFTA WR in Nevada begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-new-hampshire", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "EGRIFTA WR in New Hampshire", "boundedAnswer": "EGRIFTA WR in New Hampshire begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-new-jersey", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "EGRIFTA WR in New Jersey", "boundedAnswer": "EGRIFTA WR in New Jersey begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-new-mexico", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "EGRIFTA WR in New Mexico", "boundedAnswer": "EGRIFTA WR in New Mexico begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-new-york", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "New York", "stateSlug": "new-york", "searchQuery": "EGRIFTA WR in New York", "boundedAnswer": "EGRIFTA WR in New York begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-north-carolina", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "EGRIFTA WR in North Carolina", "boundedAnswer": "EGRIFTA WR in North Carolina begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-north-dakota", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "EGRIFTA WR in North Dakota", "boundedAnswer": "EGRIFTA WR in North Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-ohio", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "EGRIFTA WR in Ohio", "boundedAnswer": "EGRIFTA WR in Ohio begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-oklahoma", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "EGRIFTA WR in Oklahoma", "boundedAnswer": "EGRIFTA WR in Oklahoma begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-oregon", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "EGRIFTA WR in Oregon", "boundedAnswer": "EGRIFTA WR in Oregon begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-pennsylvania", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "EGRIFTA WR in Pennsylvania", "boundedAnswer": "EGRIFTA WR in Pennsylvania begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-rhode-island", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "EGRIFTA WR in Rhode Island", "boundedAnswer": "EGRIFTA WR in Rhode Island begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-south-carolina", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "EGRIFTA WR in South Carolina", "boundedAnswer": "EGRIFTA WR in South Carolina begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-south-dakota", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "EGRIFTA WR in South Dakota", "boundedAnswer": "EGRIFTA WR in South Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-tennessee", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "EGRIFTA WR in Tennessee", "boundedAnswer": "EGRIFTA WR in Tennessee begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-texas", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Texas", "stateSlug": "texas", "searchQuery": "EGRIFTA WR in Texas", "boundedAnswer": "EGRIFTA WR in Texas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-utah", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Utah", "stateSlug": "utah", "searchQuery": "EGRIFTA WR in Utah", "boundedAnswer": "EGRIFTA WR in Utah begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-vermont", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "EGRIFTA WR in Vermont", "boundedAnswer": "EGRIFTA WR in Vermont begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-virginia", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "EGRIFTA WR in Virginia", "boundedAnswer": "EGRIFTA WR in Virginia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-washington", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Washington", "stateSlug": "washington", "searchQuery": "EGRIFTA WR in Washington", "boundedAnswer": "EGRIFTA WR in Washington begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-west-virginia", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "EGRIFTA WR in West Virginia", "boundedAnswer": "EGRIFTA WR in West Virginia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-wisconsin", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "EGRIFTA WR in Wisconsin", "boundedAnswer": "EGRIFTA WR in Wisconsin begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-egrifta-wr-wyoming", "compound": "EGRIFTA WR", "compoundSlug": "egrifta-wr", "compoundAliases": [ "tesamorelin", "Egrifta WR", "Egrifta SV", "TH9507", "BLA 022505", "GHRF analog", "Egrifta", "tesamorelin medicine" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "FDA-approved US medicine with a withdrawn EU application", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "EGRIFTA WR in Wyoming", "boundedAnswer": "EGRIFTA WR in Wyoming begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/egrifta-wr", "identitySourceLabel": "Current EGRIFTA WR prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/egrifta-wr/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/egrifta-wr/countries" }, { "recordId": "pl-compound-state-liraglutide-alabama", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "Liraglutide in Alabama", "boundedAnswer": "Liraglutide in Alabama begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-alaska", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "Liraglutide in Alaska", "boundedAnswer": "Liraglutide in Alaska begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-arizona", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "Liraglutide in Arizona", "boundedAnswer": "Liraglutide in Arizona begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-arkansas", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "Liraglutide in Arkansas", "boundedAnswer": "Liraglutide in Arkansas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-california", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "California", "stateSlug": "california", "searchQuery": "Liraglutide in California", "boundedAnswer": "Liraglutide in California begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-colorado", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "Liraglutide in Colorado", "boundedAnswer": "Liraglutide in Colorado begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-connecticut", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "Liraglutide in Connecticut", "boundedAnswer": "Liraglutide in Connecticut begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-delaware", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "Liraglutide in Delaware", "boundedAnswer": "Liraglutide in Delaware begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-florida", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Florida", "stateSlug": "florida", "searchQuery": "Liraglutide in Florida", "boundedAnswer": "Liraglutide in Florida begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-georgia", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "Liraglutide in Georgia", "boundedAnswer": "Liraglutide in Georgia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-hawaii", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "Liraglutide in Hawaii", "boundedAnswer": "Liraglutide in Hawaii begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-idaho", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "Liraglutide in Idaho", "boundedAnswer": "Liraglutide in Idaho begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-illinois", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "Liraglutide in Illinois", "boundedAnswer": "Liraglutide in Illinois begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-indiana", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "Liraglutide in Indiana", "boundedAnswer": "Liraglutide in Indiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-iowa", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "Liraglutide in Iowa", "boundedAnswer": "Liraglutide in Iowa begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-kansas", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "Liraglutide in Kansas", "boundedAnswer": "Liraglutide in Kansas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-kentucky", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "Liraglutide in Kentucky", "boundedAnswer": "Liraglutide in Kentucky begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-louisiana", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "Liraglutide in Louisiana", "boundedAnswer": "Liraglutide in Louisiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-maine", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Maine", "stateSlug": "maine", "searchQuery": "Liraglutide in Maine", "boundedAnswer": "Liraglutide in Maine begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-maryland", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "Liraglutide in Maryland", "boundedAnswer": "Liraglutide in Maryland begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-massachusetts", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "Liraglutide in Massachusetts", "boundedAnswer": "Liraglutide in Massachusetts begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-michigan", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "Liraglutide in Michigan", "boundedAnswer": "Liraglutide in Michigan begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-minnesota", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "Liraglutide in Minnesota", "boundedAnswer": "Liraglutide in Minnesota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-mississippi", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "Liraglutide in Mississippi", "boundedAnswer": "Liraglutide in Mississippi begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-missouri", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "Liraglutide in Missouri", "boundedAnswer": "Liraglutide in Missouri begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-montana", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Montana", "stateSlug": "montana", "searchQuery": "Liraglutide in Montana", "boundedAnswer": "Liraglutide in Montana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-nebraska", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "Liraglutide in Nebraska", "boundedAnswer": "Liraglutide in Nebraska begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-nevada", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "Liraglutide in Nevada", "boundedAnswer": "Liraglutide in Nevada begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-new-hampshire", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "Liraglutide in New Hampshire", "boundedAnswer": "Liraglutide in New Hampshire begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-new-jersey", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "Liraglutide in New Jersey", "boundedAnswer": "Liraglutide in New Jersey begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-new-mexico", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "Liraglutide in New Mexico", "boundedAnswer": "Liraglutide in New Mexico begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-new-york", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "New York", "stateSlug": "new-york", "searchQuery": "Liraglutide in New York", "boundedAnswer": "Liraglutide in New York begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-north-carolina", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "Liraglutide in North Carolina", "boundedAnswer": "Liraglutide in North Carolina begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-north-dakota", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "Liraglutide in North Dakota", "boundedAnswer": "Liraglutide in North Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-ohio", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "Liraglutide in Ohio", "boundedAnswer": "Liraglutide in Ohio begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-oklahoma", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "Liraglutide in Oklahoma", "boundedAnswer": "Liraglutide in Oklahoma begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-oregon", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "Liraglutide in Oregon", "boundedAnswer": "Liraglutide in Oregon begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-pennsylvania", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "Liraglutide in Pennsylvania", "boundedAnswer": "Liraglutide in Pennsylvania begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-rhode-island", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "Liraglutide in Rhode Island", "boundedAnswer": "Liraglutide in Rhode Island begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-south-carolina", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "Liraglutide in South Carolina", "boundedAnswer": "Liraglutide in South Carolina begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-south-dakota", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "Liraglutide in South Dakota", "boundedAnswer": "Liraglutide in South Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-tennessee", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "Liraglutide in Tennessee", "boundedAnswer": "Liraglutide in Tennessee begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-texas", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Texas", "stateSlug": "texas", "searchQuery": "Liraglutide in Texas", "boundedAnswer": "Liraglutide in Texas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-utah", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Utah", "stateSlug": "utah", "searchQuery": "Liraglutide in Utah", "boundedAnswer": "Liraglutide in Utah begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-vermont", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "Liraglutide in Vermont", "boundedAnswer": "Liraglutide in Vermont begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-virginia", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "Liraglutide in Virginia", "boundedAnswer": "Liraglutide in Virginia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-washington", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Washington", "stateSlug": "washington", "searchQuery": "Liraglutide in Washington", "boundedAnswer": "Liraglutide in Washington begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-west-virginia", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "Liraglutide in West Virginia", "boundedAnswer": "Liraglutide in West Virginia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-wisconsin", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "Liraglutide in Wisconsin", "boundedAnswer": "Liraglutide in Wisconsin begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-liraglutide-wyoming", "compound": "Liraglutide", "compoundSlug": "liraglutide", "compoundAliases": [ "liraglutide", "Saxenda", "NN2211", "NDA 206321", "GLP-1 receptor agonist", "Saxenda by country", "liraglutida", "Liraglutid" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "Liraglutide in Wyoming", "boundedAnswer": "Liraglutide in Wyoming begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/saxenda", "identitySourceLabel": "Current SAXENDA prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/liraglutide/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/liraglutide/countries" }, { "recordId": "pl-compound-state-scenesse-alabama", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "SCENESSE in Alabama", "boundedAnswer": "SCENESSE in Alabama begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-alaska", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "SCENESSE in Alaska", "boundedAnswer": "SCENESSE in Alaska begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-arizona", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "SCENESSE in Arizona", "boundedAnswer": "SCENESSE in Arizona begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-arkansas", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "SCENESSE in Arkansas", "boundedAnswer": "SCENESSE in Arkansas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-california", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "California", "stateSlug": "california", "searchQuery": "SCENESSE in California", "boundedAnswer": "SCENESSE in California begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-colorado", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "SCENESSE in Colorado", "boundedAnswer": "SCENESSE in Colorado begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-connecticut", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "SCENESSE in Connecticut", "boundedAnswer": "SCENESSE in Connecticut begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-delaware", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "SCENESSE in Delaware", "boundedAnswer": "SCENESSE in Delaware begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-florida", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Florida", "stateSlug": "florida", "searchQuery": "SCENESSE in Florida", "boundedAnswer": "SCENESSE in Florida begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-georgia", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "SCENESSE in Georgia", "boundedAnswer": "SCENESSE in Georgia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-hawaii", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "SCENESSE in Hawaii", "boundedAnswer": "SCENESSE in Hawaii begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-idaho", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "SCENESSE in Idaho", "boundedAnswer": "SCENESSE in Idaho begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-illinois", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "SCENESSE in Illinois", "boundedAnswer": "SCENESSE in Illinois begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-indiana", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "SCENESSE in Indiana", "boundedAnswer": "SCENESSE in Indiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-iowa", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "SCENESSE in Iowa", "boundedAnswer": "SCENESSE in Iowa begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-kansas", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "SCENESSE in Kansas", "boundedAnswer": "SCENESSE in Kansas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-kentucky", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "SCENESSE in Kentucky", "boundedAnswer": "SCENESSE in Kentucky begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-louisiana", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "SCENESSE in Louisiana", "boundedAnswer": "SCENESSE in Louisiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-maine", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Maine", "stateSlug": "maine", "searchQuery": "SCENESSE in Maine", "boundedAnswer": "SCENESSE in Maine begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-maryland", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "SCENESSE in Maryland", "boundedAnswer": "SCENESSE in Maryland begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-massachusetts", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "SCENESSE in Massachusetts", "boundedAnswer": "SCENESSE in Massachusetts begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-michigan", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "SCENESSE in Michigan", "boundedAnswer": "SCENESSE in Michigan begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-minnesota", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "SCENESSE in Minnesota", "boundedAnswer": "SCENESSE in Minnesota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-mississippi", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "SCENESSE in Mississippi", "boundedAnswer": "SCENESSE in Mississippi begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-missouri", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "SCENESSE in Missouri", "boundedAnswer": "SCENESSE in Missouri begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-montana", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Montana", "stateSlug": "montana", "searchQuery": "SCENESSE in Montana", "boundedAnswer": "SCENESSE in Montana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-nebraska", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "SCENESSE in Nebraska", "boundedAnswer": "SCENESSE in Nebraska begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-nevada", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "SCENESSE in Nevada", "boundedAnswer": "SCENESSE in Nevada begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-new-hampshire", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "SCENESSE in New Hampshire", "boundedAnswer": "SCENESSE in New Hampshire begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-new-jersey", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "SCENESSE in New Jersey", "boundedAnswer": "SCENESSE in New Jersey begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-new-mexico", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "SCENESSE in New Mexico", "boundedAnswer": "SCENESSE in New Mexico begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-new-york", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "New York", "stateSlug": "new-york", "searchQuery": "SCENESSE in New York", "boundedAnswer": "SCENESSE in New York begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-north-carolina", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "SCENESSE in North Carolina", "boundedAnswer": "SCENESSE in North Carolina begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-north-dakota", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "SCENESSE in North Dakota", "boundedAnswer": "SCENESSE in North Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-ohio", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "SCENESSE in Ohio", "boundedAnswer": "SCENESSE in Ohio begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-oklahoma", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "SCENESSE in Oklahoma", "boundedAnswer": "SCENESSE in Oklahoma begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-oregon", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "SCENESSE in Oregon", "boundedAnswer": "SCENESSE in Oregon begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-pennsylvania", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "SCENESSE in Pennsylvania", "boundedAnswer": "SCENESSE in Pennsylvania begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-rhode-island", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "SCENESSE in Rhode Island", "boundedAnswer": "SCENESSE in Rhode Island begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-south-carolina", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "SCENESSE in South Carolina", "boundedAnswer": "SCENESSE in South Carolina begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-south-dakota", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "SCENESSE in South Dakota", "boundedAnswer": "SCENESSE in South Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-tennessee", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "SCENESSE in Tennessee", "boundedAnswer": "SCENESSE in Tennessee begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-texas", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Texas", "stateSlug": "texas", "searchQuery": "SCENESSE in Texas", "boundedAnswer": "SCENESSE in Texas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-utah", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Utah", "stateSlug": "utah", "searchQuery": "SCENESSE in Utah", "boundedAnswer": "SCENESSE in Utah begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-vermont", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "SCENESSE in Vermont", "boundedAnswer": "SCENESSE in Vermont begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-virginia", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "SCENESSE in Virginia", "boundedAnswer": "SCENESSE in Virginia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-washington", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Washington", "stateSlug": "washington", "searchQuery": "SCENESSE in Washington", "boundedAnswer": "SCENESSE in Washington begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-west-virginia", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "SCENESSE in West Virginia", "boundedAnswer": "SCENESSE in West Virginia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-wisconsin", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "SCENESSE in Wisconsin", "boundedAnswer": "SCENESSE in Wisconsin begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-scenesse-wyoming", "compound": "SCENESSE", "compoundSlug": "scenesse", "compoundAliases": [ "afamelanotide", "Scenesse", "CUV1647", "NDA 210797", "alpha-MSH analog", "Scenesse by country", "afamelanotide implant", "afamelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA and EU medicine records", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "SCENESSE in Wyoming", "boundedAnswer": "SCENESSE in Wyoming begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/scenesse", "identitySourceLabel": "Current SCENESSE prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/scenesse/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/scenesse/countries" }, { "recordId": "pl-compound-state-vyleesi-alabama", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Alabama", "stateSlug": "alabama", "searchQuery": "VYLEESI in Alabama", "boundedAnswer": "VYLEESI in Alabama begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "Alabama Board of Pharmacy", "stateRecordUrl": "https://albop.igovsolution.net/online/Lookups/Individual_Lookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#alabama", "stateGuideUrl": "https://peptidelocal.com/locations/alabama", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-alaska", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Alaska", "stateSlug": "alaska", "searchQuery": "VYLEESI in Alaska", "boundedAnswer": "VYLEESI in Alaska begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Professional license search", "stateRecordPublisher": "Alaska Department of Commerce, Community and Economic Development", "stateRecordUrl": "https://www.commerce.alaska.gov/cbp/main/Search/Professional", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#alaska", "stateGuideUrl": "https://peptidelocal.com/locations/alaska", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-arizona", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Arizona", "stateSlug": "arizona", "searchQuery": "VYLEESI in Arizona", "boundedAnswer": "VYLEESI in Arizona begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "License and permit verification", "stateRecordPublisher": "Arizona State Board of Pharmacy", "stateRecordUrl": "https://pharmacy.az.gov/", "supportingRecordLabel": "Primary-source license verification guidance", "supportingRecordPublisher": "Arizona State Board of Pharmacy", "supportingRecordUrl": "https://pharmacy.az.gov/apply-new-license-or-registration", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#arizona", "stateGuideUrl": "https://peptidelocal.com/locations/arizona", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-arkansas", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Arkansas", "stateSlug": "arkansas", "searchQuery": "VYLEESI in Arkansas", "boundedAnswer": "VYLEESI in Arkansas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Pharmacy roster search and license verification", "stateRecordPublisher": "Arkansas State Board of Pharmacy", "stateRecordUrl": "https://healthy.arkansas.gov/boards-commissions/boards/pharmacy-arkansas-state-board/asbp-online-services/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#arkansas", "stateGuideUrl": "https://peptidelocal.com/locations/arkansas", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-california", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "California", "stateSlug": "california", "searchQuery": "VYLEESI in California", "boundedAnswer": "VYLEESI in California begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "License verification", "stateRecordPublisher": "California State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.ca.gov/about/verify_lic.shtml", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#california", "stateGuideUrl": "https://peptidelocal.com/locations/california", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-colorado", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Colorado", "stateSlug": "colorado", "searchQuery": "VYLEESI in Colorado", "boundedAnswer": "VYLEESI in Colorado begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Business and professional license lookup", "stateRecordPublisher": "Colorado Department of Regulatory Agencies", "stateRecordUrl": "https://dora.colorado.gov/check-a-license", "supportingRecordLabel": "Colorado Pharmacy Board", "supportingRecordPublisher": "Colorado Division of Professions and Occupations", "supportingRecordUrl": "https://dpo.colorado.gov/Pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#colorado", "stateGuideUrl": "https://peptidelocal.com/locations/colorado", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-connecticut", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Connecticut", "stateSlug": "connecticut", "searchQuery": "VYLEESI in Connecticut", "boundedAnswer": "VYLEESI in Connecticut begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "eLicense pharmacy lookup", "stateRecordPublisher": "Connecticut Department of Consumer Protection", "stateRecordUrl": "https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#connecticut", "stateGuideUrl": "https://peptidelocal.com/locations/connecticut", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-delaware", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Delaware", "stateSlug": "delaware", "searchQuery": "VYLEESI in Delaware", "boundedAnswer": "VYLEESI in Delaware begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "DelPROS license lookup", "stateRecordPublisher": "Delaware Division of Professional Regulation", "stateRecordUrl": "https://delpros.delaware.gov/OH_VerifyLicense", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#delaware", "stateGuideUrl": "https://peptidelocal.com/locations/delaware", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-florida", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Florida", "stateSlug": "florida", "searchQuery": "VYLEESI in Florida", "boundedAnswer": "VYLEESI in Florida begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Health license lookup", "stateRecordPublisher": "Florida Department of Health", "stateRecordUrl": "https://mqa-internet.doh.state.fl.us/MQASearchServices/HealthCareProviders", "supportingRecordLabel": "Safe online pharmacy guidance", "supportingRecordPublisher": "U.S. FDA BeSafeRx", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#florida", "stateGuideUrl": "https://peptidelocal.com/locations/florida", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-georgia", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Georgia", "stateSlug": "georgia", "searchQuery": "VYLEESI in Georgia", "boundedAnswer": "VYLEESI in Georgia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Facility license verification", "stateRecordPublisher": "Georgia Secretary of State", "stateRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx?facility=Y", "supportingRecordLabel": "Professional license verification", "supportingRecordPublisher": "Georgia Secretary of State", "supportingRecordUrl": "https://verify.sos.ga.gov/verification/Search.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#georgia", "stateGuideUrl": "https://peptidelocal.com/locations/georgia", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-hawaii", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Hawaii", "stateSlug": "hawaii", "searchQuery": "VYLEESI in Hawaii", "boundedAnswer": "VYLEESI in Hawaii begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Professional and vocational license search", "stateRecordPublisher": "Hawaii Department of Commerce and Consumer Affairs", "stateRecordUrl": "https://pvl.ehawaii.gov/pvlsearch/app", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#hawaii", "stateGuideUrl": "https://peptidelocal.com/locations/hawaii", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-idaho", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Idaho", "stateSlug": "idaho", "searchQuery": "VYLEESI in Idaho", "boundedAnswer": "VYLEESI in Idaho begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Division of Occupational and Professional Licenses search", "stateRecordPublisher": "Idaho Division of Occupational and Professional Licenses", "stateRecordUrl": "https://edopl.idaho.gov/OnlineServices/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#idaho", "stateGuideUrl": "https://peptidelocal.com/locations/idaho", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-illinois", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Illinois", "stateSlug": "illinois", "searchQuery": "VYLEESI in Illinois", "boundedAnswer": "VYLEESI in Illinois begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Pharmacy program and license lookup", "stateRecordPublisher": "Illinois Department of Financial and Professional Regulation", "stateRecordUrl": "https://idfpr.illinois.gov/profs/pharm.html", "supportingRecordLabel": "Active license report and verification note", "supportingRecordPublisher": "Illinois Department of Financial and Professional Regulation", "supportingRecordUrl": "https://idfpr.illinois.gov/dpr/active-license-report.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#illinois", "stateGuideUrl": "https://peptidelocal.com/locations/illinois", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-indiana", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Indiana", "stateSlug": "indiana", "searchQuery": "VYLEESI in Indiana", "boundedAnswer": "VYLEESI in Indiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Free Search & Verify", "stateRecordPublisher": "Indiana Professional Licensing Agency", "stateRecordUrl": "https://mylicense.in.gov/EVerification/Search.aspx", "supportingRecordLabel": "License discipline search", "supportingRecordPublisher": "Indiana Professional Licensing Agency", "supportingRecordUrl": "https://www.in.gov/ai/appfiles/pla-litigation/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#indiana", "stateGuideUrl": "https://peptidelocal.com/locations/indiana", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-iowa", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Iowa", "stateSlug": "iowa", "searchQuery": "VYLEESI in Iowa", "boundedAnswer": "VYLEESI in Iowa begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "Iowa Board of Pharmacy", "stateRecordUrl": "https://ibop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#iowa", "stateGuideUrl": "https://peptidelocal.com/locations/iowa", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-kansas", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Kansas", "stateSlug": "kansas", "searchQuery": "VYLEESI in Kansas", "boundedAnswer": "VYLEESI in Kansas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy license portal", "stateRecordPublisher": "Kansas Board of Pharmacy", "stateRecordUrl": "https://ksbop.elicensesoftware.com/portal.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#kansas", "stateGuideUrl": "https://peptidelocal.com/locations/kansas", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-kentucky", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Kentucky", "stateSlug": "kentucky", "searchQuery": "VYLEESI in Kentucky", "boundedAnswer": "VYLEESI in Kentucky begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy licensing hub", "stateRecordPublisher": "Kentucky Board of Pharmacy", "stateRecordUrl": "https://pharmacy.ky.gov/Pages/index.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#kentucky", "stateGuideUrl": "https://peptidelocal.com/locations/kentucky", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-louisiana", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Louisiana", "stateSlug": "louisiana", "searchQuery": "VYLEESI in Louisiana", "boundedAnswer": "VYLEESI in Louisiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Louisiana Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.la.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#louisiana", "stateGuideUrl": "https://peptidelocal.com/locations/louisiana", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-maine", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Maine", "stateSlug": "maine", "searchQuery": "VYLEESI in Maine", "boundedAnswer": "VYLEESI in Maine begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy licensing and verification", "stateRecordPublisher": "Maine Office of Professional and Occupational Regulation", "stateRecordUrl": "https://www.maine.gov/pfr/professionallicensing/professions/board-pharmacy", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#maine", "stateGuideUrl": "https://peptidelocal.com/locations/maine", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-maryland", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Maryland", "stateSlug": "maryland", "searchQuery": "VYLEESI in Maryland", "boundedAnswer": "VYLEESI in Maryland begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Maryland Board of Pharmacy", "stateRecordUrl": "https://mdbop.mylicense.com/Verification/Search.aspx?facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#maryland", "stateGuideUrl": "https://peptidelocal.com/locations/maryland", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-massachusetts", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Massachusetts", "stateSlug": "massachusetts", "searchQuery": "VYLEESI in Massachusetts", "boundedAnswer": "VYLEESI in Massachusetts begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Health profession license verification", "stateRecordPublisher": "Massachusetts Bureau of Health Professions Licensure", "stateRecordUrl": "https://www.mass.gov/info-details/check-a-health-profession-license", "supportingRecordLabel": "Board of Registration in Pharmacy", "supportingRecordPublisher": "Massachusetts Department of Public Health", "supportingRecordUrl": "https://www.mass.gov/orgs/board-of-registration-in-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#massachusetts", "stateGuideUrl": "https://peptidelocal.com/locations/massachusetts", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-michigan", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Michigan", "stateSlug": "michigan", "searchQuery": "VYLEESI in Michigan", "boundedAnswer": "VYLEESI in Michigan begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "LARA licensee search", "stateRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "stateRecordUrl": "https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?TabName=APO&isLicensee=Y", "supportingRecordLabel": "Health license disciplinary action reports", "supportingRecordPublisher": "Michigan Department of Licensing and Regulatory Affairs", "supportingRecordUrl": "https://www.michigan.gov/lara/bureau-list/bpl/health/dar-reports-health/health-license-disciplinary-action-reports", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#michigan", "stateGuideUrl": "https://peptidelocal.com/locations/michigan", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-minnesota", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Minnesota", "stateSlug": "minnesota", "searchQuery": "VYLEESI in Minnesota", "boundedAnswer": "VYLEESI in Minnesota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy entity search", "stateRecordPublisher": "Minnesota Board of Pharmacy", "stateRecordUrl": "https://pha.hlb.state.mn.us/#/onlineEntitySearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#minnesota", "stateGuideUrl": "https://peptidelocal.com/locations/minnesota", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-mississippi", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Mississippi", "stateSlug": "mississippi", "searchQuery": "VYLEESI in Mississippi", "boundedAnswer": "VYLEESI in Mississippi begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Mississippi Board of Pharmacy", "stateRecordUrl": "https://gateway.mbp.ms.gov/Verification/search.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#mississippi", "stateGuideUrl": "https://peptidelocal.com/locations/mississippi", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-missouri", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Missouri", "stateSlug": "missouri", "searchQuery": "VYLEESI in Missouri", "boundedAnswer": "VYLEESI in Missouri begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "MOPRO license search", "stateRecordPublisher": "Missouri Division of Professional Registration", "stateRecordUrl": "https://mopro.mo.gov/license/s/license-search", "supportingRecordLabel": "Board disciplinary actions", "supportingRecordPublisher": "Missouri Board of Pharmacy", "supportingRecordUrl": "https://pr.mo.gov/boards/pharmacy/orders/Disciplinary%20Actions.pdf", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#missouri", "stateGuideUrl": "https://peptidelocal.com/locations/missouri", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-montana", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Montana", "stateSlug": "montana", "searchQuery": "VYLEESI in Montana", "boundedAnswer": "VYLEESI in Montana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Public license search", "stateRecordPublisher": "Montana Department of Labor and Industry", "stateRecordUrl": "https://ebizws.mt.gov/PUBLICPORTAL/searchform?mylist=licenses", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#montana", "stateGuideUrl": "https://peptidelocal.com/locations/montana", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-nebraska", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Nebraska", "stateSlug": "nebraska", "searchQuery": "VYLEESI in Nebraska", "boundedAnswer": "VYLEESI in Nebraska begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Health license information search", "stateRecordPublisher": "Nebraska Department of Health and Human Services", "stateRecordUrl": "https://www.nebraska.gov/hhs/lists/search.cgi", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#nebraska", "stateGuideUrl": "https://peptidelocal.com/locations/nebraska", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-nevada", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Nevada", "stateSlug": "nevada", "searchQuery": "VYLEESI in Nevada", "boundedAnswer": "VYLEESI in Nevada begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "License verification", "stateRecordPublisher": "Nevada State Board of Pharmacy", "stateRecordUrl": "https://bop.nv.gov/resources/ALL/License_Verification/", "supportingRecordLabel": "Approved pharmacy websites", "supportingRecordPublisher": "Nevada State Board of Pharmacy", "supportingRecordUrl": "https://bop.nv.gov/services/Approved_Pharmacy_Websites/", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#nevada", "stateGuideUrl": "https://peptidelocal.com/locations/nevada", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-new-hampshire", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "New Hampshire", "stateSlug": "new-hampshire", "searchQuery": "VYLEESI in New Hampshire", "boundedAnswer": "VYLEESI in New Hampshire begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Pharmacy facility license verification", "stateRecordPublisher": "New Hampshire Office of Professional Licensure and Certification", "stateRecordUrl": "https://forms.nh.gov/licenseverification/Search.aspx?facility=", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#new-hampshire", "stateGuideUrl": "https://peptidelocal.com/locations/new-hampshire", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-new-jersey", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "New Jersey", "stateSlug": "new-jersey", "searchQuery": "VYLEESI in New Jersey", "boundedAnswer": "VYLEESI in New Jersey begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Real-time license verification", "stateRecordPublisher": "New Jersey Division of Consumer Affairs", "stateRecordUrl": "https://newjersey.mylicense.com/verification/", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "New Jersey Division of Consumer Affairs", "supportingRecordUrl": "https://www.njconsumeraffairs.gov/phar/Pages/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#new-jersey", "stateGuideUrl": "https://peptidelocal.com/locations/new-jersey", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-new-mexico", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "New Mexico", "stateSlug": "new-mexico", "searchQuery": "VYLEESI in New Mexico", "boundedAnswer": "VYLEESI in New Mexico begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Regulation and Licensing public search", "stateRecordPublisher": "New Mexico Regulation and Licensing Department", "stateRecordUrl": "https://nmrldlpi.my.site.com/bcd/s/rld-public-search", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#new-mexico", "stateGuideUrl": "https://peptidelocal.com/locations/new-mexico", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-new-york", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "New York", "stateSlug": "new-york", "searchQuery": "VYLEESI in New York", "boundedAnswer": "VYLEESI in New York begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Online license and establishment verification", "stateRecordPublisher": "New York State Education Department", "stateRecordUrl": "https://www.op.nysed.gov/services/verifications/online-verification-searches", "supportingRecordLabel": "Pharmacist and pharmacy-establishment portal", "supportingRecordPublisher": "New York State Education Department", "supportingRecordUrl": "https://www.op.nysed.gov/pharmacist", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#new-york", "stateGuideUrl": "https://peptidelocal.com/locations/new-york", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-north-carolina", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "North Carolina", "stateSlug": "north-carolina", "searchQuery": "VYLEESI in North Carolina", "boundedAnswer": "VYLEESI in North Carolina begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "License and permit verification portal", "stateRecordPublisher": "North Carolina Board of Pharmacy", "stateRecordUrl": "https://portal.ncbop.org/Verification/", "supportingRecordLabel": "Disciplinary action search", "supportingRecordPublisher": "North Carolina Board of Pharmacy", "supportingRecordUrl": "https://portal.ncbop.org/Discipline/actions.aspx", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#north-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/north-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-north-dakota", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "North Dakota", "stateSlug": "north-dakota", "searchQuery": "VYLEESI in North Dakota", "boundedAnswer": "VYLEESI in North Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "North Dakota Board of Pharmacy", "stateRecordUrl": "https://www.nodakpharmacy.com/verify.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#north-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/north-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-ohio", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Ohio", "stateSlug": "ohio", "searchQuery": "VYLEESI in Ohio", "boundedAnswer": "VYLEESI in Ohio begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Ohio professional and business license look-up", "stateRecordPublisher": "eLicense Ohio", "stateRecordUrl": "https://elicense.ohio.gov/OH_VerifyLicense", "supportingRecordLabel": "Board of Pharmacy actions", "supportingRecordPublisher": "State of Ohio Board of Pharmacy", "supportingRecordUrl": "https://www.pharmacy.ohio.gov/Pubs/BoardActions", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#ohio", "stateGuideUrl": "https://peptidelocal.com/locations/ohio", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-oklahoma", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Oklahoma", "stateSlug": "oklahoma", "searchQuery": "VYLEESI in Oklahoma", "boundedAnswer": "VYLEESI in Oklahoma begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy facility search", "stateRecordPublisher": "Oklahoma State Board of Pharmacy", "stateRecordUrl": "https://lv.pharmacy.ok.gov/osbpinquire/FacilitySearch.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#oklahoma", "stateGuideUrl": "https://peptidelocal.com/locations/oklahoma", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-oregon", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Oregon", "stateSlug": "oregon", "searchQuery": "VYLEESI in Oregon", "boundedAnswer": "VYLEESI in Oregon begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy facility verification", "stateRecordPublisher": "Oregon Board of Pharmacy", "stateRecordUrl": "https://orbop.mylicense.com/verification/Search.aspx?Facility=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#oregon", "stateGuideUrl": "https://peptidelocal.com/locations/oregon", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-pennsylvania", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Pennsylvania", "stateSlug": "pennsylvania", "searchQuery": "VYLEESI in Pennsylvania", "boundedAnswer": "VYLEESI in Pennsylvania begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Professional and occupational license verification", "stateRecordPublisher": "Pennsylvania Department of State", "stateRecordUrl": "https://www.pa.gov/services/dos/verify-a-professional-or-occupational-license", "supportingRecordLabel": "State Board of Pharmacy", "supportingRecordPublisher": "Pennsylvania Department of State", "supportingRecordUrl": "https://www.pa.gov/agencies/dos/department-and-offices/bpoa/boards-commissions/pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#pennsylvania", "stateGuideUrl": "https://peptidelocal.com/locations/pennsylvania", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-rhode-island", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Rhode Island", "stateSlug": "rhode-island", "searchQuery": "VYLEESI in Rhode Island", "boundedAnswer": "VYLEESI in Rhode Island begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Health license verification", "stateRecordPublisher": "Rhode Island Department of Health", "stateRecordUrl": "https://healthri.mylicense.com/Verification/Search.aspx?facility=Y&SubmitComplaint=Y", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#rhode-island", "stateGuideUrl": "https://peptidelocal.com/locations/rhode-island", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-south-carolina", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "South Carolina", "stateSlug": "south-carolina", "searchQuery": "VYLEESI in South Carolina", "boundedAnswer": "VYLEESI in South Carolina begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy license lookup", "stateRecordPublisher": "South Carolina Department of Labor, Licensing and Regulation", "stateRecordUrl": "https://verify.llronline.com/LicLookup/Pharmacy/Pharmacy.aspx?div=24", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#south-carolina", "stateGuideUrl": "https://peptidelocal.com/locations/south-carolina", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-south-dakota", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "South Dakota", "stateSlug": "south-dakota", "searchQuery": "VYLEESI in South Dakota", "boundedAnswer": "VYLEESI in South Dakota begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy business lookup", "stateRecordPublisher": "South Dakota Board of Pharmacy", "stateRecordUrl": "https://sdbop.igovsolution.net/online/Lookups/LookUp_Business.aspx", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#south-dakota", "stateGuideUrl": "https://peptidelocal.com/locations/south-dakota", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-tennessee", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Tennessee", "stateSlug": "tennessee", "searchQuery": "VYLEESI in Tennessee", "boundedAnswer": "VYLEESI in Tennessee begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Health licensure verification", "stateRecordPublisher": "Tennessee Department of Health", "stateRecordUrl": "https://internet.health.tn.gov/Licensure/default.aspx", "supportingRecordLabel": "Tennessee Board of Pharmacy", "supportingRecordPublisher": "Tennessee Department of Health", "supportingRecordUrl": "https://www.tn.gov/health/health-program-areas/health-professional-boards/pharmacy-board.html", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#tennessee", "stateGuideUrl": "https://peptidelocal.com/locations/tennessee", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-texas", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Texas", "stateSlug": "texas", "searchQuery": "VYLEESI in Texas", "boundedAnswer": "VYLEESI in Texas begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Pharmacy license search", "stateRecordPublisher": "Texas State Board of Pharmacy", "stateRecordUrl": "https://www.pharmacy.texas.gov/dbsearch/phy_search.asp", "supportingRecordLabel": "Peptide compounding safety risks", "supportingRecordPublisher": "U.S. FDA", "supportingRecordUrl": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#texas", "stateGuideUrl": "https://peptidelocal.com/locations/texas", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-utah", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Utah", "stateSlug": "utah", "searchQuery": "VYLEESI in Utah", "boundedAnswer": "VYLEESI in Utah begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Division of Professional Licensing search", "stateRecordPublisher": "Utah Division of Professional Licensing", "stateRecordUrl": "https://secure.utah.gov/llv/search/index.html", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#utah", "stateGuideUrl": "https://peptidelocal.com/locations/utah", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-vermont", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Vermont", "stateSlug": "vermont", "searchQuery": "VYLEESI in Vermont", "boundedAnswer": "VYLEESI in Vermont begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Office of Professional Regulation license lookup", "stateRecordPublisher": "Vermont Office of Professional Regulation", "stateRecordUrl": "https://secure.professionals.vermont.gov/prweb/PRServletCustom/app/NGLPGuestUser_/V9csDxL3sXkkjMC_FR2HrA*/!STANDARD?UserIdentifier=LicenseLookupGuestUser", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#vermont", "stateGuideUrl": "https://peptidelocal.com/locations/vermont", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-virginia", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Virginia", "stateSlug": "virginia", "searchQuery": "VYLEESI in Virginia", "boundedAnswer": "VYLEESI in Virginia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "DHP License Lookup", "stateRecordPublisher": "Virginia Department of Health Professions", "stateRecordUrl": "https://dhp.virginiainteractive.org/Lookup/Index", "supportingRecordLabel": "Board of Pharmacy case decisions", "supportingRecordPublisher": "Virginia Department of Health Professions", "supportingRecordUrl": "https://www.dhp.virginia.gov/enforcement/cdecision/boardresults.asp?board=2&send=View", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#virginia", "stateGuideUrl": "https://peptidelocal.com/locations/virginia", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-washington", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Washington", "stateSlug": "washington", "searchQuery": "VYLEESI in Washington", "boundedAnswer": "VYLEESI in Washington begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Provider credential or facility search", "stateRecordPublisher": "Washington State Department of Health", "stateRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/provider-credential-or-facility-search", "supportingRecordLabel": "Pharmacy and pharmaceutical-firm licensing", "supportingRecordPublisher": "Washington State Department of Health", "supportingRecordUrl": "https://doh.wa.gov/licenses-permits-and-certificates/facilities-z/pharmacies-and-pharmaceutical-firms/licensing-information", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#washington", "stateGuideUrl": "https://peptidelocal.com/locations/washington", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-west-virginia", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "West Virginia", "stateSlug": "west-virginia", "searchQuery": "VYLEESI in West Virginia", "boundedAnswer": "VYLEESI in West Virginia begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy public verification", "stateRecordPublisher": "West Virginia Board of Pharmacy", "stateRecordUrl": "https://www.wvbop.com/public/verify/index.asp", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#west-virginia", "stateGuideUrl": "https://peptidelocal.com/locations/west-virginia", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-wisconsin", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Wisconsin", "stateSlug": "wisconsin", "searchQuery": "VYLEESI in Wisconsin", "boundedAnswer": "VYLEESI in Wisconsin begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "License search", "stateRecordPublisher": "Wisconsin Department of Safety and Professional Services", "stateRecordUrl": "https://app.wi.gov/licensesearch", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#wisconsin", "stateGuideUrl": "https://peptidelocal.com/locations/wisconsin", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" }, { "recordId": "pl-compound-state-vyleesi-wyoming", "compound": "VYLEESI", "compoundSlug": "vyleesi", "compoundAliases": [ "bremelanotide", "Vyleesi", "PT-141", "NDA 210557", "melanocortin receptor agonist", "Vyleesi by country", "bremelanotide medicine", "bremelanotida" ], "evidenceLane": "FDA-approved medicine", "identityStatus": "Product-specific FDA-approved US medicine record", "state": "Wyoming", "stateSlug": "wyoming", "searchQuery": "VYLEESI in Wyoming", "boundedAnswer": "VYLEESI in Wyoming begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.", "reviewedDate": "2026-07-20", "identityRecordUrl": "https://peptidelocal.com/medicines/vyleesi", "identitySourceLabel": "Current VYLEESI prescribing information", "identitySourcePublisher": "National Library of Medicine, DailyMed", "identitySourceUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf", "stateRecordLabel": "Board of Pharmacy license verification", "stateRecordPublisher": "Wyoming State Board of Pharmacy", "stateRecordUrl": "https://pharmacyboard.wyo.gov/", "supportingRecordLabel": "Locate a state-licensed online pharmacy", "supportingRecordPublisher": "U.S. Food and Drug Administration", "supportingRecordUrl": "https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy", "canonicalAtlasUrl": "https://peptidelocal.com/peptides/vyleesi/us-states#wyoming", "stateGuideUrl": "https://peptidelocal.com/locations/wyoming", "countryMapUrl": "https://peptidelocal.com/peptides/vyleesi/countries" } ] }